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Chapter 1: Introduction 
1.1 Bacterial nucleotide-based second messengers 
Signal transduction is an important mechanism in bacteria in order to adapt to environmental 
changes. Key components are nucleotide-based second messengers that are synthesized upon 
signal sensing. Bacteria possess a plethora of signal transduction systems, many comprising 
signal receptors associated with the cell membrane in order to sense extracellular signals 
(Goudreau and Stock 1998). 
In the late 1950s during intensive studies of the hormone epinephrine (also known as adrena-
line) the first nucleotide-based second messenger cyclic AMP (cAMP) was discovered which 
leads to hormone-induced changes in the metabolism of mammalian cells. Directly afterwards, 
cAMP was identified in bacterial cells, linked to catabolic repression (Makman and Sutherland 
1964; Ullmann and Monod 1968; Brückner and Titgemeyer 2002). Shortly after the allomone 
guanosine-(penta)-tetraphosphate ((p)ppGpp) was discovered in E.coli to appear in response 
to nutrition limitation (Cashel and Gallant 1969). These discoveries set the foundation of a 
simple model which is considered as todays central dogma of signal transduction in cells 
(Sutherland and Rall 1957; Rall and Sutherland 1958). Thirty years after cAMP was discovered 
the existence of the first cyclic dinucleotide bis-(3’,5’)-cyclic di-guanosine monophosphate 
(cyclic di-GMP/c-di-GMP) was reported (Ross et al. 1987). Due to the high research interest 
on c-di-GMP it became one of the most comprehensively studied secondary nucleotides. It is 
a ubiquitous bacterial second messenger which is in general involved in different physiological 
functions including cell differentiation, flagella motility, biofilm formation, virulence and other 
processes (Jenal 2004; Cotter and Stibitz 2007; Hengge 2009; Romling et al. 2013). 
Over the past few years a wealth of different nucleotide-based secondary metabolites was de-
scribed comprising linear and cyclic nucleotides as well as cyclic di- and tri- nucleotides 
(Pesavento and Hengge 2009; Severin and Waters 2019; Whiteley et al. 2019). A biological 
relevance of the bacterial second messenger bis-(3'-5')-cyclic dimeric adenosine monophos-
phate (cyclic di-AMP/c-di-AMP) was initially discovered in 2008 during structural analyses of 
the DNA integrity scanning protein DisA from Thermotoga maritima. Thenceforward, DisA 
was described as the first diadenylate cyclase (DAC) synthesizing c-di-AMP. Subsequently c-
di-AMP was shown to be produced by a variety of different proteins (Witte et al. 2008; 
Commichau et al. 2019).  
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1.2 C-di-AMP a nucleotide-based second messenger  
Since the discovery of c-di-AMP the research interest on its synthesis and function has in-
creased rapidly (Corrigan R. M. and Gründling 2013; Commichau et al. 2015a; Commichau et 
al. 2019). The community around secondary metabolites ascertained quickly the enormous po-
tential of this small molecule among other known second messengers, not least due to its 
uniqueness of being essential. Like c-di-GMP, c-di-AMP is carrying two nucleotide moieties 
(adenine moiety) that are linked by 3’-5’ phosphodiester bond forming a ribose-phosphate ring 
(Romling et al. 2013; He et al. 2020).  
Several studies referred to c-di-AMP as the only known essential signaling nucleotide (under 
standard conditions) due to its important role in potassium homeostasis and osmotic adaptation, 
yet an extensive excess is harmful to the cell (Woodward et al. 2010; Luo Y and Helmann 
2012; Mehne et al. 2013; Gundlach et al. 2015a; Commichau et al. 2017; Gundlach et al. 2017a; 
Gundlach et al. 2017b; Commichau et al. 2019). However, it is not only an important compo-
nent in osmoregulation, it is also involved in a plethora of different physiological functions 
(Corrigan Rebecca M and Gründling 2013; Commichau et al. 2019). Furthermore, c-di-AMP 
is known to be the first secondary metabolite to regulate a biological process on two distinct 
levels, namely protein expression and protein activity (Nelson et al. 2013; Gundlach et al. 
2017b; Gundlach et al. 2019). Over the years the presence of c-di-AMP in pathogenic bacteria 
expressing a diadenylate cyclase was reported in several studies, however, its existence in hu-
man cells could not be verified so far. The importance of c-di-AMP for the bacterial survival 
opened new perspectives in antibiotic research since there is an urgent need of new substances 
to control bacterial infections (Song et al. 2005; Woodward et al. 2010; Corrigan et al. 2011; 
Bai et al. 2012). 
c-di-AMP is synthesized out of two ATP molecules by the diadenylate cyclases, releasing two 
pyrophosphates as a side product (PPi). Its degradation into the linear phosphoadenylyl aden-
osine nucleotide (5’pApA) which can be further hydrolyzed to AMP is facilitated by specific 
phosphodiesterases (Rao et al. 2010; Manikandan et al. 2014; Huynh and Woodward 2016; 
Commichau et al. 2019). 
 
1.3 Diadenylate cyclases and c-di-AMP synthesis 
DACs were detected in a wide range of different bacterial species. So far five different classes 
of DACs have been identified (DisA, CdaA, CdaS, CdaM, and CdaZ) many in Gram-positive 
bacteria belonging to the phyla of Firmicutes and Actinobacteria but also in Gram-negative 
bacteria and archaea (Romling 2008; Corrigan Rebecca M and Gründling 2013; Blötz et al. 
2017; Commichau et al. 2019). These different classes of DACs share the highly conserved 
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diadenylate cyclase domain (DAC domain) accompanied by different types of regulatory do-
mains (Fig. 1) (Witte et al. 2008; Corrigan Rebecca M and Gründling 2013; Commichau et al. 




In contrast to many pathogenic bacteria (Listeria monocytogenes, Staphylococcus aureus, 
Staphylococcus pneumonia) that possess only a sole class of DACs, some bacteria are equipped 
with for example three different classes like bacteria of the order Bacillales. Bacillus subtilis 
for instance is known to carry the DAC prototype DisA, a DNA-damage sensing protein 
(Oppenheimer-Shaanan et al. 2011). In response to DNA lesions the synthesis of c-di-AMP is 
reduced leading to a delay in sporulation while an elevated intracellular c-di-AMP level stim-
ulates spore formation (Bejerano-Sagie et al. 2006; Oppenheimer-Shaanan et al. 2011). The 
second DAC type, c-di-AMP synthase S (CdaS), was reported to be exclusively needed for the 
successful germation of spores in the order Bacillales, yet its function and regulation is still not 
well understood (Corrigan Rebecca M and Gründling 2013; Mehne et al. 2013; Mehne et al. 
2014). The third DAC domain protein in B. subtilis is the most abundant and conserved class 
of DACs represented by CdaA (Romling 2008; Luo Y and Helmann 2012). Interestingly the 
deletion of all three DACs is lethal for the survival of B. subtilis emphasizing the essentiality 
of c-di-AMP (Luo Y and Helmann 2012; Bai et al. 2013; Mehne et al. 2013; Witte et al. 2013). 
Thus far, DisA is the only DACs which was crystallized with its product c-di-AMP enabling a 
better understanding of the DAC reaction mechanism. DisA is a homo octamer composed of 
two “head-to-head” tetrameric DAC domain rings and an N-terminal part described as the 
DNA binding domain (HhH domain). The catalytic site is positioned between the interface of 
the tetrameric rings, where two DAC domain monomers are facing each other in order to form 
one reaction center (Fig. 2 A & B) (Witte et al. 2008). Each DAC dimer was described to form 
one c-di-AMP molecule and two pyrophosphates out of two ATP molecules in a metal-ion 
dependent manner (Mg2+or Mn2+). 
Figure 1: Diadenylate cyclase domain 
(DAC domain) organization of the 
different classes. The different do-
mains are characterized by a colour 
code. The highly conserved DAC do-
main is represented in blue. HhH, helix-
hinge-helix domain; TM, transmem-
brane domain; cc, coiled-coil domain; 
H1 and H2, inhibitory helix 1 and 2; 
PYK, pyruvate kinase-like domain 
(modified from Commichau et al. 
2019). 
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By sequence alignment three highly conserved amino acid motifs were identified in the nucle-
otide binding pocket. Structural and biochemical analyses demonstrate the involvement of 
these amino acids in nucleotide binding and catalysis (for DisA: D75GA, T107RHR, S127) (Witte 
et al. 2008). Crystallization of DisA in complex with an ATP analogue enabled the characteri-
zation of its pre-reaction state and the description of a detailed reaction mechanism (Müller et 
al. 2015).  
 
Figure 2: Crystal structure of DisA and active site. (A) Overall octameric DisA (PDB code: 3C21) structure 
with a central DAC domain (molecule A light and molecule B dark blue) and the C-terminal DNA binding HhH 
domain (cyan) depicted as a cartoon model. Both functional domains of the protein are linked by a helical spine 
linker (dark and light grey). (B) DisA cartoon model of the two protomers forming the central, functional DAC 
unit with a bound c-di-AMP. The colour code as described in A (PDB code: 4YVZ). (C) Pre-reaction state with 
bound ATP analogue 3’-deoxyATP and a Mn2+ ion. The ATP is displayed in ball and stick mode (carbon in 
yellow, phosphates in orange, oxygens in red, and nitrogen in blue). Shown are amino acids that are involved in 
metal ion and phosphate coordination. The two DAC domains that are facing each other are coloured in light and 
dark blue. (D) Post-catalytic state with c-di-AMP bound. C-di-AMP is depicted in ball and sticks (carbon in light 
blue and dark blue, phosphates in orange, oxygens in red, and nitrogen in blue). All amino acids involved in purine 
base coordination are shown as sticks.  
 
The N1 nitrogen of the nucleotide adenine is forming a hydrogen bond with the amide of the 
leucine main chain at position 94 while the N6 amine is hydrogen bonded by the leucine main 
chain carbonyl and the threonine 111 side chain (Fig. 2C). The three phosphates of the ATP 
analogue (3’deoxyATP) are bent around a catalytic metal ion. While the b- and g-phosphate 
are additionally coordinated by the Arg108, His109, Ser127 and Arg130 through hydrogen bonds, 
the a-phosphate interacts with Thr107 and Asp75 of the opposite monomer (Fig. 2D). An inter-
action of the g-phosphate with the amino acids Ser127, Arg128 and Arg130 result in its polarization 
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which is described as the preparation of the first reaction step (Müller et al. 2015). The reaction 
mechanism was reported as a two-step synthesis with two transition state complexes (Fig. 3). 
The polarized g-phosphate facilitates the nucleophilic attack of the ribose 3’OH on the a-phos-
phate on the neighboring ATP molecule resulting in the release of the first pyrophosphate and 
the formation of a linearized intermediate (pppApA). The second step is described as an addi-
tional nucleophilic attack of the second ribose 3’OH and a-phosphate which is facilitated by a 
complex formation of the deprotonated pppApA with the catalytic metal ion (Mg2+ or Mn2+). 
This process results in the cyclization of two ATP molecules and therefore the formation of c-
di-AMP (Manikandan et al. 2014). A similar mechanism was also reported for the enzyme 
cyclic GMP-AMP synthase (cGAS) (Ablasser et al. 2013; Kranzusch 2019). 
In comparison to ATP, c-di-AMP is less coordinated. In the pre-catalytic state, the phosphates 
mainly contribute to the coordination of the nucleotide while the post-catalytic state shows less 
interaction points in order to facilitate product release (Fig. 3) (Müller et al. 2015). The guani-
dine group of arginine 108 which is positioned in one of the conserved amino acid patches 
binds the ribose via stacking. In addition, the ribose 3’ hydroxyl is forming a hydrogen bond 
with the amide nitrogen of glycine 76 located in the first conserved amino acid motif (DGA) 
and the aspartic acid 75 is positioned in the vicinity of the phosphate moiety. The adenine 
moiety of c-di-AMP is coordinated as described for the ATP analogue binding (Witte et al. 
2008; Müller et al. 2015). 
 
 
Figure 3: The two-step mechanism of c-di-AMP synthesis. c-di-AMP is synthesized out of two ATP molecules 
in a metal ion-dependent manner. The first synthesis step describes the nucleophilic attack by the 3’OH group of 
one ATP on the a-phosphate of the opposite ATP molecule which results in the intermediate I pppApA and the 
release of PPi. This follows a second synthesis steps, which involves the intermediate II (pppApA in complex 
with Mn2+). A similar nucleophilic attack results in formation of c-di-AMP and the release of PPi. Important 
residues are depicted in stick mode (carbon in light blue, oxygens in red, and nitrogen in blue) generated with 
pymol (modified from Opoku-Temeng C. et al. 2016) (Manikandan et al. 2014, Schrödinger L.L.C. 2010). 
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1.4 The most abundant and conserved diadenylate cyclase 
Many bacteria that are known to synthesize c-di-AMP possess either the DAC class DisA or 
CdaA, whereas the latter is described as the most prevailing DAC domain containing protein 
among different bacterial species (Corrigan et al. 2013; Commichau et al. 2019). In most Fir-
micutes the gene of CdaA is embedded in a well-known and highly conserved gene cluster 
which encodes besides cdaA, the regulatory protein CdaR as well as the glucosamine mutase 
GlmM (Mehne et al. 2013; Rismondo et al. 2016; Zhu et al. 2016). 
CdaA is a membrane bound protein harboring an N-terminal transmembrane domain consisting 
of three a-helices followed by a linker (coiled-coil) connecting the membrane domain and the 
cyclase domain (Fig. 1) (Gundlach et al. 2015a; Rismondo et al. 2016).  
In 2015 the first crystal structure of a truncated L. monocytogenes CdaA monomer in complex 
with an ATP molecule and a bound Mg2+ ion was solved. Protein purification was established 
with a truncated variant due to the transmembrane domain which hampers the solubility suc-
cess. Henceforth, ∆100CdaA referrers to the truncated CdaA variant missing the first 100 
amino acids, composed of the linker (coiled-coil) and the preceding membrane domain. Bio-
chemical characterization of the full length CdaA and also its truncated variants indicated as 
described for DisA a metal ion dependency. In comparison to DisA which shows cyclase ac-
tivity in presence of Mg2+ or Mn2+ ions CdaA exhibits in vitro activity either in presence of the 
divalent metal ions Mn2+ or Co2+ (Witte et al. 2008; Manikandan et al. 2014; Müller et al. 2015; 
Rosenberg et al. 2015).  
In agreement with DisA, also the cyclase domain in CdaA shows an overall globular fold. The 
core of the DAC domain is formed by a slightly twisted b-sheet made of seven parallel and 
antiparallel b-strands (b1-b7) which is surrounded by five a-helices (Fig. 4A) (Rosenberg et 
al. 2015).  
The previous structural and biochemical analysis of DisA suggested a two-step catalytic mech-
anism (Manikandan et al. 2014; Müller et al. 2015). In order to form c-di-AMP two ATP mol-
ecules are required to be positioned in close vicinity which is ensured by two DAC domains 
facing each other (Witte et al. 2008). In line with the solved DisA structure and biochemical 
data a model of a CdaA pair in a face-to-face orientation forming a homodimer was suggested 
(Fig. 4C) (Witte et al. 2008; Rosenberg et al. 2015).  
The nucleotide binding pocket is defined by a-helix 4, the b-strands 1 and 5 as well as several 
loops connecting a1 and b1, a3 and b3, a4 and b4, and b5 and b6. Structural-based sequence 
alignment unveiled three conserved amino acid patches also seen in DisA. The first conserved 
motif consists of a D171GA sequence. In the CdaA dimer model the aspartic acid is positioned 
close to the ATP a-phosphate and the ribose. The adenine moiety in CdaA is coordinated sim-
ilar as described for DisA (CdaA: Thr202, Leu188; DisA: Thr111, Leu94) (Rosenberg et al. 2015). 
Amino acid motif two (GTR203HR) possesses an arginine 203 which stacks against the ribose 
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with its guanidine group. The third and last amino patch embodies the conserved serine 222 
followed by two glutamic acids 223 and 224 which take over the function of the two arginine 
128 and 130 in DisA to coordinate the catalytic metal ion and the b- and g-phosphate. Addi-
tionally, the histidine 204 in CdaA contributes to the coordination of the phosphates as it was 
reported for the ATP analogue in DisA (Fig. 4B). In summary, the amino acid arrangement in 
the nucleotide binding center is similar to that in DisA from T. maritima. Also, sequence align-
ment of DACs from different organisms suggest the presence of these described amino acids 
that importantly contribute to ATP and c-di-AMP binding. Taken together these findings em-
phasize a similar synthesis mechanism between different classes of DACs which explains the 
high conservation.  
 
Figure 4: Crystal structure of CdaA. (A) Overall structure of the truncated ∆100CdaA. CdaA shows an overall 
globular fold with a slightly twisted b-sheet which is surrounded by five a-helices. The protein structure is de-
picted in cartoon mode in dark blue and the surface is represented in light blue. (B) Nucleotide binding site in 
CdaA. The bound ATP is depicted in ball and sticks mode (carbon in yellow, phosphates in orange, oxygens in 
red, and nitrogen in blue). The Mg2+ is represented as green sphere. All amino acids are shown that contribute to 
ATP binding. The dashed lines represent binding interactions of up to 3.2 Å. (C) The CdaA dimer model was 
generated by superposition of the DisA dimer. The two DAC domain monomers are coloured dark and light blue. 
In the interface two bound ATPs are oriented antiparallel to each other.  
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1.5 Regulation of c-di-AMP synthesis in CdaA 
The intracellular c-di-AMP level needs to be tightly controlled. Even though its synthesis is 
crucial for some bacteria to grow, an excessive accumulation is equally harmful (Mehne et al. 
2013; Gundlach et al. 2015a). Since the gene encoding CdaA is embedded upstream of CdaR 
and GlmM in a conserved gene cluster a direct interaction and functional relation between these 
proteins was suggested and proven in several studies (Corrigan et al. 2011; Luo Y and Helmann 
2012; Witte et al. 2013).  
CdaR is described as a CdaA regulator containing four similar YbbR domains of unknown 
function as well as an N-terminal transmembrane domain (Barb et al. 2010). An in silico mem-
brane topology prediction suggested the location of CdaR outside the cell (Corrigan Rebecca 
M and Gründling 2013). Furthermore, it has been shown that CdaR is able to interact with itself 
via the YbbR domain but also with the full-length CdaA and has an influence on the intracel-
lular c-di-AMP level (Luo Y and Helmann 2012; Gundlach et al. 2015a). On the one hand 
CdaR was described to negatively affect the CdaA activity (L. monocytogenes, S. aureus and 
Lactococcus lacti) (Gundlach et al. 2015a; Bowman et al. 2016; Rismondo et al. 2016) yet on 
the other hand it shows a stimulating effect (B. subtilis) (Mehne et al. 2013). So far, a conclu-
sive role of CdaR and whether it acts as a signaling receptor is unknown. Even structural data 
of the CdaR YbbR domain I and IV did not suggest a putative function (Barb et al. 2010; 
Corrigan Rebecca M and Gründling 2013).  
The second protein suggested to be involved in CdaA regulation is the cytosolic phosphoglu-
cosamine mutase GlmM which is required for cell wall synthesis. GlmM catalyzes glucosa-
mine-6-phosphate into glucosamine-1-phospahate, an early intermediate of the peptidoglycan 
biosynthesis (Mengin-Lecreulx and Van Heijenoort 1996; Barreteau et al. 2008). Previously a 
physical interaction between CdaA and GlmM was reported which was in comparison to the 
strong CdaA-CdaR interaction described as weak but significant (Mehne et al. 2013; Gundlach 
et al. 2015a). An osmoresistance study in L. lactis unveiled a suppressor mutant strain carrying 
a mutation in the GlmM protein resulting in a decrease of the intracellular c-di-AMP concen-
tration. This proves a functional relevance of the GlmM-CdaA interaction and describes GlmM 
as a negative effector of CdaA (Zhu et al. 2016).  
The intracellular c-di-AMP level is not only regulated through the regulation of its synthesizing 
enzyme CdaA but also through other mechanisms like degradation or secretion (Commichau 
et al. 2015b). Specific phosphodiesterases (PDE) are known to degrade c-di-AMP via hydrol-
ysis similar to the two-step mechanism described for c-di-AMP synthesis (Manikandan et al. 
2014). Four classes of PDEs have been identified (Commichau et al. 2019). L. monocytogenes 
and B. subtilis possess the two main PDEs, the GdpP-type (in lmoPdeA) and PgpH-type. 
Orthologs of the GdpP-type PDE have been identified in a plethora of different Firmicutes 
(Rao et al. 2011). A deletion or depletion was described to result in an increased c-di-AMP 
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level accountable for increased resistance to b-lactam antibiotics (Corrigan et al. 2011; Luo Y 
and Helmann 2012; Witte et al. 2013). 
The GdpP-type PDE belongs to the DHH/DHHA1 domain family and carries two transmem-
brane domains followed by a Per-Arnt-Sim (PAS) domain and a highly modified GGDEF do-
main preceding the catalytic DHH/DHHA1 domain degrading c-di-AMP in a metal ion de-
pendent manner (Rao et al. 2010). GGDEF domains were previously reported as the functional 
domain of diguanylate cyclases catalyzing the reaction of two GTP molecules to c-di-GMP 
(Hengge 2009). In the described phosphodiesterase this domain is missing the conserved 
GGDEF motif and is lacking cyclase activity. Instead it exhibits ATPase activity with an un-
defined physiological role (Rao et al. 2010). A binding of b-type heme to the regulatory PAS 
domain has been demonstrated to have an inhibitory effect on the GGDEF and DHH/DHHA1 
domains, respectively (Rao et al. 2011). In addition, the alamone ppGpp which is known to be 
elevated during the stringent response has been described to competitively inhibit the 
DHH/DHHA1 activity linking the c-di-AMP and ppGpp signaling pathways (Rao et al. 2010). 
The second type of PDEs present in L. monocytogenes and B. subtilis are the PgpH-type spe-
cifically degrading c-di-AMP. These enzymes consist of an extracellular seven-transmembrane 
helix-HDED domain (7TMR-HDED), followed by seven transmembrane helices and an HD 
domain. An additional transmembrane helix is located at the N-terminus preceding the 7TMR-
HDED domain. The HD domain is described as the catalytic domain hydrolyzing c-di-AMP 
and is also reported to be inhibited by ppGpp (Huynh et al. 2015). A third way to regulate the 
intracellular c-di-AMP concentration is its export via secretion systems like multidrug efflux 
pumps (MDRs) (Woodward et al. 2010). While some bacteria tried to evade the hosts immune 
response due to secretion of the signaling molecule, they evolved mechanisms to hydrolyze 
external c-di-AMP (Andrade et al. 2016). Instead, the human pathogen L. monocytogenes for 
example actively secretes c-di-AMP which trigger the mammalian host Type I interferon re-
sponse as a result of STING activation (Crimmins et al. 2008; Woodward et al. 2010; Archer 
et al. 2014; Dey et al. 2015). In addition, c-di-AMP binds to the oxidoreductase RACON a 
cytosolic sensor of cyclic dinucleotides and inhibits its activity which results in an enhanced 
cell-to-cell spread of the bacteria (McFarland et al. 2017; McFarland et al. 2018). 
 
1.6 The complex network of c-di-AMP 
The huge research interest over the last ten years on the small molecule c-di-AMP unveiled 
insights into its complex signaling network and a variety of different binding partners.  
The first described c-di-AMP binding protein is the transcription factor DarR of the TetR fam-
ily from Mycobacterium smegmatis (Zhang et al. 2013). DarR represses its own gene expres-
sion and that of three further proteins by binding to a palindromic sequence in their promotor 
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region which is stimulated by binding of c-di-AMP to DarR (Zhang et al. 2013; Commichau 
et al. 2015b). Due to its important role in osmoregulation further c-di-AMP targets were iden-
tified that are involved in potassium ion transport. c-di-AMP was reported to regulate a bio-
logical process on the level of protein expression and at the same time on protein activity 
(Corrigan Rebecca M and Gründling 2013; Nelson et al. 2013; Gundlach et al. 2017b; 
Gundlach et al. 2019). The B. subtilis high affinity potassium ion uptake system KtrAB (in L. 
monocytogenes KdpABC (probably does not contribute to K+ uptake) and S. aureus 
KdpFABC) and KimA were described to be inhibited upon binding of c-di-AMP to the protein 
but also to the corresponding mRNA which leads to a repression of protein expression 
(Corrigan et al. 2013; Nelson et al. 2013; Gundlach et al. 2017b; Gundlach et al. 2019). So far 
a c-di-AMP-dependent riboswitch to control protein expression was not detected in L. mono-
cytogenes rising the question whether c-di-AMP controls protein expression in these bacteria 
(Gibhardt et al. 2019). In addition, the low affinity transporter system KtrCD and the KdpD 
sensor kinase which controls the expression of the Kdp potassium transporter, get inhibited 
upon c-di-AMP binding (Moscoso et al. 2016).  
Potassium ions are the most abundant cations in living cells. Not only because of its importance 
in ribosome functionality but also for maintenance of the intracellular pH (Epstein 2003). How-
ever, an intracellular ion excess can be harmful to the cell and therefore it needs to be tightly 
regulated (Chandrangsu et al. 2017). Both, high affinity potassium transporters are expressed 
under low external K+ ion concentrations to ensure the required intracellular ion level which is 
essential for bacterial growth. In contrast, under high external K+ ion concentration the low 
affinity transporter KtrCD is expressed. A high external K+ ion concentration was described to 
activate the accumulation of c-di-AMP which in turn leads to a reduced K+ ion uptake 
(Gundlach et al. 2017b). It has been reported that c-di-AMP binds to the RCK_C domains 
(regulator of conductance of K+) of KtrAB and KtrCD forming a gating component of potas-
sium ion channels. RCK_C domains have been described as c-di-AMP binding domains also 
present in other proteins. So far five proteins were identified in B. subtilis to possess an RCK_C 
domain, many of these proteins are described to be potential K+ ion transporters. The RCK_C 
domain containing KhtSTU complex and CpaA from S. aureus for instants which are known 
to bind c-di-AMP are suggested to be involved in potassium ion export (Fujisawa et al. 2007; 
Gundlach et al. 2019). In group B Streptococcus, bacteria that have been identified for neonatal 
septicaemia and meningitis and in L. lactis c-di-AMP binds to the RCK_C domain containing 
transcription regulator BusR. Upon binding of c-di-AMP, BusR has been shown to negatively 
regulate the expression of the glycine betaine transporter BusAB (Devaux et al. 2018; Pham et 
al. 2018). 
Only recently it has been shown that c-di-AMP also negatively effects the potassium ion 
transport in L. lactis upon binding to the high affinity K+ ion transporters KupA and KupB 
(Quintana et al. 2019). 
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The human pathogen S. pneumoniae was also reported to modulate K+ ion homeostasis via c-
di-AMP signaling. CabP was identified to specifically bind c-di-AMP which interacts with the 
K+ ion importer SPD_0076 and as a result reduces ion uptake (Bai et al. 2014). Yet c-di-AMP 
is not only involved in controlling the cellular potassium transport but osmolyte homeostasis 
in general. One class of proteins that were also identified to bind c-di-AMP are the so-called 
CBS domain containing proteins. These domains are also known as Bateman domains named 
after Alexander Bateman who firstly described this specific CBS domain fold of cystathionine-
b-synthases (Bateman 1997). CBS domains are able to bind a great variety of different adenine 
derivatives (Day et al. 2007; Baykov et al. 2011; Ereño-Orbea et al. 2013). Hence, it should be 
kept in mind that not all CBS domains bind the secondary dinucleotide. Indeed, in B. subtilis 
the majority of CBS domains do not bind c-di-AMP (Devaux et al. 2018; Gundlach et al. 2019). 
Only three out of sixteen CBS domain containing proteins were observed so far to bind c-di-
AMP: the Mg2+ ion transporter MgtE, YkuL/DarB (CbpB in L. monocytogenes), a protein of 
unknown function, and the glycine betaine-carnitine transporter OpuCA. Whereas the latter 
has also been confirmed to be inhibited upon c-di-AMP binding in L. monocytogenes and S. 
aureus resulting in an impaired carnitine uptake (Schuster et al. 2016; Gundlach et al. 2019). 
Interestingly the deletion of the sole DAC CdaA in L. monocytogenes resulted in the develop-
ment of suppressor mutants in rich medium carrying mutations in CbpB (B. subtilis 
DarB/YkuL) and PstA (B. subtilis DarA) (Sureka et al. 2014). CbpB is subordinated to the 
proteins possessing the highly conserved CBS domain whereas PstA/DarA was described to 
be similar to the PII-like domain proteins (Gundlach et al. 2015b). Both proteins have been 
identified to bind c-di-AMP, but their function still needs to be elucidated. Furthermore, the 
pyruvate carboxylase (PycA) was identified as a potential c-di-AMP binding protein. As de-
scribed for other c-di-AMP interacting proteins, the binding to PycA has a negative effect on 
its activity through allosteric inhibition (Sureka et al. 2014). Therefore it was suggested that c-
di-AMP also plays an important role in linking osmoregulation and metabolic homeostasis 
(Whiteley et al. 2017). 
The fact that c-di-AMP binds to different proteins in the bacterial cells most of which are os-
motransporters emphasizes the importance to keep the osmotic level in balance in order to 
regulate the cellular turgor (Commichau et al. 2017).  
 
Chapter 1: Introduction 
 12 
 
Figure 5: c-di-AMP synthesis, degradation and its interaction partners. The nucleotide-based second mes-
senger c-di-AMP is synthesized by proteins containing a DAC domain. In this figure the two main DACs (CdaA 
and DisA) are shown. The DAC activity of the membrane bound CdaA is modulated by the extracellular located 
CdaR and the glucosamine mutase GlmM. c-di-AMP can be degraded into pApA by specific phosphodiesterases. 
Here only the membrane bound PDEs are shown that degrade c-di-AMP either to pApA or AMP. The cytosolic 
DhhP-type PDEs are not shown. However, c-di-AMP is not only removed from the cell by degradation but also 
by secretion through secretion systems like MDR, a multidrug resistance transporter. In addition, targets are dis-
played that have been shown to bind c-di-AMP. Some of these targets are of unknown function like DarA and 
DarB but many others were identified to bind to osmolyte transporters and therefore regulate the uptake and export 
of osmolytes. c-di-AMP not only binds directly to the protein itself. It has also been shown to regulate protein 
expression as it was reported for KimA. The red arrow represents activation and the arrow with a flat end repre-
sents the inhibition through c-di-AMP binding (modified from Commichau et al. 2019). 
 
1.7 CdaA as a new antibiotic target?  
Due to the rapid adaptation of bacteria to environmental changes and as a result to antibiotics 
many bacteria developed resistances to the available repertoire of antimicrobial drugs. The 
WHO declares antibiotic resistance as a “global health concern” since bacteria spread easily 
around the world and are not stopped by national borders (Ventola 2015; Wang et al. 2018). 
According to the German federal government each year in Germany 400,000 to 600,000 people 
become infected by antibiotic resistant bacteria (German Federal Government 2020). It has 
been reported that 10,000 to 15,000 patients die due to the lack of effective antibiotic agents.  
The Director-General of the WHO Dr. Tedros Adhanom Ghebreyesus said “Never has a thread 
of antimicrobial resistance been more immediate and the need for solutions more urgent” em-
phasizing the desperate need of new substances to combat against resistant bacteria (WHO 
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new antimicrobial substances. The overuse and misuse of antibiotic drugs needs to be drasti-
cally reduced (Phillips et al. 2004; Hume 2011; Michael et al. 2014). In 2017 the WHO pub-
lished a “priority pathogen” list filing bacterial pathogens that have an increased risk to the 
human health due to the lack of effective drugs (WHO 2017; Asokan et al. 2019). 
Hence, there is an urgent need of identifying new drug targets and antibacterial substances. 
One major challenge of developing new effective antibiotics is the identification of suitable 
drug targets. A pivotal aspect of an auspicious target is its conservation as well as its essential 
function for a wide range of different bacterial species. An interaction with the potential target 
through stimulation or inhibition should result in a decreased growth of the bacteria in order to 
be considered as a drug target. In addition, it is of great importance not to neglect that a poten-
tial target lacks structural and functional homology to human proteins in order to avoid side 
effects (Silver 2011). The c-di-AMP synthesizing enzymes DACs were suggested in many 
studies to function as a promising target for novel antibiotic agents (Corrigan R. M. and 
Gründling 2013; Rosenberg et al. 2015; Commichau et al. 2019). So far DACs as well as its 
product c-di-AMP could not be detected in humans. It has been reported that the synthesis of 
c-di-AMP in bacteria that possess a DAC is essential under standard conditions due to its reg-
ulatory function in osmolyte homeostasis (Gundlach et al. 2015a; Commichau et al. 2017; 
Gundlach et al. 2017a). An uncontrolled transport of osmolytes which is triggered due to loss 
of c-di-AMP in the cell was identified to result in cell lysis (Luo Yun and Helmann 2012; 
Mehne et al. 2013; Rismondo et al. 2016). Interestingly, the intracellular excess as well as a 
reduced amount of c-di-AMP have been linked to either increased resistance or susceptibility 
to b-lactam antibiotics, respectively. On the one hand it has been shown in several studies that 
mutation that lead to a reduced intracellular c-di-AMP level get more susceptible to methicillin, 
oxacillin and cefuroxime. The increased susceptibility might be a result of a reduced structural 
stability of the bacterial cell wall (Dengler et al. 2013; Witte et al. 2013; Cheng et al. 2016; 
Rismondo et al. 2016). On the other hand, it has been reported that a deletion or depletion of 
the c-di-AMP specific PDEs resulted in a higher resistance to b-lactam antibiotics due to the 
increased c-di-AMP level (Corrigan et al. 2011; Luo Yun and Helmann 2012; Witte et al. 
2013). In S. aureus an elevated cellular c-di-AMP level resulted in a significantly increased 
number of cross-linked peptidoglycans which in fact emerged an increased resistance to cell 
wall targeting enzymes (Corrigan et al. 2011). In addition, several known human pathogens 
were identified to express DACs, like Mycobacterium tuberculosis, S. aureus, Group B Strep-
tococcus and S. pneumoniae, some of these bacteria listed here are also constituents of the 
WHO “priority pathogen” list (Song et al. 2005; Woodward et al. 2010; Corrigan et al. 2011; 
Luo Yun and Helmann 2012; Andrade et al. 2016; WHO 2017; Devaux et al. 2018; Asokan et 
al. 2019). Taken together all these aspects, it might be worth to consider DACs, in particular 
CdaA/DacA, as a potential new antibiotic target.  
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1.8 Diadenylate cyclase inhibitors  
DAC domain containing enzymes are potential targets for the development of new antibiotic 
agents owing to their synthesis of c-di-AMP. Inhibiting substances were already described for 
the DAC class DisA but no CdaA inhibitors have been reported so far (Zheng et al. 2014; 
Opoku-Temeng and Sintim 2016a). The ATP analogue 3’-deoxyATP misses its 3’OH group 
and is therefore unable to from c-di-AMP. Hence it inhibits synthesis as a completive inhibitor 
with an IC50 (50 % inhibitor concentration) at 3.8 µM (Müller et al. 2015). The screening of 
two compound libraries unveiled two additional DisA inhibitors: bromophenol thiohydantoin 
(Br-TH) with an IC50 of 56 µM and suramin an antiparasitic drug with an IC50 of 1.1 µM (Zheng 
et al. 2014; Opoku-Temeng and Sintim 2016b). The last molecule which is known to inhibit 
cyclase activity in DisA is theaflavin digallate with an IC50 of 3.4 µM. It was shown, that its 
inhibitory effect is non-competitive with ATP (Opoku-Temeng and Sintim 2016a; Commichau 
et al. 2019).  
 
1.9 Objective of this thesis  
Infections caused by antimicrobial resistant bacteria are one major health concern of humanity. 
Bacteria use their ability of rapid adaptation to environmental changes in order to combat 
against antibiotics. This enables bacteria to develop resistances and to survive even under usu-
ally life-threatening conditions. The misuse e.g. in agriculture and overuse due to insufficient 
education on how and when antibiotics should be used leads to an increase of bacterial species 
that are resistant to one or more antibiotic substances (Phillips et al. 2004; Hume 2011; Michael 
et al. 2014; Woolhouse et al. 2016). The number of resistant bacteria increases, while the num-
ber of effective antibiotics decreases. The identification of new targets to stop bacterial growth 
is difficult since these need to be essential for the bacterial survival and structural homologs 
should rather be absent in humans (Silver 2011).  
The second messenger c-di-AMP was reported to be essential for the survival of different path-
ogenic bacteria and it is not synthesized by mammals (Gundlach et al. 2015a; Commichau et 
al. 2017; Gundlach et al. 2017a). Hence its synthesizing enzymes, the DAC domain containing 
proteins, were assumed to be a good target for novel antibiotics (Corrigan R. M. and Gründling 
2013; Rosenberg et al. 2015; Heidemann et al. 2019). This work focuses on the structural and 
biochemical characterization of the most abundant DAC class CdaA from L. monocytogenes. 
Both, crystallization and biochemical experiments, might give further insights into the func-
tionality of CdaA, how its synthesis is inhibited in the cell and how it can be synthetically 
inhibited. In addition, c-di-AMP binding receptors are structurally and biochemically charac-
terized in order to better understand the interaction network of c-di-AMP and its effect on ef-
fector proteins.  
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Cyclic di-AMP (c-di-AMP) is the only second messenger
known to be essential for bacterial growth. It has been found
mainly in Gram-positive bacteria, including pathogenic bacteria
like Listeria monocytogenes. CdaA is the sole diadenylate cyclase
in L. monocytogenes, making this enzyme an attractive target for
the development of novel antibiotic compounds. Here we report
crystal structures of CdaA from L. monocytogenes in the apo
state, in the post-catalytic state with bound c-di-AMP and cata-
lytic Co2! ions, as well as in a complex with AMP. These struc-
tures reveal the flexibility of a tyrosine side chain involved in
locking the adenine ring after ATP binding. The essential role of
this tyrosine was confirmed by mutation to Ala, leading to dras-
tic loss of enzymatic activity.
Bacteria have the ability to perceive environmental changes,
leading to rapid and effective adaptation by utilizing different
proteins as well as second messengers to transduce signals in
the cell. In response to external stimuli, the intracellular con-
centration of second messengers, like cyclic dinucleotides and
linear mononucleotides, varies to regulate and coordinate cel-
lular processes (1–3). Cyclic di-AMP (c-di-AMP)2 is the most
recently discovered bacterial signaling nucleotide and, to date,
has been found mostly in Gram-positive bacteria. c-di-AMP is
involved in different cellular processes, such as DNA integrity
scanning, cell wall metabolism, and osmolyte homeostasis (for a
review, see Refs. 4 –6). c-di-AMP is the only essential second
messenger in bacteria because of its role in potassium homeo-
stasis. It regulates potassium importers at high intracellular K!
concentrations, whereas c-di-AMP is not essential at low K!
concentrations (7). Interestingly, c-di-AMP becomes toxic
when its degradation is blocked; hence, a tightly controlled
intracellular c-di-AMP concentration is required for bacterial
growth (8).
Proteins containing a diadenylate cyclase (DAC) domain
have been bioinformatically identified, mainly in Gram-posi-
tive bacteria of the phyla Actinobacteria and Firmicutes but
also in Gram-negative Cyanobacteria, Chlamydiae, Bacte-
roidetes, Fusobacteria, and Deltaproteobacteria and even in
archaea of the phylum Euryarchaeota (5). Several DAC
domain– containing proteins from various bacterial species
have also been experimentally proven to produce c-di-AMP.
Many of these bacteria are well-known pathogens, e.g. Myco-
bacterium tuberculosis (9), Staphylococcus aureus (10) and Lis-
teria monocytogenes (11). In total, eight families of diadenylate
cyclases have been identified so far, sharing the highly con-
served DAC domain (12). However, DACs differ in their addi-
tional domains and domain organization, suggesting that DAC
enzymes are regulated by different signals (12).
The three-dimensional structure of a DAC domain was first
reported for DisA, a multidomain protein with an N-terminal
DAC domain (13). This structure revealed that, within the
homo-octameric DisA, two adjacent and properly positioned
DAC domains, each with one ATP bound, catalyze the synthe-
sis of c-di-AMP. Based on the homology of all DAC domains, it
was proposed that DAC domains with bound ATP need to
dimerize in a specific arrangement to catalyze c-di-AMP
formation.
The importance of c-di-AMP for the growth of several path-
ogenic bacteria is marked by an increased resistance to cell
wall–targeting antibiotics (10, 14). Its absence in humans
makes DAC enzymes an interesting target for the development
of novel antibiotics by structure-based drug design. Therefore,
CdaA, the only DAC of the human pathogen L. monocytogenes,
was previously characterized biochemically and structurally.
The analysis revealed that CdaA is active with Co2! or Mn2!
ions as cofactors but inactive in the presence of Mg2! ions (15).
The CdaA crystal structure unveiled the monomeric and cata-
lytically inactive enzyme–substrate complex with bound ATP
and Mg2!, leaving the structure of a dimeric and active form
with a bound Co2! or Mn2! cofactor still to be determined.
Such a crystal structure could shed light on the role of the metal
ion in the catalytic reaction.
In this study we report two new crystal structures of CdaA
from L. monocytogenes at 2.0 Å and 2.8 Å resolution, represent-
ing the enzyme in its apo form and the post-catalytic homodi-
meric enzyme–product complex, respectively. The structure of
CdaA with bound c-di-AMP was obtained by co-crystallization
of CdaA in the presence of ATP and Co2! ions. Comparison of
the CdaA structure in the apo state with the ligand-bound
forms of CdaA (ATP, AMP, or c-di-AMP) revealed conforma-
tional changes of a tyrosine residue present in the active site.
Mutation of this tyrosine to alanine abolishes c-di-AMP forma-
tion and, thus, demonstrates its functional importance. Fur-
thermore, we confirmed that CdaA is active in the presence of
Mn2! or Co2! ions, with significantly higher activity in the case
of Mn2!, but it is inactive in the presence of Mg2! ions. These
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new CdaA structures could serve as an important starting point
for future rational drug design.
Results
Structure-based development of novel antibiotic drugs
requires high-resolution three-dimensional structures of the
targeted enzyme and enzyme–inhibitor complexes. CdaA of
the human pathogen L. monocytogenes appears to be an attrac-
tive target, as c-di-AMP synthesis is essential for bacterial
growth and CdaA is the only DAC in this pathogenic bacte-
rium, whereas there are no DACs in humans. For this study,
truncated !100CdaA, missing the N-terminal transmembrane
(TM) helices and the 20 amino acids linking the TM to the DAC
domain, was used because the transmembrane helices hamper
the solubility of the recombinant full-length protein. We have
demonstrated previously that this truncated !100CdaA has
preserved its enzymatic activity with a higher enzymatic activ-
ity for Co2" compared with Mn2" but no activity for of Mg2"
(15). Although, in this previous study, the in vitro activity was
measured by LC-MS/MS, we now applied a direct fluores-
cence-based measurement of c-di-AMP formation by its bind-
ing to coralyne (16). In contrast to the results obtained with the
LC-MS/MS method, more efficient c-di-AMP synthesis was
observed in the presence of Mn2" compared with Co2" (Fig.
1A).
Structure of apo CdaA
One approach for identification of potential inhibitors is
crystallographic fragment screening, which desires crystals of
CdaA in its apo state. Therefore, !100CdaA was crystallized in
the absence of ATP and divalent metal ions. Crystals of apo-
CdaA were obtained and belong to space group P212121, con-
taining two !100CdaA molecules per asymmetric unit. The
phase problem was solved by means of molecular replacement
using the monomeric !100CdaA structure of L. monocytogenes
(PDB code 4RV7) as a search model. The resulting crystal struc-
ture of apo-CdaA was determined at 2.0 Å resolution (Table 1).
The CdaA monomer is composed of a slightly twisted central
!-sheet made up of seven mixed-parallel and antiparallel
!-strands (!1–!7), flanked on both sides by five "-helices ("1–
"5) in total (Fig. 2). The two !100CdaA molecules in the asym-
metric unit are structurally very similar, as indicated by the root
mean square deviation (r.m.s.d.) of 1.19 Å between all C"
positions.
The structure of apo-CdaA closely resembles that of CdaA
with bound ATP (PDB code 4RV7), as they exhibit an r.m.s.d. of
1.56 Å, but a few differences are seen in a loop region (residues
137–140) and the C-terminal residues. Careful inspection of
the difference electron density map revealed a small molecule
bound to the surface of one of two CdaA molecules in the asym-
metric unit (Fig. S1). This electron density was interpreted as a
sucrose molecule originating from the utilized cryo-protectant
solution. In the apo-CdaA crystal structure, the active site is
accessible from solvent channels; hence, this crystal form of
apo-CdaA appears to be suitable for a fragment screen.
Structure of the CdaA– c-di-AMP complex
To gain more insight into the structure and function of
CdaA, we also crystallized !100CdaA in the presence of ATP
and the cofactor Co2". The obtained crystals belong to a differ-
Figure 1. In vitro diadenylate cyclase activity of !100CdaA. Presented is a histogram displaying three independent measurements. A control measurement
was performed using WT !100CdaA without addition of any divalent metal cations. The histogram represents the divalent metal cation preferences of WT
!100CdaA. The highest amount of c-di-AMP was formed in the presence of MnCl2, whereas, in the presence of CoCl2, the amount of the product is significantly
reduced. For MgCl2 and CaCl2, production of c-di-AMP could not be confirmed, as it was within the range of the control. Additionally, it represents the
importance of Tyr-187 on catalysis. The mutant Y187A causes a significant reduction (5-fold) of diadenylate cyclase activity, confirming its essential role in
c-di-AMP synthesis.
Structures of the diadenylate cyclase CdaA
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ent space group (H32) than the previously determined struc-
ture but also contain two CdaA molecules in the asymmetric
unit. The newly obtained crystal structure was determined at
2.8 Å resolution. The two CdaA molecules in the asymmetric
unit superpose very well, as the r.m.s.d. calculated between all
C! positions amounts to 0.65 Å. Analysis of the protein con-
tact surfaces in the crystal revealed that one of the two CdaA
molecules in the asymmetric unit forms a dimer with a sym-
metry mate related by a crystallographic two-fold axis (Fig.
3A). This CdaA homodimer corresponds to the catalytically
active DAC domain dimers seen in the DisA homo-octamer.
The calculated r.m.s.d between superimposed CdaA and
DisA dimers amounts to 1.72 Å (198 matched C! positions,
Fig. S4). The CdaA–CdaA dimer interface buries about 605
Å2 of the accessible surface area (7.3%) and is stabilized by six
hydrogen bonds and two salt bridges. However, additional
interactions between the monomers are mediated by the
ligand bound to the active site (see below). Surprisingly, the
difference electron density map clearly revealed the pres-
ence of a c-di-AMP molecule and two metal ions bound in
the active site of the CdaA crystallographic dimer (Fig. S2A).
As only ATP and Co2! were added to the protein right
before it was subjected to crystallization, the c-di-AMP must
have formed during or after crystallization droplets were set
up. It appears very likely that the bound metal ion is a Co2!,
as no other catalytic metal cation was present in the crystal-
lization solution. The Co2! is coordinated by the phosphate
moiety and the carboxylate group of Glu-224 as well as the
carboxylate group of Asp-171 and the imidazole ring nitro-
gen of His-170 of the symmetry-related subunit (Fig. 3, B and
C). The metal– oxygen distances of 2.1 Å for Asp-171 and
Glu-224 and 2.3 Å for phosphate correspond to distances
observed in other proteins containing a Co2! ion (17). Elon-
gated distances observed between Co2! and the imidazole
ring of His-170 (3.1 Å) and the c-di-AMP 3"OH group (3.8 Å)
indicate that this complex corresponds to the post-catalytic
state. To fulfill its catalytic role, the metal ion must be
shifted. Only then it can act as Lewis acid to increase the
nucleophilicity of the metal-activated 3" hydroxyl group of
ATP and enhance the electrophilicity of the phosphorus
atom of the adjacent ATP molecule.
The asymmetric unit of the crystal contains a second CdaA
molecule that also accommodates a nucleotide bound in
the active site but no bound metal ion (Fig. 4). Based on the
observed difference omit electron density map (Fig. S2B), the
nucleotide was identified as AMP. Because previous crystal
structures of DisA and CdaA with bound ATP or 3"-dATP
showed well-defined electron density for the " and # phos-
phates, it appears likely that the second CdaA molecule indeed
has AMP bound, which must have formed out of ATP during
the crystallization process. ATP hydrolysis also explains the
presence of another difference electron density map peak,
which has been interpreted as a free phosphate. This phosphate
ion is bound in the vicinity of the c-di-AMP molecule and could
potentially mark an exit route of the pyrophosphate molecule
on the surface of CdaA.
Conformational rearrangements of the active site induced by
ligands
The comparison of CdaA in the apo state to CdaA com-
plexed with AMP or c-di-AMP unveils different orientations
of the Tyr-187 side chain, which is located in close proximity
to the adenine base. In the CdaA apo state, this tyrosine side
chain is rotated outward from the active site, leading to an
opening of the binding site for the adenine base (Fig. 5). In
the monomeric CdaA–AMP complex, the tyrosine is rotated
inward at the active site and stacks on the adenine in an
almost coplanar orientation. In contrast, in the dimeric c-di-
Table 1
Crystallographic data collection and refinement statistics
!100CdaA with
AMP and c-di-AMP !100CdaA-APO !100CdaA_Y187A-APO
Crystallographic data
Beamline Petra III-P14, EMBL, Hamburg Petra III-P14, EMBL, Hamburg Petra III-P13, EMBL, Hamburg
Wavelength (Å) 0.97620 0.97620 0.97625
Resolution range (Å)a 42.27–2.80 (2.90–2.80) 45.89–2.00 (2.10–2.00) 46.49–2.23 (2.33–2.23)
Unique reflections 9,435 24,884 19,512
Redundancy 5.6 (5.7) 7.1 (7.0) 5.8 (4.2)
Completeness (%) 93.0 (95.4) 99.7 (98.5) 97.1 (79.3)
Space group H32 P212121 P212121
a (Å) 121.90 42.69 46.49
b (Å) 121.90 64.67 65.13
c (Å) 141.59 129.75 131.33
Rmerge (%) 10.9 (80.5) 9.4 (119.0) 8.0 (52.0)
I/$ (I) 12.4 (1.9) 13.6 (2.0) 15.6 (2.8)
CC1/2 99.8 (72.6) 99.9 (77.2) 99.8 (80.5)
Refinement statistics
Rwork/Rfree 0.1875/0.2337 0.1858/0.2245 0.1837/0.2258
No. of atoms 2453 2610 2740
Average B-factor (Å2) 58.0 47.6 39.8
Root mean square deviation
Bonds Å 0.003 0.008 0.006
Angles (°) 0.644 1.003 1.258
Ramachandran plot
Favored (%) 98.05 98.11 98.79
Allowed (%) 1.95 1.57 1.21
Outlier (%) 0.00 0.31 0. 00
PDB codes 6HVL 6HVM 6HVN
a Values for the data in the highest-resolution shell are shown in parentheses.
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AMP complex, the tyrosine side chain is flipped outward, as
the Thr-202 side chain of the other subunit packs against the
adenine ring (Fig. 3B).
To investigate whether Tyr-187 plays an important role in
c-di-AMP formation, a Y187A mutant was generated. This
mutation led to a significant reduction (about 80%) in activity,
confirming the functional impact of Tyr-187 (Fig. 1B). To
exclude that the Y187A mutation perturbed the fold of
CdaA, the crystal structure of !100CdaA_Y187A was deter-
mined as well (Table 1). Comparison with the structure of
WT !100CdaA demonstrates no structural changes caused
by the mutation.
Discussion
Synthesis of c-di-AMP requires dimerization and proper ori-
entation of two DAC domains, each with one ATP bound and
accompanied by the metal ion cofactor. In DisA, this is achieved
permanently by the homo-octameric oligomerization state
(13). The first structure of CdaA of L. monocytogenes showed
that the DAC domain crystallized as a monomer even though
ATP was bound to the active site (15). However, for the previ-
ous study and this one, a truncated CdaA was used. So far, the
influence of the missing transmembrane domain on oligomer-
ization and catalytic activity is unknown.
Here, a new crystal form of CdaA was obtained that contains
two CdaA molecules with different nucleotides bound. One
CdaA molecule forms a catalytically active dimer with a sym-
metry mate in the crystal. This dimer contains a c-di-AMP mol-
ecule and two metal ions in the active site; hence, it closely
resembles the dimer arrangement of DAC domains seen in
DisA (Fig. S4).
The c-di-AMP must have been formed during crystalliza-
tion, as only ATP and Co2" ions were added to CdaA. This
complex corresponds to the enzyme–product complex, which
is supposed to have a lower stability. However, c-di-AMP medi-
ates multiple contacts between the monomers, increasing the
interaction surface area between the monomers, and the cata-
lytically active dimer appears to be caught in the crystalline
lattice.
Conserved active-site residues of DisA and CdaA directly
involved in substrate binding and catalysis have been identified
previously (15, 18). Each of the mutations in DisA (D75N,
R130A, RHR (108 –110)AAA, T107V"T111V), and in CdaA
(D171N, G172A, and T202N) led to a reduction or complete
loss of enzymatic activity. However, by analyzing the structure
of the monomeric CdaA in the asymmetric unit with bound
AMP, we realized that the Tyr-187 side chain might also be
involved in substrate binding, as it stacks on the adenine ring,
but it is rotated outward in the structure of apo CdaA (Fig. 5).
Hence, it appears likely that, upon binding of ATP to mono-
meric CdaA, Tyr-187 rotates toward the adenine moiety and
locks the ATP in the active site by a !–! stacking interaction, as
observed for many other ATP binding proteins (19). However,
upon CdaA dimerization, the tyrosine side chain is replaced by
the side chain of Thr-202 of the other subunit, which then sta-
bilizes the bound ATP. The replacement of the Tyr by a side
chain from the other subunit might facilitate product release
after catalysis, as, upon dimer dissociation, the product can be
released more easily. By mutation of Tyr-187 to Ala, which
strongly reduced the activity in vitro, we demonstrate that Tyr-
187 indeed plays an essential role in c-di-AMP formation by
CdaA. Notably, this Tyr-187 is conserved in most CdaA
enzymes but not in other DAC proteins, like DisA, suggesting a
slightly different mechanism of substrate binding between dif-
ferent classes of DACs.
A remarkable difference between DisA and CdaA concerns
the metal ion specificity in the catalytic center. Although DisA
appears to be active with Mg2" and Mn2" (20), CdaA is not
active in the presence of Mg2". Such unexpected differences in
metal ion preferences have also been observed for other protein
families, e.g. the metal-dependent serine/threonine phospho-
protein phosphatase family (21). Because the catalytic mecha-
nism of phosphoprotein phosphatase enzymes as well as that of
DAC proteins does not require the redox potential of Mn2" to
carry out the catalyzed reaction, it is not clear why some mem-
bers of the DAC family would prefer Mn2" or other divalent
cations over Mg2" (22). Hence, the observed strict dependence
of CdaA on Mn2" or Co2" ions raised questions concerning its
structural basis. The observed metal ion dependence is most
likely related to different chemical properties of the cation, e.g.
ionic radius, and to the amino acid composition of the active
site.
Comparison of the DisA and CdaA structures reveals sig-
nificant differences in metal ion coordination. In the catalyt-
ically active dimer of DisA with bound ATP, the Mg2" ion is
coordinated by three phosphate groups and the Asp carbox-
ylate. In CdaA, more protein residues contribute to metal
binding, resulting in a more crowded active site. In addition
to Asp-171 (which corresponds to Asp-75 of DisA), the side
chains of Glu-224 and His-170 coordinate the Co2" ion.
These two residues are not structurally conserved in DisA, as
Figure 2. Crystal structure of !100CdaA in the apo state, refined at 2 Å
resolution. The fold of the CdaA DAC domain consists of seven "-strands
forming a central "-sheet surrounded by five #-helices. The positions of res-
idues forming the active site are highlighted in red.
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there is an Arg instead of the Glu and a Met instead of the
His. The side chains of both Arg and Met are rotated out-
ward from the metal binding site, making it less crowded.
Hence, the major difference appears to be presence of the
His. Although Mg2! strongly prefers coordination by Asp
and Glu, the transition metal ions Mn2! and Co2! are bound
as well by His, as deduced from analysis of all metal binding
sites in known protein structures (23).
The reason for this difference between DisA and CdaA is
most likely related to the fact that DisA contains stably asso-
ciated, catalytically active dimers, whereas, for CdaA, the
catalytic dimer might just exist transiently. Therefore, in
DisA, Asp-171, which belongs to the second DAC domain, is
sufficient for binding the substrate ATP and the metal ion. In
CdaA, ATP and the metal ion are initially bound to the mono-
meric DAC domain by the Glu-224 side chain, and solvent
molecules complete the metal coordination sphere. Upon
formation of the catalytically active dimer, the metal ion
needs to be slightly repositioned to be further coordinated by
His-170 and Asp-171, provided by the second monomer (Fig.
S3).
Recently, CdaA from S. aureus was characterized struc-
turally and biochemically (24). Surprisingly, in contrast to
L. monocytogenes CdaA, the S. aureus CdaA homolog shows
activity not only in the presence of transition metal ions but
also in the presence of Mg2!. Comparison of the active sites
of both available CdaA structures unveils identical position-
ing of the amino acids directly involved in c-di-AMP and
Figure 3. The active site of dimeric CdaA with bound c-di-AMP. A, the catalytically active "100CdaA homodimer is depicted as a cartoon, and the bound
reaction product c-di-AMP is shown as balls and sticks (carbon in pale blue and blue, phosphate in orange, oxygen in red, and nitrogen in dark blue). The two
"100CdaA monomers are colored according to the c-di-AMP in pale blue and blue, respectively. Co2! ions are depicted as pale red spheres. B, detailed view of
the CdaA active site. Amino acids involved in binding the c-di-AMP molecule (colored and depicted as in A) are shown as sticks (carbon in pale blue and blue,
oxygen in red, and nitrogen in dark blue). The Co2! ions are colored and depicted according to A. For simplicity, only one half of the two-fold symmetric CdaA
active site is shown. C, detailed view of the Co2! binding site and its coordination sphere.
Structures of the diadenylate cyclase CdaA
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metal ion coordination (Fig. S5). The largest structural dif-
ferences can be observed for N- and C-terminal !-helices
and a loop connecting "-strand 4 and !-helix 4. The latter is
located in close proximity to the phosphate moiety of ATP
and could indirectly alter the metal binding preferences or
even metal catalytic efficiency. This could serve as a poten-
tial explanation for the metal ion promiscuity of CdaAs
showing strict conservation of three residues (His-170, Asp-
171, and Glu-224) directly involved in metal binding, as
revealed by sequence alignment of ten bacterial CdaAs (Fig.
S6). The chemical properties of these three residues are most
likely the structural basis for the observed metal ion prom-
iscuity of CdaAs, which has also been observed for other
enzymes, e.g. mannosylglycerate synthase (25). The observed
capability of utilizing several ions by one enzyme is still one
of many not well-understood marvels of enzymology that
require further investigation.
Experimental procedures
Bacterial strains and growth conditions
For cloning procedures and protein overexpression, Esche-
richia coli strains DH5! and BL21(DE3) were used. The E. coli
strains were cultivated in 2xYT ((trypton 1.6% (w/v), yeast
extract 1.0% (w/v), NaCl 0.5% (w/v)) medium, whereas trans-
formed cells were selected on lysogeny broth-medium plates
containing ampicillin (100 #g/ml).
Plasmid construction
For purification, the DAC-type CdaA was equipped with a
GST tag. CdaA is known to be a transmembrane protein. The
!300cdaA allele, which lacks the TM domain, was amplified
using the primer pairs JH004 forward (5"-CCGGATCCTATG-
GATCAAGAATTGAGCG-3")/JH005 reverse (5" GGCTC-
GAG TCATTCGCTTTTGCCTCCTTTCC-3"). As a template,
the plasmid pBP33 was used (15). The resulting PCR products
were cloned in the pGEX-6P-1 (GE Healthcare) expression vec-
tor using the restriction sites XhoI and BamHI, leading to plas-
mid pGEXpBP33, which encodes for the truncated !100CdaA
protein with an N-terminal GST tag.
Site-directed mutagenesis
!100CdaA mutants were generated with site-directed
mutagenesis to identify amino acid residues that have an
important function in the catalytic reaction mechanism. The
CdaA mutant Y187A was created by PCR using the mutagene-
sis primer pairs JH_Y187A_forward (5"-CAGCAAGTGCCTT-
GCCA CTTTCAGATAGCCCGTTCTTATCCAAAGAAC-
3") and JH_Y187A_reverse (5"-GTGGCAAGGCACTTGCTG-
CCGATGC AATTTCGTTTCCTTTAATAATAACTGC-3"),
resulting in the plasmid encoding the truncated mutant variant
!100CdaA_Y187A.
Figure 4. Structure of the CdaA-AMP complex. A, CdaA monomer (cartoon, pale green) with a bound AMP molecule depicted as balls and sticks. B, a detailed
view of the active site showing the amino acids (sticks, carbon in pale green, oxygen in red, and nitrogen in blue) involved in AMP binding. The bound AMP is
shown as a ball-and-stick model (carbon in wheat, phosphate in orange, oxygen in red, and nitrogen in dark blue).
Figure 5. Conformational switch of Tyr-187 during c-di-AMP synthesis.
For convenience, only the !100CdaA monomer (gray) with bound AMP (car-
bon in wheat, phosphate in orange, oxygen in red, and nitrogen in dark blue)
and Tyr-187 (wheat) is shown. AMP is depicted as a ball-and-stick model. The
side chain of Tyr-187 (pale blue) of the !100CdaA– c-di-AMP complex struc-
ture is superimposed. Upon ATP binding to monomeric CdaA, Tyr-187 stacks
parallel on the adenine base ($–$ interaction) and stabilizes the protein–
substrate complex. Upon homodimer formation, the side chain of Tyr-187
rotates outwards as it is replaced by the Thr-202 side chain of the second
monomer in the catalytically active homodimer.
Structures of the diadenylate cyclase CdaA
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Protein expression and purification
E. coli BL21(DE3) was used for expression of the fusion pro-
tein GST-!100CdaA. The cells were grown in 1 liter of 2xYT
medium at 37 °C. Protein expression was induced after the cul-
ture reached an A600 of " 0.6 by addition of 1 mM isopropyl
1-thio-!-D-galactopyranoside and incubated at 16 °C for 18 h.
After harvesting and subsequent to cell disruption with a
microfluidizer (M-110S Microfluidizer, Microfluidics) and
centrifugation at 15,600 # g for 30 min to remove cell debris,
the lysate was loaded onto a GSH-Sepharose column (GE
Healthcare) in 300 mM NaCl, 20 mM Tris/HCl (pH 7.5), and 10
mM EDTA. The target protein GST-!100CdaA was eluted
from the column with 40 mM reduced GSH. The eluate was
incubated overnight with PreScission protease (1:100 (w/w)) in
cellulose tubing placed in dialysis buffer (100 mM NaCl and 20
mM Tris/HCl (pH 7.5)) at 4 °C to remove the high GSH concen-
tration and to dissect the GST tag from !100CdaA. To remove
the cleaved-off tag from the truncated CdaA, a second GSH-
Sepharose purification step was included.
Crystallization and cryoprotecion
For crystallization, the sitting-drop vapor diffusion method
was applied. Initial crystallization trials were performed at
20 °C using !100CdaA at a concentration of 4.0 mg/ml supple-
mented with 500 "M CoCl2 and 500 "M ATP. Rectangular crys-
tals grew after approximately 48 h in a 2-"l droplet composed of
the aforementioned protein solution mixed with reservoir in a
1:1 ratio. The reservoir was composed of 0.2 M Ca(CH3COO)2,
0.1 M Na-HEPES (pH 7.5), and 10% (w/v) PEG8000. Crystals
were cryoprotected by soaking them in a reservoir solution sup-
plemented with 25% PEG8000.
For crystallization of the apo form and the Y187A variant of
!100CdaA, a protein concentration of 6.0 mg/ml was used,
keeping the 2-"l droplet size and 1:1 protein-to-reservoir ratio.
To facilitate crystal growth, microseeding was performed in
combination with small alterations of NaCl concertation. Thin
crystal plates were obtained after approximately 18 h in a salt
concentration ranging between 3.7– 4.5 M NaCl and 0.1 M Na-
HEPES (pH 8.5). Crystals were cryoprotected by soaking them
in a saturated sucrose solution obtained by solubilizing sucrose
in reservoir solution.
X-ray data collection and processing
Diffraction images were collected at PETRA III EMBL beam-
lines P13 and P14 (DESY, Hamburg, Germany) and processed
with the XDS package (26, 27). Data collection and processing
statistics are summarized in Table 1. A trigonal lattice with unit
cell parameters of a $ b $ 121.90 Å, c $ 141.59 Å was deter-
mined for the crystals containing the CdaA– c-di-AMP com-
plex. Cell content analysis indicated the presence of two CdaA
molecules occupying the asymmetric unit (Vm $ 2.89 Å3/Da,
corresponding solvent content of 57.4%). The crystals of apo
CdaA and the Y187A mutant exhibited an orthorhombic lattice
and the unit cell parameters of a $ 42.96 Å, b $ 64.67 Å, c $
129.75 Å and a $ 46.49 Å, b $ 65.13 Å, c $ 131.33 Å, respec-
tively. The Matthews coefficient (Vm $ 2.55 Å3/Da, corre-
sponding solvent content of 51.78%) implicates two molecules
occupying the asymmetric unit.
Structure determination and refinement
The crystallographic phase problem was solved by molecular
replacement with PHASER (28) using the structure of the DAC
!100CdaA from L. monocytogenes (PDB code 4RV7) as a search
model. Manual model building was preformed with Coot (29),
and the structure was refined with Refmac (30) and PHENIX
(31). To monitor the refinement progress using Rfree, 5% of the
reflections were selected randomly and excluded from refine-
ment. During the refinement process, the coordination dis-
tance for the Co2% ion in the ligand-bound structure was
restrained to 2.1 Å for the Glu-224 and Asp-171 side chains and
to 2.3 Å for the cyclic di-AMP phosphate. The final structure of
the CdaA– c-di-AMP complex was refined at a resolution of 2.8
Å to Rwork of 18.7% and Rfree of 23.4%. The apo-CdaA was
refined at a resolution of 2.0 Å to Rwork of 18.6% and Rfree of
22.5%. The structure of the Y187A mutant was determined at
2.32 Å resolution and refined to 17.5% and 22.0% for Rwork and
Rfree, respectively. Protein contact areas in the crystals were
analyzed using “Protein interfaces, surfaces and assemblies”
services at the European Bioinformatics Institute using stan-
dard settings (32).
In vitro DAC activity assay
Diadenylate cyclase activity was measured with a quantita-
tive fluorescence assay based on an increased fluorescence sig-
nal because of the specific interaction of the fluorescent dye
coralyne with c-di-AMP (16). A 200-"l reaction mixture con-
tained 40 mM Tris/HCl (pH 7.5), 100 mM NaCl, 10 mM XCl2
(X $ Mg, Co, Mn, or Ca) and 100 "M ATP. The reaction was
started by addition of 10 "M !100CdaA and incubated for 1 h at
37 °C. To stop the reaction, the reaction mixture was boiled for
5 min and centrifuged for another 5 min at 13,400 # g to
remove the precipitated protein. For quantification of the syn-
thesized c-di-AMP, 250 mM KBr and 10 "M coralyne were
added to the reaction mixture. After incubating the samples for
30 min in the dark, c-di-AMP concentration was determined by
excitation at a wavelength of 420 nm and measuring the fluo-
rescence emission at a wavelength of 475 nm using a microplate
reader (Victor Nivo multimode microplate reader, PerkinElmer
Life Sciences).
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Supporting	Figure	S1:		Crystal structure of apo ∆100CdaA with a bound sucrose molecule. 
(A) ∆100CdaA monomer is depicted in cartoon mode (light grey). The sucrose molecule 
(represented as sticks with carbons in green cyan and oxygen in red) is bound in a cavity formed 
by helix α1, loop connecting β1 and α3, loop between β3 and β4, and helix α3. An omit mFo-
DFc electron density map (blue mesh) is contoured at a sigma level 3.0. (B) Detailed view of 
the sucrose binding. Amino acids (sticks, carbon in gray, oxygen in red and nitrogen in dark 
blue) that are involved in sucrose binding are shown in stick mode, and hydrogen bonds are 
indicated by dashed lines.  
 
 




Supporting	Figure	S2:	Crystal structure of ∆100CdaA with a bound c-di-AMP. (A) The 
crystallographic homo-dimer forming the catalytically active form of CdaA with bound c-di-
AMP is depicted as ribbon cartoon (light blue and dark blue). The two monomers are related 
by a crystallographic two-fold symmetry axis. The difference electron density mFo-DFc omit 
map contoured at 3 σ revealed the presence of a c-di-AMP molecule (sticks; carbon in yellow, 
phosphate in orange, oxygen in red and nitrogen in blue) and a Co2+
 
ion (red sphere) in the 
active site. (B) The active site of the second CdaA molecule (light green/cartoon mode) 
present the asymmetric unit, which does not form an active dimer, is loaded with an AMP 
molecule (Carbon in wheat, rest coloured as in A). The omit mFo-DFc electron density map 
(blue mesh) is contoured at a 3 σ. 








Supporting	Figure	S3:	Superposition	of a ∆100CdaA dimer with bound c-di-AMP and a 
∆100CdaA monomer with bound ATP (PDB code: 4RV7). The overlay shows a slightly 
different positioning of the metal ions. Colouring of the ∆100CdaA dimer and the c-di-AMP 
is according to Figure 3. The ∆100CdaA monomer is depicted in ribbon cartoon mode 
(yellow). The bound ATP is shown in stick model (carbon in yellow, phosphate in orange, 
oxygen in red and nitrogen in dark blue) and the Mg2+ and Co2+ ions as a green and light pink 
sphere, respectively.  
 







Supporting Figure S4: Superposition of DisA and ∆100CdaA homodimers. The catalytically 
active ∆100CdaA homo-dimer is shown as on Figure 3 (cartoon in blue and pale blue, c-di-
AMP is depicted as colour coded balls and sticks, Co2+ ions are depicted as orange spheres). 














Supporting Figure S5: Superposition of S. aureus DacACD (6GYX) and L. monocytogenes 
∆100CdaA (6HVL) monomers. The ∆100CdaA monomer is shown as on Figure 4 (cartoon in 
pale green, AMP is depicted as colour coded balls and sticks. The CacACD monomer is coloured 
pale pink, ApCpp is depicted in colour coded balls and stick mode, Mn2+ ion is shown as a 
magenta sphere. The amino acids His, Glu and Asp, which are involved in metal ion 












Supporting Figure S6: Sequence alignment of CdaAs from different organisms. The highly 
conserved residues that are involved in metal ion binding are labelled with orange stars at the 
bottom. The structurally divergent loop region connecting a-helix 4 and b-strand 4, which is in 
the close vicinity of the phosphate moiety of ATP, is marked with an orange box 
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The second messenger cyclic di-AMP (c-di-AMP) is essential for growth of many bacteria as 
it controls the cellular osmolyte homeostasis. c-di-AMP can regulate the synthesis of potassium 
uptake systems in some bacteria and also directly inhibits and activates potassium import and 
export systems, respectively. Therefore, c-di-AMP production and degradation have to be 
tightly regulated depending on the environmental osmolarity. The Gram-positive pathogen Lis-
teria monocytogenes relies on the membrane-bound diadenylate cyclase CdaA for c-di-AMP 
production and degrades the nucleotide with two phosphodiesterases. While the enzymes pro-
ducing and degrading the dinucleotide have been reasonably well examined, the regulation of 
c-di-AMP production is not well understood yet. Here we demonstrate that the extracytoplas-
mic regulator CdaR interacts with CdaA via its transmembrane helix to modulate c-di-AMP 
production. Moreover, we show that the phosphoglucosamine mutase GlmM forms a complex 
with CdaA and inhibits the diadenylate cyclase activity in vitro. We also found that GlmM 
inhibits c-di-AMP production in L. monocytogenes when the bacteria encounter osmotic stress. 
Thus, GlmM is the major factor controlling the activity of CdaA in vivo. GlmM can be assigned 
to the class of moonlighting proteins because it is active in metabolism and adjusts the cellular 
turgor depending on environmental osmolarity.  
 
3.2 Introduction 
The Gram-positive bacterium Listeria monocytogenes thrives in diverse environmental niches 
and has the remarkable ability to invade and reproduce inside human cells when ingested with 
contaminated food (Hamon et al., 2006; Radoshevich and Cossart, 2018). Depending on where 
a L. monocytogenes cell is growing, the extracellular osmolarity can vary greatly. Therefore, 
the bacterium must be endowed with sophisticated regulatory systems allowing the cells to 
adjust the cellular turgor to the extracellular osmolarity (Bremer and Krämer, 2019). L. mono-
cytogenes indeed possess regulatory systems to respond to osmotic stress, especially elevated 
osmolarity (Wood, 1999; Sleator and Hill, 2002; Wood, 2011).  
Cyclic di-AMP (c-di-AMP) plays a central role in the adaptation of bacteria to the environ-
mental osmolarity (Commichau et al., 2015, 2018, 2019; Corrigan and Gründling, 2013; Fahmi 
et al., 2017; Stülke and Krüger, 2020; Witte et al., 2008). The dinucleotide is in fact essential 
for Bacillus subtilis, Lactococcus lactis, L. monocytogenes and other Gram-positive bacteria 
since the dinucleotide prevents the uptake of potassium and other osmolytes to toxic levels by 
direct binding to the respective transport systems (Bai et al., 2013, 2014; Blötz et al., 2017; 
Commichau et al., 2018, 2019; Corrigan et al., 2011, 2013; Devaux et al., 2018; Gibhardt et 
al., 2019; Gundlach et al., 2017; Gundlach et al. 2019; Huynh et al., 2016; Kim et al., 2015; 
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Luo and Helmann, 2012; Mehne et al., 2013; Pham et al., 2018; Pham and Turner, 2019; Quin-
tana et al., 2019; Rismondo et al., 2016; Schuster et al., 2016; Whiteley et al., 2015, 2017; 
Witte et al., 2013; Woodward et al., 2010; Zarella et al., 2018; Zeden et al., 2018).  
Recently, it has been shown that c-di-AMP is also involved in osmoadaptation of cyanobacteria 
and archaea (Braun et al., 2019; Rubin et al., 2018). Beside its role in modulating osmolyte 
transport, c-di-AMP regulates the expression of genes encoding osmolyte transporters by bind-
ing to OFF-riboswitches in B. subtilis and Bacillus thuringiensis (Jones et al., 2014; Gao and 
Serganov, 2014; Gundlach et al., 2017; Nelson et al., 2013; Ren and Patel, 2014; Wang et al., 
2019), the sensor kinase KdpD of the KdpDE two-component system in S. aureus (Moscoso 
et al., 2015) and the transcription factor BusR in L. lactis and S. agalactiae (Pham et al., 2018; 
Devaux et al., 2018). Thus, archaea and bacteria have evolved species-specific mechanisms to 
regulate the cellular turgor by employing different osmolyte transporters, but all organisms use 
c-di-AMP in this essential process (Commichau et al., 2018). 
In the past years, several additional c-di-AMP targets of which some are also involved in os-
moadaptation have been identified. For instance, c-di-AMP controls the synthesis of cell wall-
lytic enzymes in Streptomyces coelicolor (St Onge and Elliot, 2017; St-Onge et al., 2015; Sex-
ton et al., 2015). Moreover, c-di-AMP stimulates the DNA-binding activity of the M. smegma-
tis transcription factor DarR, which controls the expression of three genes (Zhang et al., 2013). 
Furthermore, c-di-AMP binds to and inhibits the pyruvate carboxylase in L. lactis and L. mon-
ocytogenes (Choi et al., 2017; Sureka et al., 2014). In the latter organism, c-di-AMP also binds 
to the cystathione-beta-synthase domain-containing (CBS) proteins CbpA and CbpB as well as 
to the PII-like signal transduction protein PstA (also designated as DarA) (Choi et al., 2015; 
Sureka et al., 2014). Like L. monocytogenes PstA, the homologs from B. subtilis and S. aureus 
have been biochemically and structurally characterized (Campeotto et al., 2015; Gundlach et 
al., 2015; Müller et al., 2015). A recent study revealed that c-di-AMP also binds to the B. 
subtilis DarB protein, a homolog of CbpB from L. monocytogenes (Gundlach et al., 2019). The 
same study confirmed that c-di-AMP binds to the osmoprotectant transporter subunit OpuCA. 
Moreover, the K+/H+ antiporter KhtT, the Mg2+ importer MgtE and CpaA were shown to be 
bona fide c-di-AMP-binding proteins. However, the impact of c-di-AMP binding on the func-
tion of these proteins in B. subtilis, of CbpA in L. monocytogenes, and of the CbpB and PstA 
homologs remains to be elucidated.  
c-di-AMP is synthesized by diadenylate cyclases from two molecules of ATP (Commichau et 
al., 2019; Corrigan and Gründling, 2013; Witte et al., 2008). All diadenylate cyclases share the 
diadenylate cyclase (DAC) domain that is fused to regulatory domains, controlling c-di-AMP 
synthesis (Commichau et al., 2019; Corrigan and Gründling, 2013; Witte et al., 2008). So far, 
five different types of diadenylate cyclases have been described (Commichau et al., 2019). 
Bacteria like B. subtilis possess three diadenylate cyclases: the vegetative enzymes DisA and 
CdaA, and the sporulation-specific enzyme CdaS (Luo and Helmann, 2012; Oppenheimer-
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Shanaan et al., 2011; Bejerano-Sagie et al., 2006; Mehne et al., 2013, 2014). DisA is a soluble 
enzyme while CdaA is attached to the membrane via three transmembrane helices (FIG 1B) 
(Witte et al., 2008; Rismondo et al., 2016). In contrast to B. subtilis and its close relatives, the 
majority of bacteria that are known to produce c-di-AMP have only one diadenylate cyclase, 
either DisA or CdaA (Corrigan and Gründling, 2013).  
CdaA is the most-abundant cyclase that is present in many pathogenic bacteria, including L. 
monocytogenes (Woodward et al., 2010; Corrigan et al., 2011; Kamegaya et al., 2011; Dengler 
et al., 2013; Barker et al., 2013; Du and Sun, 2015). Therefore, the diadenylate cyclase CdaA, 
which has been biochemically and structurally characterized, is considered to be an interesting 
target for novel antibiotics (Rosenberg et al., 2015; Heidemann et al., 2019; Tosi et al., 2019). 
c-di-AMP must also be removed from the cell to enable the bacteria to take up osmolytes under 
hyperosmotic conditions, or to re-establish an equilibrium after exceeded c-di-AMP synthesis. 
Indeed, several studies revealed that bacteria can secrete c-di-AMP via multidrug resistance 
transporters (Woodward et al., 2010; Schwartz et al., 2012; Kaplan Zeevi et al., 2013; Barker 
et al., 2013). However, c-di-AMP is mainly degraded by specific phosphodiesterases (PDEs) 
that can be assigned to different classes (Commichau et al., 2019; Huynh and Woodward, 
2016). The GdpP- and PgpH-type PDEs are localized at the membrane and contain domains 
that are involved in signaling and c-di-AMP degradation (Rao et al., 2010; Tan et al., 2013; 
Hyunh et al., 2015; Huynh and Woodward, 2016; Wang et al., 2018). The DhhP-type PDEs 
are soluble and form the third class of c-di-AMP-degrading enzymes (Huynh and Woodward, 
2016; Drexler et al., 2017). As described above, c-di-AMP plays a central role in osmoadapta-
tion. Therefore, the cellular c-di-AMP levels have to be tightly adjusted to the environmental 
osmolarity (Pham et al., 2016). Indeed, perturbation of c-di-AMP metabolism negatively af-
fects growth of a variety of bacteria (Witte et al., 2013; Mehne et al., 2013; Rismondo et al., 
2016; Gundlach et al., 2015, 2016; Bowman et al., 2016; Commichau et al., 2018; I et al., 
2019).  
The cdaA gene located within the conserved cdaA-cdaR-glmM module (FIG 1B). The cdaR 
and glmM genes encode the CdaR protein and the phosphoglucosamine mutase GlmM, respec-
tively, of which the latter is essential for cell wall biosynthesis. CdaR inhibits the diadenylate 
cyclase CdaA in L. lactis, L. monocytogenes and S. aureus (Rismondo et al., 2016; Zhu et al., 
2016; Tosi et al., 2019). Moreover, GlmM interacts and inhibits CdaA in L. lactis and S. aureus 
in vivo (Zhu et al., 2016; Tosi et al., 2019). The interaction between GlmM and CdaA was also 
confirmed in B. subtilis (Gundlach et al., 2015). Recently, it was demonstrated that GlmM 
inhibits CdaA in vitro and both enzymes form a complex in S. aureus (Tosi et al., 2019). Thus, 
GlmM is a moonlighting enzyme because it is active in cell wall biosynthesis and involved in 
the regulation of osmolyte homeostasis (Jefferey, 1999; Jeffery 2019). 
In this study, we have analysed how CdaR and GlmM affect the activity of CdaA in L. mono-
cytogenes. We show that CdaR is an extracytoplasmic protein that is attached to the membrane, 
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modulating CdaA activity and therefore the adaptation of the bacteria to hyperosmotic growth 
conditions. We also demonstrate that GlmM forms a complex with CdaA and that the cell wall 
enzyme inhibits the diadenylate cyclase in vivo and in vitro. Furthermore, we detected an in-
hibitory effect of GlmM on CdaA activity when the cells experience a hyperosmotic shock. 
The fact that GlmM and CdaA also form a complex in L. monocytogenes suggest that the 
GlmM- and CdaR-dependent modulation of the CdaA cyclase activity is conserved among 
Gram-positive bacteria possessing the cdaA-cdaR-glmM module.  
 
3.3 Results 
3.3.1 Cellular localization of CdaA, CdaR and GlmM and CdaR membrane topology 
analysis.  
Previous studies revealed that CdaR and GlmM interact with CdaA and control its DAC activ-
ity (Mehne et al., 2013; Bharat Siva Varma et al., 2015; Rismondo et al., 2016; Bowman et al., 
2016). CdaR is most likely attached to the membrane because the protein contains a transmem-
brane I domain (FIG 1A), while GlmM is supposed to be a soluble protein. So far, it has re-
mained elusive whether GlmM localizes at the membrane. To address this question, we sepa-
rated whole cell-lysates into cytosolic and membrane fractions and analysed the subcellular 
localization of CdaA, CdaR and GlmM by Western blotting using polyclonal antibodies that 
were raised against the three L. monocytogenes proteins (see Materials and Methods). As a 
control, we detected the soluble PrfA protein, the key regulator of virulence gene expression 
in L. monocytogenes (Brehm et al., 1996). The ΔcdaA and ΔcdaR mutant strains BPL77 and 
LMR45, respectively, were included to evaluate whether CdaA and CdaR affect synthesis and 
membrane localization of GlmM. As expected, CdaA, CdaR, GlmM and PrfA were detectable 
in the whole cell-lysates of the wild type strain (FIG 1C). Moreover, CdaR and CdaA were 
enriched in the membrane fractions and GlmM and PrfA both localize mainly in the cytosolic 
fraction (FIG 1C). The lack of CdaA and CdaR did not affect the cellular localization of GlmM 
and PrfA. CdaR was not detectable in the ΔcdaA mutant strain probably because of a negative 
polar effect on cdaR due to cdaA deletion. To conclude, under the conditions tested, GlmM is 
a soluble protein that localizes mainly in the cytoplasm.  
The membrane topology of CdaR was previously predicted in silico (Corrigan and Gründling, 
2013; Rismondo et al., 2016; Bowman et al., 2016). However, it was never analysed experi-
mentally whether the YbbR domains of CdaR are located in the extracytoplasmic space. To 
address this question, we made use of the plasmid pKTop encoding a dual phoA-lacZ reporter 
system (Karimova et al., 2009). The reporter system of the E. coli alkaline phosphatase frag-
ment PhoA 22-472 fused in frame with the α-peptide of the E. coli β-galactosidase, LacZ 4-60 
Chapter 3: An extracytoplasmic protein and a moonlighting enzyme modulate synthesis of 
the essential signaling nucleotide c-di-AMP in Listeria monocytogenes 
 
 38 
(Alexeyev and Winkler, 1999). In this fusion approach, an extracytoplasmic localization results 
in high alkaline and low β-galactosidase activity, while a cytoplasmatic localization of the re-
porter results in low alkaline and high β-galactosidase activity (Karimova et al., 2009). The 
full-length cdaR gene as well as the cdaR ΔTM and cdaR ΔybbR fragments encoding the trun-
cated CdaR variants CdaR ΔTM (34-452) and CdaR ΔybbR (1-33) variants, respectively, were 
introduced into the plasmid pKTop (FIG 1D). We also cloned the prfA (lmo0200) and prkA 
(lmo1820) genes encoding the soluble transcription factor PrfA and the membrane-associated 
serine/threonine kinase PrkA (FIG 1D) (Lima et al., 2011). Next, E. coli DH5α was trans-
formed with the newly constructed plasmids and the empty plasmid (control), and the trans-
formants were analysed on dual-indicator LB plates containing both a blue chromogenic sub-
strate for phosphatase activity (X-Phos) and a red chromogenic substrate for β-galactosidase 
activity (Red-Gal). As expected, the cells carrying the empty plasmid and producing the PrfA 
fusion protein exhibited a red phenotype (Lac+), indicating a cytosolic localization of the PhoA-
LacZ reporter and the PrfA-PhoA-LacZ fusion (FIG 1E). By contrast, the cells producing the 
PrkA- and CdaR-PhoA-LacZ fusion proteins exhibited a blue phenotype (Pho+), indicating that 
the C-termini of both proteins are located in the extracytoplasmic space (FIG 1E). The cells 
producing the CdaR ΔTM and CdaR ΔybbR hybrid proteins exhibited high β-galactosidase and 
high phosphatase activities, respectively (FIG 1E). Thus, the TM domain is required for mem-
brane-association of CdaR and sufficient to promote extracytoplasmic localization of the 
PhoA-LacZ fusion. The transmembrane orientation of PrfA, PrkA, CdaR and the truncated 
CdaR variants was also confirmed by assaying the enzymatic activities of the hybrid proteins 
using cell-free crude extracts (FIG 1F) (see Materials and Methods). To conclude, the PhoA-
LacZ experiment revealed that the YbbR domains of CdaR are located in the extracytoplasmic 
space. 
 
3.3.2 In vivo CdaA-CdaR-GlmM complex formation.  
To test whether the phosphoglucosamine mutase GlmM and the diadenylate cyclase CdaA 
from L. monocytogenes form a complex in vivo, we performed a bacterial two-hybrid (B2H) 
experiment, which is based on the interaction-mediated reconstitution of the Bordetella per-
tussis adenylate cyclase in E. coli (Karimova et al., 1998). We also included CdaR that was 
previously shown to interact with CdaA (Gundlach et al., 2015; Rismondo et al., 2016). The 
B2H experiment revealed that all proteins showed self-interaction and confirmed the formation 
of a CdaR-CdaA complex, which is likely mediated by the TM domains (FIG 2) (Rismondo et 
al., 2016). The experiment also revealed that the phosphoglucosamine mutase GlmM and the 
diadenylate cyclase CdaA from L. monocytogenes form a complex. Thus, the CdaA-CdaR-
GlmM complex formation and the GlmM- and CdaR-dependent modulation of the CdaA 
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cyclase activity seems to be conserved among bacteria possessing the cdaA-cdaR-glmM mod-
ule. 
 
3.3.3 In vitro CdaA-GlmM complex formation.  
To assess whether GlmM and CdaA of L. monocytogenes form a complex in vitro, we purified 
the His-tagged and GST-tagged GlmM and Δ100CdaA proteins, respectively, from E. coli and 
performed a pull-down assay. The Δ100CdaA cyclase variant lacks the N-terminal TM do-
mains and 20 additional amino acids forming the linker between TM and DAC domain, which 
facilitates the purification success of the membrane protein (Rosenberg et al., 2015; Heidemann 
et al., 2019). The elution fraction containing the GST-Δ100CdaA fusion protein was incubated 
with the PreScission protease to cut off the GST-tag (see Materials and Methods). The proteins 
were mixed in a 1:1 ratio and added to a gravity flow column containing TALON-cobalt beads. 
As a control, the Δ100CdaA was pipetted alone onto a column. Both columns were washed, 
the proteins were eluted with imidazole and the fractions were analysed by SDS page. While 
GlmM disappeared from the washing fractions, Δ100CdaA was present in each of the fractions 
(FIG 3A). By contrast, Δ100CdaA was only detectable in the first washing fraction of the con-
trol batch, indicating that the protein does not bind to the beads (FIG 3B). The presence of 
Δ100CdaA in the washing and elution fractions that were obtained from the column containing 
both proteins indicates that the immobilized GlmM protein interacts and retains the cyclase. 
To conclude, GlmM and Δ100CdaA from L. monocytogenes form an unstable complex in vitro. 
We also performed size exclusion chromatography to get further experimental evidence for the 
formation of GlmM-Δ100CdaA complex. When the two proteins were purified separately, two 
peaks appeared due to the presence of GlmM and Δ100CdaA (FIG 4A). By contrast, when the 
proteins were co-purified, two faster eluting peaks appeared, indicating the formation of high-
molecular weight complexes consisting of GlmM and Δ100CdaA (elution peaks 1 and 2; FIG 
4A). The subsequent SDS page analysis of the elution fractions confirmed that both proteins 
co-eluted from the column, indicating the formation of a GlmM-Δ100CdaA complex (FIG 4B). 
To estimate the size and stoichiometry of the GlmM-Δ100CdaA complex, we performed SEC-
MALS and ITC. Based on the SEC-MALS elution profile, the GlmM-Δ100CdaA complex had 
an estimated molecular weight of 105.0 kDa ± 2.18 % (FIG 5A, Table 1). These data are con-
sistent with a GlmM-Δ100CdaA complex comprising one GlmM dimer (estimated mass 85.63 
kDa ± 2.072 %) interacting with one Δ100CdaA dimer (estimated mass of the dimer 36.27 kDa 
± 1.7 %), with a theoretical molecular weight of 134.7 kDa (Table 1). The ITC analysis further 
supports the formation of a weak GlmM-Δ100CdaA complex (KD = 1.09 µM ± 66.5 nM) con-
sisting of GlmM and Δ100CdaA in 1:1 ratio (FIG 5B and 5C). The parameters for the titration 
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series of the ITC analysis are given in Table S3. Taken together, the biochemical analyses show 
that GlmM and Δ100CdaA from L. monocytogenes form a complex. 
 
3.3.4 Role of CdaR in salt adaptation and in controlling cellular c-di-AMP levels. 
To evaluate whether CdaR is involved in osmotic stress tolerance in L. monocytogenes, we 
performed a high-throughput screen based on the Biolog phenotype microarray technology 
(Biolog Inc.; Bochner et al., 2001). The Biolog assay allows assessing and comparing the re-
sponses of bacterial strains to more than 1000 distinct growth conditions by cultivating strains 
in 96-well microplates, with each well presenting a different culture condition. The metabolic 
activity of the cells is determined by measuring their respiration, which converts the colourless 
tetrazolium into a purple dye. The colour intensity, which corresponds to the metabolic activity 
of the cell, can be measured. We determined the metabolic activities of the L. monocytogenes 
wild type and ΔcdaR strains in the microarray plates PM 1 – 10 and 13B (see FIG S1). The 
Biolog assay revealed strong metabolic differences among the strains in the plate PM9, which 
is supplemented with increasing amounts of the osmolyte sodium chloride and other salts, and 
in the plates PM 6-8, which are supplemented with di- or tri-peptides (especially if containing 
aromatic amino acids) that are known to be important osmolytes for L. monocytogenes (White-
ley et al., 2015, 2017, FIG 6A, FIG S1).  
To uncover whether the lack of CdaR also affects growth of L. monocytogenes in the presence 
of osmolytes, we cultivated the strains in BHI broth with increasing amounts of sodium chlo-
ride, potassium chloride or sorbitol. As shown in FIG 6B, the wild type was more resistant to 
osmotic stress than the ΔcdaR strain. This indicates that CdaR, which was shown to inhibit 
CdaA and thus c-di-AMP production in L. monocytogenes (Rismondo et al., 2016), is indeed 
involved in the adaptation of the bacterium to osmotic stress during growth in BHI rich me-
dium. 
Next, we assessed to role of CdaR and truncated variants ΔTM and ΔybbR 1-4 lacking the 
transmembrane and the four YbbR domains, respectively, in modulating c-di-AMP production 
in L. monocytogenes during adaptation to osmotic stress. For this purpose, we introduced plas-
mids allowing the IPTG-dependent expression of the full-length and truncated cdaR alleles into 
the genome and deleted the native cdaR gene see (Materials and Methods). The wild type strain 
carrying the integrated empty vector served as a control. The strains were cultivated in LSM 
medium until an OD600 of 0.5-0.6 and samples for determining the cellular c-di-AMP levels 
were taken. The cultures were split and diluted with pre-warmed LSM medium containing 
sodium chloride to a final concentration of 0.5 M, or with equal amounts of standard LSM 
medium as a control. The cultures were further incubated for 25 minutes and samples for de-
termining the cellular c-di-AMP levels were taken (FIG 6C).  
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As shown in FIG 6D, in all strains the c-di-AMP levels did not change when the cultures were 
diluted with standard LSM medium. Previously, it has been observed that the overexpression 
of the cdaR gene in L. monocytogenes during growth in BHI rich medium inhibits c-di-AMP 
production. Here we show that CdaR has a positive effect on the cellular c-di-AMP levels when 
the bacteria are grown in LSM medium (FIG 6D, middle panel). Thus, the effect of CdaR on 
c-di-AMP production seems to depend on the medium and growth conditions. The c-di-AMP 
levels were similar in the ΔcdaR strains carrying the empty vector and the vector encoding the 
CdaR ΔTM variant. Thus, CdaR has to be attached to the cell surface to be able to regulate the 
activity of CdaA.  
Surprisingly, the c-di-AMP levels were strongly reduced in bacteria producing only the TM 
domain of CdaR (ΔybbR 1-4 variant). This could indicate that the TM domain of CdaR controls 
the dimerization of CdaA, which is crucial for c-di-AMP synthesis. Except for the strain pro-
ducing only the TM domain of CdaR, the c-di-AMP levels dropped upon osmotic stress, espe-
cially in the case of the wild type and CdaR overexpressing strains (FIG 6 D). To conclude, 
CdaR influences c-di-AMP production in L. monocytogenes during growth in LSM medium. 
However, CdaR does not seem to be the sole regulator of CdaA activity. Under osmotic stress 
the bacteria can adjust the cellular levels of the signaling nucleotide independent of CdaR, as 
demonstrated by the reduction of c-di-AMP in the cdaR deletion mutant. 
 
3.3.5 Control c-di-AMP synthesis by CdaR and GlmM in E. coli.  
Next, we assessed the ability of GlmM, CdaR, and of the N- and C-terminally truncated CdaR 
variants ΔTM, ΔybbR 4, ΔybbR 3-4, ΔybbR 2-4 ΔybbR 1-4 to modulate the activity of CdaA 
in a heterologous system. For this purpose, we introduced the plasmid pBP384 allowing the 
expression of the L. monocytogenes kimA potassium transporter gene E. coli strain LB2003 
lacking the native potassium transporters. Expression of the kimA gene allows the E. coli strain 
to grow in minimal medium under potassium limitation (Gibhardt et al., 2019). Since c-di-
AMP inhibits KimA when CdaA is also synthesized by the E. coli strain, the growth rate of the 
bacteria serves as a read out to evaluate whether proteins activate or inhibit the cyclase (FIG 
6E).  
Indeed, while the wild type CdaA reduced the growth rate of the reporter strain, the growth 
rate was about 2-fold higher when the catalytically inactive CdaA D171N variant was produced 
(FIG 6F). The growth was also faster when the full-length and the C-terminally truncated CdaR 
variants were synthesized. Thus, CdaR inhibits CdaA but the YbbR domains are not crucial for 
regulating the cyclase in a heterologous system. When the N-terminally truncated CdaR variant 
ΔTM was produced, CdaA was only slightly inhibited. Thus, the ability of CdaR to inhibit 
CdaA depends on the cellular localization (see FIG 6D). The growth rate of the E. coli strain 
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synthesizing GlmM was also increased, indicating that the cell wall enzyme is also capable of 
modulating the activity of CdaA in L. monocytogenes (FIG 6F). However, at least in E. coli, 
CdaR has as a stronger ability of modulating the cyclase activity than GlmM alone (Fig. 6F). 
To conclude, CdaR as well as GlmM can modulate the enzymatic activity of CdaA, if expressed 
in a heterologous system. 
 
3.3.6 GlmM negatively regulates CdaA activity in vitro.  
A previous suppressor screen with L. lactis revealed that GlmM inhibits the cyclase activity of 
CdaA in vivo (Zhu et al., 2015). It has also been observed that the replacement of isoleucine 
154 by phenylalanine within a region of high sequence conservation in GlmM enabled the 
enzyme to stronger inhibit CdaA (Zhu et al., 2015) (FIG 7A). Moreover, a recent study showed 
that GlmM inhibits CdaA in S. aureus (Tosi et al., 2019).  
To assess whether GlmM also inhibits Δ100CdaA in vitro, we purified the L. monocytogenes 
enzymes and determined the activity of the cyclase using the coralyne assay for c-di-AMP 
quantification (Zheng et al., 2014; Heidemann et al., 2019). To evaluate whether the tyrosine 
153 and phenylalanine 154 residues are important for the GlmM-dependent regulation of 
Δ100CdaA, we also purified the GlmM Y153A, F154I and F154A variants (see Materials and 
Methods) (FIG 7A). As previously described, Δ100CdaA was only capable of producing c-di-
AMP in the presence of Mn2+ and Co2+ ions (Rosenberg et al., 2015; Heidemann et al., 2019) 
(FIG 7B). As expected, no c-di-AMP was formed in the control sample when only GlmM and 
Mn2+ ions were present. However, a decrease in c-di-AMP production was detected in these 
samples containing CdaA and Mn2+ upon addition of increasing amounts of GlmM (FIG 7B). 
No c-di-AMP was detected when Δ100CdaA was mixed at a 1:2 molar ration with GlmM. The 
inhibition of CdaA by GlmM variants with the amino acid replacements at position 154 was 
slightly reduced. The amino acid replacement at position 153 did not affect the GlmM-depend-
ent inhibition of Δ100CdaA (FIG 7B).  
To conclude, GlmM inhibits CdaA from L. monocytogenes and the phenylalanine residue at 
position 154 in GlmM is important for controlling the activity of the cyclase. 
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3.3.7 Inhibition of CdaA by GlmM in L. monocytogenes.  
To evaluate whether GlmM also inhibits the activity of CdaA in L. monocytogenes in vivo, we 
constructed strains allowing the IPTG-dependent overproduction of the wild type GlmM and 
the GlmM F154I variants. As shown above, the GlmM F154I variant does not inhibit CdaA as 
strong as the wild type GlmM enzyme (see above) (FIG 7B).  
To assess whether a GlmM from a bacterium that does not produce c-di-AMP is capable of 
inhibiting CdaA, we replaced the native glmM gene with the glmM gene from E. coli. The wild 
type L. monocytogenes strain carrying the integrated empty vector served as a control. As 
shown in FIG 7C, growth of the strains was not affected when the GlmM variants were over-
produced after the addition of IPTG. Surprisingly, the strain carrying the inducible E. coli 
glmM allele grew also in the absence of IPTG. It is tempting to speculate that GlmM from E. 
coli is more active than the L. monocytogenes enzyme, thereby allowing the bacteria to produce 
sufficient amounts of precursors for cell wall biosynthesis in the absence of IPTG. By contrast, 
the strains in which the native GlmM variants were depleted grew much slower than the wild 
type strain (FIG 7C). To conclude, the native GlmM can be replaced by the F154I variant and 
by the homolog from E. coli in L. monocytogenes without affecting bacterial growth.  
Next, we determined the intracellular c-di-AMP levels in the L. monocytogenes strains produc-
ing the different GlmM variants during growth in LSM medium. As shown in FIG 7D, the c-
di-AMP levels were only slightly reduced in the strains overproducing the GlmM variants. 
Thus, the overproduction of GlmM per se is not sufficient for inhibiting CdaA in vivo. To 
assess whether the GlmM variants modulate the production of c-di-AMP in L. monocytogenes 
during adaptation to osmotic stress, we cultivated the strains in LSM medium until an OD600 
of 0.5-0.6 and samples for determining the cellular c-di-AMP levels were taken. The cultures 
were split and diluted with pre-warmed LSM medium containing sodium chloride to a final 
concentration of 0.5 M, or with equal amounts of standard LSM medium as a control. The 
cultures were further incubated for 25 minutes and the c-di-AMP levels were compared with 
those obtained from culture samples prior to the dilution step.  
As shown in FIG 7D, in all strains the c-di-AMP levels did not change when the cultures were 
diluted with LSM medium. By contrast, the cellular c-di-AMP levels strongly decreased in the 
strains overproducing the native GlmM enzyme after salt stress (FIG 7D). The decrease of the 
c-di-AMP level was less pronounced in a strain producing the GlmM F154I variant, indicating 
that the phenylalanine residue at position 154 in GlmM is important for controlling CdaA ac-
tivity in vivo.  
The E. coli GlmM enzyme did not inhibit the production of c-di-AMP in L. monocytogenes 
during adaptation to osmotic stress. To conclude, GlmM also inhibits CdaA in L. monocyto-
genes and the GlmM-dependent control of c-di-AMP synthesis depends on osmotic stress. 
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In the present study, we have confirmed that CdaR directly interacts with CdaA and modulates 
the activity of the diadenylate cyclase of L. monocytogenes (FIG 2). As previously reported, 
CdaR and CdaA form a complex in B. subtilis and L. monocytogenes (Gundlach et al., 2015; 
Rismondo et al., 2016; Zhu et al., 2016). However, due to the fact that the membrane topology 
of CdaR was unknown, it was unclear which domain of the regulatory protein interacts with 
CdaA. Our topology analysis suggests that the YbbR domains of CdaR are exposed to the 
peptidoglycan layer of the cell envelope (FIG 1, FIG 8). Therefore, the interaction between 
CdaR and CdaA, and thus the control of the diadenylate cyclase, is very likely to be mediated 
through the transmembrane helices. Indeed, the cellular c-di-AMP levels were strongly reduced 
in a L. monocytogenes cdaR mutant strain overproducing only the transmembrane helix of 
CdaR (FIG 6D). The molecular details underlying the inhibition of CdaA by the transmem-
brane helix and the extracytoplasmic signal perceived by the YbbR domains remain to be elu-
cidated.  
Previously, we have reported that CdaR inhibits CdaA in L. monocytogenes cells that were 
cultivated in BHI rich medium (Rismondo et al., 2016). The inhibition of CdaA by CdaR was 
also shown in S. aureus (Bowman et al., 2016). Interestingly, the inhibitory effect of CdaR was 
increased under acidic conditions, a phenomenon that remains to be resolved. CdaR of S. au-
reus is also capable of reducing c-di-AMP production by CdaA in the environment of an E. 
coli cell (FIG 6F) (Zhu et al., 2016).  
Here we have observed that the overproduction of CdaR may also stimulate c-di-AMP synthe-
sis in L. monocytogenes cells that were cultivated in LSM defined medium (FIG 6D). Moreo-
ver, for B. subtilis it has been shown that CdaR stimulates the activity of CdaA when the cdaR 
and cdaA genes are co-expressed in E. coli (Mehne et al., 2013). Thus, depending on the growth 
conditions and the cellular environment, CdaR either inhibits or activates the diadenylate 
cyclase CdaA. Since CdaR is facing towards the peptidoglycan layer of the cell envelope it is 
tempting to speculate that the YbbR domains perceive mechanical shear forces arising as a 
result of a displacement of the membrane and the peptidoglycan in response to an osmotic up- 
or downshift (FIG 8). This model implies that the YbbR domains of CdaR interact with the 
peptidoglycan, or with proteins that are embedded in the cell wall, or that the reported self-
interaction of the YbbR domains effect the interaction of CdaA via the transmembrane domains 
(Rismondo et al., 2016).  
However, so far, we were unable to detect an interaction between the YbbR domains and the 
peptidoglycan layer (unpublished data). Thus, the signals that are perceived by the YbbR do-
mains of CdaR and transmitted by the transmembrane helix to CdaA remain to be identified. 
Structural studies of the YbbR domains I and IV of the CdaR protein from Desulfitobacterium 
hafniense Y51 uncovered similarities to the C-terminal domains of the TL5 and L25 ribosomal 
proteins (Barb et al., 2011). However, the potential interaction partners of C-terminal domains, 
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which are exposed to the surface of the ribosome are currently unknown. It will be interesting 
to find out whether the YbbR domains of different proteins respond to similar or different 
stimuli.  
In the present study, we have also demonstrated that the phosphoglucosamine mutase GlmM 
directly interacts with CdaA and inhibits the activity of the cyclase in vitro and in vivo (FIG 
7B and 7D). Furthermore, we could show that only the native phosphoglucosamine mutase is 
capable of inhibiting CdaA when the cells encounter hyperosmotic growth conditions (FIG 
7D). Since the formation of a CdaA-GlmM complex has also been reported to occur in bacteria 
like B. subtilis, L. lactis and S. aureus, which are phylogenetically related to L. monocytogenes 
(Gundlach et al., 2015; Zhu et al., 2016; Tosi et al., 2019), the GlmM-dependent control of 
CdaA seems to be specific and a conserved among species possessing the cdaA-cdaR-glmM 
module. The specificity of the interaction between GlmM and CdaA is further supported by 
the observation that the replacement of the phenylalanine (F) at position 154 in GlmM by either 
isoleucine (I) or alanine (A) decreases the ability of the enzyme to inhibit CdaA (FIG 7B). The 
amino acid at the position 154 was previously reported to be important for the GlmM-depend-
ent control of CdaA activity in the L. lactis strain MG1363 (FIG 7A) (Zhu et al., 2016). How-
ever, albeit to a lesser extent, the GlmM F154I and F154A variants of L. monocytogenes still 
inhibited CdaA, indicating that additional residues of the phosphoglucosamine mutase are in-
volved in the formation of the protein complex. Indeed, a recent structural model of the CdaA-
GlmM complex from S. aureus revealed that other amino acid residues surrounding the phe-
nylalanine 154 might be important for the regulatory protein-protein interaction (Tosi et al., 
2019). However, a more comprehensive mutational study and a structural analysis of the CdaA-
GlmM complex might provide insights into the molecular details of the interaction.  
Given the fact that the GlmM enzyme has an additional function beside its role in providing 
precursors for cell wall biosynthesis, the phosphoglucosamine mutase can be assigned to the 
class of “moonlighting proteins” (Jeffery, 2019). In general, moonlighting proteins perform 
two or more distinct and physiologically relevant biochemical or biophysical functions in the 
cell (Jeffery, 2019). Research in recent years has shown that the phenomenon of moonlighting 
is widespread among bacterial proteins. For instance, the B. subtilis and E. coli UDP-glucose 
diacylglycerol glucosyltransferases UgtP and OpgH, respectively, which are active in lipid me-
tabolism, act as metabolic sensors coupling the nutritional availability to cell division and thus 
cell size (Weart et al., 2007; Hill et al., 2013). The glutamate dehydrogenases RocG and GudB1 
of B. subtilis are active in glutamate degradation and in controlling de novo synthesis of gluta-
mate (Commichau et al., 2007a; Stannek et al., 2015). For many moonlighting enzymes, the 
signals controlling the secondary function of the enzymes have been identified (Commichau 
and Stülke, 2008). However, this is not the case for GlmM, which controls the activity of CdaA 
and thus the uptake of osmolytes via transporters whose activities are regulated by c-di-AMP 
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(Stülke and Krüger, 2020). Even though osmoregulation has been intensively studied in bacte-
ria, it is still rather unclear how the cell senses the environmental osmolarity to adjust the turgor 
accordingly. The present study and a previous report revealed that GlmM alone is sufficient to 
inhibit CdaA (Tosi et al., 2019) and the membrane bound CdaR protein rather plays a minor 
role in modulating the CdaA activity in these coccoid bacteria. This idea is supported by the 
finding that some bacterial isolates like the L. lactis strain MG1363, which does not produce a 
functional CdaR protein, still adjusts the cellular c-di-AMP levels by employing GlmM (Zhu 
et al., 2016). 
So how does a cell synthesizing CdaA and GlmM sense osmotic up- and downshifts and how 
is c-di-AMP production regulated by employing the phosphoglucosamine mutase? Over the 
past years it has been observed that in many bacteria c-di-AMP is controlling the uptake and 
efflux of potassium ions to adjust the cellular turgor (Stülke and Krüger, 2020). Thus, the cel-
lular potassium concentration could control the regulatory interaction between GlmM and 
CdaA. However, in addition to potassium, other osmolytes like glycine betaine and carnitine 
are taken up by c-di-AMP-regulated transporters (Commichau et al., 2018; Stülke and Krüger, 
2020). Therefore, it can be assumed that a mechanism, which is independent of a specific os-
molyte, ensures the adjustment of the cellular turgor. 
It would be an attractive idea to assume that the volume changes in response to an osmotic up- 
or downshift would result in a transient change in the cellular GlmM concentration, which in 
turn could affect c-di-AMP synthesis. The adjustment of the c-di-AMP levels would then lead 
to an inhibition and activation of osmolyte uptake and export, respectively, to adjust the cellular 
turgor to the environment. However, the most exciting question of how the cell uses c-di-AMP 
to adapt the turgor to the environmental osmolarity remains to be answered.  
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3.5 Experimental Procedure 
3.5.1 Chemicals, media, bacterial strains and growth conditions.  
Chemicals and media were purchased from Sigma-Aldrich (Munich, Germany), Carl Roth 
(Karlsruhe, Germany) and Becton Dickinson (Heidelberg, Germany). Primers were purchased 
from Sigma-Aldrich (Munich, Germany) and are listed in Table S1. E. coli strains were grown 
in lysogeny broth (LB) and in M9 minimal medium, as previously described (Gibhardt et al., 
2019). Agar plates were prepared with of 15 g agar/l (Roth, Germany). E. coli transformants 
were selected on LB plates containing kanamycin (50 µg/ml) or ampicillin (100 µg/ml). L. 
monocytogenes was grown in brain-heart-infusion (BHI) medium (Sigma-Aldrich, Germany) 
or in Listeria Synthetic Medium (LSM; Whiteley et al., 2017), as previously described 
(Gibhardt et al., 2019). All bacteria used in this study are listed in Table S2.  
Potassium transporter deficient E. coli strains LB650 and LB2003 were cultivated in LB-K 
medium (NaCl substituted by 1 % KCl (w/v)) (Stumpe and Bakker 1997). M9 medium was 
used for E. coli growth experiments with the following composition: 37.85 mM Na2HPO4, 
22.05 mM KH2PO4, 18.75 mM NH4Cl, 1 mM MgSO4, 0.1 mM CaCl2, 0.5 μM FeCl3, 28 mM 
D-glucose or glycerol as sources of carbon (Gibhardt et al., 2019). For the E. coli strain LB650 
the M9 medium was supplemented with amino acids L-valine, L-isoleucine, L-methionine, L-
proline, L-serine (each 0.02 % (w/v)) and 3 μM thiamine. For the E. coli strain LB2003 the M9 
medium was supplemented with 0.0066 % (w/v) casein hydrolysate (acid) (Oxoid), 0.004 % 
(w/v) L-proline and 3 μM thiamine. For experiments with defined potassium concentrations, 
the KH2PO4 salt was replaced by NaH2PO4 and KCl was added as indicated. If not specified 
different, IPTG was used at a concentration of 50 μM and L-arabinose at 0.005 % (w/v). 
Growth in liquid medium was monitored using 96-well plates (Microtest Plate 96-Well,F, Sar-
stedt) at 37°C and medium orbital shaking at 237 cpm (4 mm) in an Epoch 2 Microplate Spec-
trophotometer, equipped with the Gen5 software (02.09.2001; BioTek Instruments) and the 
OD600 was measured in 15 min intervals.  
To evaluate the growth of the ΔcdaR mutant (LMJR45) compared to the EGD-e wt under os-
motic stress conditions, bacteria were grown overnight from single colonies in 5 ml BHI me-
dium at 37°C and 220 rpm. 10 ml BHI were inoculated from the pre-cultures to an OD600 of 
0.1 and grown at 37°C and 220 rpm until they reached an OD600 of 0.4-0.8. The optical density 
was adjusted to 0.2 and 100 μl of the cell suspension was pipetted into 96-well plates, contain-
ing 100 μl BHI medium with 0, 0.25, 0.5, 0.75, 1, 1.5 and 2 M of NaCl, KCl, or D-sorbitol. 
Bacteria were grown using an Epoch2 multiwell platereader as described above. The growth 
rates of the exponential phases were determined as described previously (Gibhardt et al., 2019) 
and plotted against the osmolyte concentration.  
The essentiality of the GlmM variants for growth of the L. monocytogenes strains BPL63, 
BPL64 and BPL65 lacking the native glmM copy was analysed as follows. The strain BPL45 
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served as a control. 5 ml BHI medium were inoculated with the strains and incubated over 
night at 37°C at 220 rpm. The 2 ml of the cultures were centrifuged for 1 min at 20,000 g, the 
cells were washed twice in BHI and used to inoculate the next cultures (5 ml each) at an OD600 
of about 0.1. The cultures were incubated for 24 h, the cells were washed again three times in 
BHI medium and used to inoculate 96 well plates containing 200 µl BHI medium without and 
with 1 mM IPTG to an OD600 of about 0.1. Growth was monitored in a microplate reader at 
37°C. 
 
3.5.2 DNA manipulation, construction of plasmids and mutant strains.  
The plasmids that were used and constructed in this study are listed in Table S2. Transfor-
mation of E. coli was performed using standard procedures (Sambrook et al., 1989). Plasmids 
were isolated from E. coli using the Nucleospin Extract Kit (Macherey and Nagel, Germany). 
PCR products were purified using the PCR Purification Kit (Qiagen, Germany). DNA poly-
merases, restriction enzymes, DNA ligases were purchased from Thermo Scientific (Germany) 
and used according to the manufacturer’s instructions. Other DNA sequencing performed the 
SeqLab Sequence Laboratories (Göttingen, Germany). L. monocytogenes chromosomal DNA 
was isolated using the NucleoSpin Microbial DNA Kit (Macherey and Nagel, Germany).  
L. monocytogenes mutant strains were constructed using the pMAD plasmid system (Arnaud 
et al., 2004), as previously described (Gibhardt et al., 2019). Deletion of genes in L. monocyto-
genes was confirmed by colony PCR (Dussurget et al., 2002) and DNA sequencing. The inser-
tion of pIMK3-derived plasmids (Monk et al., 2008) into the attB site of the tRNAArg locus in 
the L. monocytogenes genome was confirmed by PCR (Rismondo et al., 2016). The plasmid 
pBP1002 was constructed for the deletion of the glmM gene in L. monocytogenes. The DNA 
fragments surrounding the glmM gene were amplified by PCR with the primer pairs RB6/RB7 
and RB8/RB9, fused in a second PCR. The fusion product was digested with the enzymes 
EcoRI and BamHI, and ligated to the plasmid pMAD (Arnaud et al., 2004).  
The plasmid pBP223 was constructed for the overexpression and purification of N-terminally 
Strep-tagged CdaR protein lacking the amino acids 1-28. The cdaR fragment was amplified by 
PCR using the primer pair JR28/JR56. The PCR product was digested with SacI and BamHI 
and ligated to the plasmid pGP172 (Merzbacher et al., 2004). The plasmids pBP260 (cdaA-
cdaR ΔTM), pBP261 (cdaA-cdaR ΔybbR 4), pBP262 (cdaA-cdaR ΔybbR 3-4), pBP263 (cdaA-
cdaR ΔybbR 2-4), pBP264 (cdaA-cdaR ΔybbR 1-4) and pBP387 (cdaA-cdaR) were con-
structed for the arabinose-dependent expression of CdaA together with CdaR variants in the E. 
coli strain LB2003. 
The cdaA-cdaR ΔTM, cdaA-cdaR ΔybbR 4, cdaA-cdaR ΔybbR 3-4, cdaA-cdaR ΔybbR 2-4, 
cdaA-cdaR ΔybbR 1-4 and cdaA-cdaR operons were amplified by PCR using the primers 
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JH51/JH135//JH136/JH103 (fragments joined by SOE PCR; Horton et al., 1990), JH51/JH138, 
JH51/JH139, JH51/JH140, JH51/JH137, and JH51/JH103, respectively, digested with XbaI 
and HindIII and ligated to the plasmid pBAD33 (Guzman et al., 1995). The plasmids pBP388 
(cdaA-cdaR-glmM) and pBP389 (cdaA-glmM) were constructed for the expression of CdaA 
together with CdaR/GlmM and with GlmM, respectively, in the E. coli strain LB2003. For this 
purpose, the glmM gene was amplified by PCR using the primer pair JH104/JH105, digested 
with HindIII and PstI, and ligated to pBP387 and pBP370 (Gibhardt et al., 2019) yielding in 
the plasmids pBP388 and pBP389, respectively. The plasmids pBP255 and pBP259 were con-
structed for the expression of the cdaR ΔTM and cdaR ΔYbbR 1-4 genes in L. monocytogenes, 
respectively. The cdaR fragments were amplified using the primer pairs JH130/JH22 and 
JH21/JH131, digested with NcoI and SalI, and ligated to the plasmid pIMK3 (Monk et al., 
2008).  
The plasmids pBP1000, pBP1001 and pBP1003 were constructed for the expression of the 
glmM-E. coli, glmM-L. monocytogenes and glmM T460A-L. monocytogenes phosphoglucosa-
mine mutase genes in L. monocytogenes. The glmM genes were amplified by PCR using chro-
mosomal DNA from E. coli W3110 and L. monocytogenes and the primer pairs RB3/RB4 and 
RB1/RB2 and (Table S1 and S2). The PCR products were digested with PstI/NcoI and ligated 
to the plasmid pIMK3 (Monk et al., 2008). The T460A nucleotide exchange was introduced 
using the mutagenic primer RB5 as described previously (Commichau et al., 2007a).  
The plasmids pBP366 and pBP369 were constructed for the overexpression and purification of 
His-tagged GlmM and GST-tagged GlmM proteins, respectively. The glmM gene was ampli-
fied by PCR using the primer pairs FC334/FC335 and JR72/JR73 and chromosomal DNA from 
L. monocytogenes. The glmM genes were digested with BsaI/XhoI and BamHI/XhoI and ligated 
with the plasmids pET SUMOadapt and pGEX-6P1, respectively, that were digested with the 
same enzyme pairs.  
The plasmids GlmM_Y153A, GlmM_F154A and GlmM_F154I for the overexpression GlmM 
variants GlmM Y153A, GlmM F154A and GlmM F154I for the in vitro DAC assay were con-
structed by site-directed mutagenesis (Heidemann et al., 2019) using the primer pairs 
GlmM_Y153A_F/GlmM_Y153A_R, GlmM_F154A_F/GlmM_F154A_R and 
GlmM_F154I_F/GlmM_F154I_R (Table S1) and the plasmid pBP366 as a template (Table 
S2).  
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3.5.3 Determination of membrane topology.  
To determine the membrane topology of CdaR, the plasmids pBP250 (CdaR), pBP251 (CdaR 
ΔYbbR 1-4), pBP252 (CdaR ΔTM), pBP253 (PrkA) and pBP254 (PrfA) were constructed. The 
full-length cdaR, prkA and prfA genes were amplified with the primer pairs JH121/JH122, 
JH126/JH127 and JH128/JH129, respectively. The cdaR ΔybbR 1-4 and cdaR ΔTM fragments 
encoding truncated CdaR variants were amplified with the primer pairs JH121/JH124 and 
JH123/JH122, respectively. The PCR products were digested with BamHI and KpnI, and li-
gated to the pKTop plasmid (Karimova et al., 2009) digested with the same enzymes. Next, the 
plasmids pBP250, pBP251, pBP252, pBP253, pBP254 and pKTop were introduced into E. coli 
DH5α by transformation. The strains were grown in LB medium from an OD600 of 0.1 to 0.3-
0.6 from overnight cultures. The OD600 was adjusted to 0.1 and 5 µl of the cell suspensions 
were propagated on LB plates containing kanamycin, 1 mM IPTG, 80 µg/ml 5-bromo-4-
chloro-3-indolyl phosphate (X-Phos, Sigma-Aldrich), 100 µg/ml 6-chloro-3-indolyl-β-D-ga-
lactopyranoside (Red-Gal, Sigma-Aldrich) and 50 mM sodium phosphate buffer (pH 7). The 
plates were incubated for 24 h at 37°C (Karimova et al., 2009).  
For the quantification of the alkaline phosphatase and β-galactosidase activity a slightly mod-
ified procedure as described by (Thongsomboon et al., 2018) was applied. DH5α cells that 
were grown in LB medium to an OD600 of 0.5-0.6 at 37°C and 220 rpm were harvested (1.5 
ml) by centrifugation at 20,000 g at 4°C for 2 min. Two of the cell pellets were washed in 1 ml 
Z buffer (60 mM Na2HPO4, 40 mM NaH2PO4, 10 mM KCl, 1 mM MgSO4) and the remaining 
two pellets were washed in 1 ml 10 mM Tris (pH 8). Next, the cell pellets were re-suspended 
in 1 ml of the washing buffers and lysed by adding 50 µl 0.1 % (w/v) SDS and 50 µl chloroform 
and by vortexing for 10 s followed by a 10 min long incubation at room temperature. To deter-
mine the β-galactosidase activity, 200 µl of Z buffer containing 4 mg/ml o-nitrophenyl-β-D-
galactopyranoside (ONPG, Sigma-Aldrich) was added. Reactions were stopped by adding 500 
µl 1 M Na2CO3 when samples turned yellow and the time was noted. The OD415 was deter-
mined after centrifugation for 10 min at 20,000 g. The specific β-galactosidase activity 
[µmol/min/mg] was calculated. For determining the alkaline phosphatase activity, 800 µl of 
the cells that were lysed in 10 mM Tris (pH 8) were added to 100 µl pNPP solution (SigmaFast 
solution 1 mg/ml p-nitrophenyl phosphate in 200 mM Tris pH 8, Sigma-Aldrich). The samples 
were incubated at 37°C until they turned yellow. Reactions were stopped by adding 100 µl 3 
M NaOH, the time was noted. The OD415 was determined after centrifugation for 10 min at 
20,000 g. The specific alkaline phosphatase activity [µmol/min/mg] was calculated. 
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3.5.4 Bacterial two-hybrid (B2H) assay.  
The primary protein-protein interactions were analysed using the (B2H) system (Claessen et 
al., 2008; Karimova et al., 1998). Plasmid pairs pUT18C/pKT25 and pUT18/p25-N were used 
for the expression of proteins fused to the C and N termini, respectively, of the T18 and T25 
fragments of CyaA (Karimova et al., 1998). The plasmids constructed for the B2H analysis are 
listed in Table S2. The genes were amplified using the oligonucleotides listed in Table S1 and 
cloned between the XbaI and KpnI sites of the plasmids pUT18, pUT18C, p25-N, and pKT25. 
pUT18C-zip and pKT25-zip served as controls. The construction of the plasmids for the ex-
pression of the cdaA and cdaR genes has been described previously (Rismondo et al., 2016). 
The glmM gene was amplified using the primer pair FC336/FC337. The DNA sequences were 
verified using the oligonucleotides FC146, FC147, FC148, and FC150. Plasmids were used for 
the co-transformation of E. coli BTH101, and the protein-protein interactions were then ana-
lysed by plating the cells on LB plates containing 100 µg/ml ampicillin, 50 µg/ml kanamycin, 
100 µg/ml X-Gal, and 0.5 mM IPTG. The plates were incubated for a maximum of 36 h at 
30°C.  
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3.5.5 Protein expression and purification.  
Derivatives of the E. coli strain BL21(DE) carrying plasmids for the overexpression of 
Δ100CdaA and GlmM were cultivated in 1 l 2 x YT medium at 37°C (Heidemann et al., 2019). 
Protein expression was induced by the addition of 1 mM isopropyl-β-D-thiogalactopyranoside 
(IPTG) when the cultures had reached an OD600 of about 0.6. The cultures were further incu-
bated for 18 h at 16°C. The cells were disrupted in lysis buffer (20 mM Tris-HCl pH 7.5, 200 
mM NaCl, 20 mM imidazole) using the M-11S Microfluidizer (Microfluidics) and the soluble 
fraction was separated from the cell debris by centrifugation for 30 min at 15,600 g. His6-
tagged GlmM protein from L. monocytogenes was purified using a Ni-sepharose column (GE 
Healthcare) and the S200 16/60 gel filtration system (GE Healthcare). Proteins were eluted 
from the column using elution buffer (20 mM Tris-HCl pH 7.5, 200 mM NaCl, 350 mM imid-
azole). The GST-tagged GlmM and Δ100CdaA proteins were purified as described previously 
(Heidemann et al., 2019). Protein concentrations were determined using the Bradford assay 
(Bradford, 1976) or a Nanodrop spectrophotometer at a wavelength of 280 nm (Desjardins et 
al., 2009). The plasmid pBP223 was used to overexpress the N-terminally Strep-tagged CdaR 
(ΔTM 1-28) from L. monocytogenes using BL21(DE3) as described previously for CdaA (Ros-
enberg et al., 2015). 
 
3.5.6 Isolation of protein fractions and Western blotting.  
Purified Strep-CdaR and GST-tag-free GlmM proteins were used to generate rabbit polyclonal 
antibodies, as previously described (Rosenberg et al., 2015). L. monocytogenes strains were 
cultivated in 300 ml shake flasks containing 100 ml LSM medium at 37°C and 220 rpm until 
an OD600 of about 0.5. The cells were harvested by centrifugation at 4°C for 10 min at 3300 g 
washed once with 10 ml ZAP buffer (10 mM Tris-HCl pH 7.5, 200 mM NaCl). The cell pellets 
were resuspended in 400 μl ZAP buffer containing DNase I (0.5 U/ml, Sigma-Aldrich) and 
cOmplete EDTA-free Protease Inhibitor Cocktail (1 tablet/50 ml, Sigma-Aldrich). 200 μl of 
the cell suspensions were added to 0.5 g glass beads (0.1 mm diameter, Carl Roth) and dis-
rupted using a TissueLyser II (Qiagen) for 15 min at 30 Hz and 4°C. 600 μl of the buffer was 
added and the tubes were incubated for 10 min on ice. Samples were centrifuged for 2 min at 
20000 g and 4°C and the supernatant transferred to a new tube (whole cell lysate). 1 ml of each 
supernatant was subjected to ultracentrifugation at 235,000 g for 1 h at 4°C. The supernatants 
were transferred to new tubes (cytosolic fraction) and the pellets were resuspended in 1 ml of 
ZAP buffer.  
After a second ultracentrifugation for 30 min, the supernatants were transferred to a new tube 
and the pellets were resuspended (membrane fractions) in 100 μl of the ZAP buffer containing 
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17 mM 3-[(3-cholamidopropyl)-dimethylammonio]-1-propanesulfonate hydrate (CHAPS; 
Sigma-Aldrich). The protein concentrations were determined by Bradford assay (Bradford, 
1976) and 10 µg of the protein extracts were separated using 12 % SDS PAGE gels. Proteins 
were transferred on a polyvinylidene difluoride membrane (Bio-Rad) by electroblotting (Com-
michau et al., 2007b). Proteins were detected using polyclonal antibodies (1:1000 dilutions) 
raised against CdaA (Rosenberg et al., 2015), CdaR, GlmM and PrfA (Dormeyer et al., 2018). 
The primary antibodies were visualized by using anti-rabbit IgG (immunoglobulin G) AP (al-
kaline phosphatase) secondary antibodies (Promega) and the CDP* detection system (Roche 
Diagnostics). Images were taken using the Inta chemo cam (Intas). 
 
3.5.7 Protein pull-down assay.  
The pull-down assay to analyse the interaction between His-tagged GlmM and Δ100CdaA was 
performed as described previously (Tosi et al., 2019) using 1 ml TALON-cobalt beads (GE 
Healthcare) and gravity flow columns as described previously (Merzbacher et al., 2004). The 
proteins (50 µM each) were premixed on ice and incubated for 20 min. The beads were washed 
five times with 1 ml washing buffer (20 mM Tris-HCl pH 7.5, 200 mM NaCl) and the proteins 
were eluted in two steps using 1 ml elution buffer (20 mM Tris-HCl pH 7.5, 200 mM NaCl, 
500 mM imidazole). Aliquots of the load, flow-through, washing and elution fractions were 
run on a 15 % SDS PAGE gel and proteins were visualized by Coomassie staining.  
 
3.5.8 Size exclusion chromatography and multiangle light scattering (SEC-MALS).  
The SEC-MALS analysis was three times performed as described previously (Rosenberg et al., 
2015). The GST-tag-free GlmM and Δ100CdaA proteins were mixed 1:1 (1 mg/ml each) and 
500 µl of the protein mixture were loaded onto the column. 
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3.5.9 Isothermal calorimetry (ITC).  
The ITC experiments were carried out with an VP-ITC microcalorimeter (MicroCal Inc., 
Northampton, MA) in order to determine the affinity of GlmM to Δ100CdaA and the oligomer-
ization state using tag-free proteins. In a typical setup, Δ100CdaA (34 µM in 20 mM Tris-HCl, 
pH 7.5, 200 mM NaCl) was placed in the sample cell, and GlmM (290 µM in the same buffer) 
was placed in the titration syringe. All experiments were carried out at 20 °C with and a stirring 
speed of 307 rpm. The parameters used for the titration series are given in Table S3. Data 
analysis was carried out using MicroCal PEQ-ITC Analysis, Malvern Panalytical software. 
 
3.5.10 Phenotypic microarray assay.  
The Phenotype MicroArray assay (PM; Biolog Inc.; Bochner et al., 2001) was employed to 
screen for a phenotype of the ΔcdaR mutant (LMJR45). The L. monocytogenes wild type strain 
and the ΔcdaR mutant were streaked on BHI plates and incubated over night at 37°C. Single 
colonies were used to inoculate 10 ml of BHI medium and the cultures were grown at 37°C 
and 220 rpm to an OD600 of 0.4-0.5. 9 ml of the cultures were harvested by centrifugation at 
3300 g for 10 min at 4°C and the pellet were resuspended in 1 ml BHI with 25 % (w/v) glycerol, 
frozen in liquid nitrogen and stored at -80°C. A 10 μl inoculation loop was used to freshly re-
streak the bacteria from the cryocultures on BHI agar plates, prior to each PM and incubated 
for 20 h at 37°C. The cells were scratched evenly from the bacterial lawn, resuspended in the 
manufactures inoculation fluid and adjusted to an OD600 of 0.3 in 1 ml of the inoculation fluid. 
The remaining treatment was performed according to the recommendations of the manufac-
turer. The cells were incubated on the different PM 96-well plates with 100 μl of cells per well 
for 48 hours at 37°C with orbital shaking (237 cpm, 4 mm) and the OD590 was measured in 30 
min intervals using an Epoch2 multiwell reader, equipped with the Gen5 software (02.09.2001; 
BioTek Instruments) . 
 
3.5.11 Analysis of the c-di-AMP pools.  
L. monocytogenes was cultivated overnight in 10 ml LSM with kanamycin. The pre-cultures 
were used to inoculate 75 ml LSM with kanamycin and 1 mM IPTG to an OD600 of 0.1. Bacteria 
were incubated at 37°C with agitation (220 rpm) until they reached an OD600 of 0.5-0.6. At this 
time point (time 0 min) two times 10 ml samples for the determination of the c-di-AMP con-
centration and two times 1 ml samples for the determination of the protein concentration were 
taken (see below). Two times 24 ml of each culture were transferred into new flasks with either 
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6 ml of LSM or 6 ml of LSM with 2.5 M NaCl (- and + 0.5 M NaCl, respectively). Cultures 
were incubated for another 25 min and once more samples were taken for c-di-AMP and pro-
tein amount determination (time 25 min). The 1 ml samples for protein concentration determi-
nation were harvested by centrifugation at 20000 g for 1 min at 4°C and further processed as 
described earlier (Rismondo et al., 2016). The 10 ml samples for determination of the c-di-
AMP concentration, were rapidly cooled by swirling in liquid nitrogen, centrifuged for 5 min 
at 3300 g and 4°C and the pellets frozen in liquid nitrogen. Samples were further processed 
and analysed via HPLC/MS-MS as described previously (Rismondo et al., 2016). 
 
3.5.12 In vitro diadenylate cyclase (DAC) assay.  
The DAC assay to monitor the activity of Δ100CdaA and the effect of the wild type and the 
GlmM mutant variants on the diadenylate cyclase was performed as described previously 
(Heidemann et al. 2019). The enzyme reaction mixtures were incubated at 30°C. 
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Figure Legends  
FIG 1 The domains of CdaA and CdaR, the genomic context of the cdaR, cdaR and glmM 
genes, localization of the encoded proteins and topology analysis. (A) CdaA contains three 
transmembrane domains (TM) and a diadenylate cyclase domain (DAC) that is surrounded by 
coiled-coil (CC) domains (Rosenberg et al., 2019; Heidemann et al., 2019). CdaR contains a 
TM domain and four YbbR domains of unknown function (Barb et al., 2011). (B) The bi-
cistronic cdaAR operon encodes the diadenylate cyclase CdaA and its regulator CdaR. The 
glmM gene encodes the essential phosphoglucosamine mutase GlmM. The lmo2121 and 
lmo2117 genes of unknown function surround the cdaAR-glmM module. Arrows and circles 
indicate transcription start sites and terminators, respectively (Toledo-Arana et al., 2009). (C) 
Western blot analysis to analyse the subcellular localization of CdaA, CdaR and GlmM. The 
preparation of the whole cell lysate, the cytosolic fraction and the membrane fraction is de-
scribed in the Materials and Methods section. The proteins were separated using 12 % SDS 
PAGE gels. CdaA, CdaR, GlmM and PrfA (control) were detected using the polyclonal anti-
bodies α-CdaA, α-CdaR, α-GlmM and α-PrfA, respectively. (D) Schematic illustration of the 
PhoA-LacZ fusion proteins that were used to analyse the topology of CdaR. The membrane-
attached PASTA kinase PrkA and the cytosolic PrfA protein served as controls. (E) The E. coli 
strain DH5α carrying the plasmids pKTop (empty plasmid), pBP253 (PrkA), pBP252 (PrfA), 
pBP250 (CdaR), pBP251 (CdaR ΔTM) and pBP251 (CdaR ΔYbbR), were propagated on LB 
kanamycin plates containing the chromogenic substrates X-Phos and Red-Gal for PhoA and 
LacZ, respectively. (F) Quantification of the LacZ and PhoA activities detectable in the E. coli 
strains that were propagated on the agar plate shown in (E). The bacteria were cultivated in LB 
medium and the enzyme activities were determined as described in the Materials and Methods 
section. Data points represent biologically independent replicates (n = 4). Bars indicate means 
of replicates and the standard deviations are shown. 
 
 
FIG 2 B2H assay to study the interactions among CdaA, CdaR and GlmM. The cdaA, cdaR 
and glmM genes were introduced into the plasmids pUT18, pUT18C, p25-N and pKT25. Plas-
mids pUT18 and pUT18C allow the expression of the proteins fused either to the N- or the C-
terminus of the T18 domain of the B. pertussis adenylate cyclase respectively. Plasmid p25-N 
and pKT25 allow the expression of the proteins fused to the N- or the C-terminus of the T25 
domain of the adenylate cyclase. The E. coli transformants were spotted onto LB plates sup-
plemented with X-Gal and IPTG and incubated for 36 h at 30°C.  
 
 
FIG 3 In vitro pull-down assay to analyse the interaction between Δ100CdaA and GlmM. (A) 
The tag-less Δ100CdaA and the His-tagged GlmM proteins were mixed in a 1:1 ratio (50 µM 
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each) incubated for 20 min on ice and loaded onto the gravity flow column containing TALON-
cobalt beads. The flow-through was collected and the beads were washed five times to remove 
the unbound proteins. The proteins were eluted in two steps. The proteins in 7 µl of the fractions 
were separated using a 15 % SDS PAGE gel and the proteins were visualized by Coomassie 
staining. (B) Control experiment to assess whether the same amount of the tag-less Δ100CdaA 




FIG 4 Size exclusion chromatography to analyse the interaction between Δ100CdaA and 
GlmM. (A) Size exclusion chromatography profiles of the tag-less GlmM (blue line) and 
Δ100CdaA (black line) proteins and the GlmM-Δ100CdaA complex (red line). The proteins (1 
mg/l each) were either analysed individually or in a mixture. The elution peaks were analysed 
using the ASTRA software version 6.1. (B) Coomassie-stained SDS PAGE gels (15 %) con-
taining 7 µl aliquots of the elution peaks obtained with the individual proteins or of the GlmM-
Δ100CdaA complex. S, size standard (Page Ruler Plus Prestained, Thermo Scientific). 
 
 
FIG 5 Assessment of the molecular mass of the GlmM-Δ100CdaA complex and of the stoi-
chiometry of the protein-protein interaction. (A) The SEC-MALS was performed as described 
in the MATERIALS AND METHODS section. The elution volumes and the molecular masses 
calculated from the scattered signals indicate the formation of dimers of the Δ100CdaA and 
GlmM proteins and of dimers of Δ100CdaA and GlmM in the GlmM-Δ100CdaA complex. 
The UV light detector signals for GlmM, Δ100CdaA and the GlmM-Δ100CdaA complex are 
shown in dark blue, red and black, respectively. The estimated molecular masses that were 
calculated by analysing the light that was scattered (LS) by GlmM, Δ100CdaA and the GlmM-
Δ100CdaA complex are indicated by the short light blue, pink and grey lines, respectively. (B) 
Binding of GlmM to Δ100CdaA was studied by means of ITC. The cell and the syringe con-
tained 34.1 µM Δ100CdaA and 290.6 µM GlmM, respectively, see Materials and Methods 




FIG 6 Phenotypes associated with CdaR in L. monocytogenes and regulation of c-di-AMP 
synthesis by CdaR and GlmM in E. coli. (A) Phenotype microarray results of L. monocytogenes 
EGD-e wild type strain versus the ΔcdaR strain LMJR45 on Biolog PM9 wells A1-A9. Yellow 
colour indicates identical metabolic activities of the wild type and the ΔcdaR mutant. Red and 
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green colours indicate higher metabolic activities of the wild type and the ΔcdaR mutant, re-
spectively. (B) Influence of NaCl, KCl and sorbitol on the growth rates of the L. monocytogenes 
EGD-e wild type strain and the ΔcdaR strain LMJR45 in BHI medium. The growth rates of the 
strains in the absence of NaCl, KCl and sorbitol were set to 100 %. (C) Schematic illustration 
of the experimental approach to assess the role of CdaR and truncated CdaR variants in mod-
ulating c-di-AMP synthesis in L. monocytogenes upon salt shock. The strains BPL45 (wild 
type + empty vector (EV)), BPL46 (ΔcdaR + empty vector (EV)), BPL16 (ΔcdaR + CdaR), 
BPL47 (ΔcdaR + CdaR ΔTM) synthesizing CdaR without the transmembrane (TM) helix (see 
Fig. 1A), and BPL47 (ΔcdaR + CdaR ΔYbbr1-4) synthesizing only the TM helix of CdaR (see 
Fig. 1A) were grown in LSM medium at 37°C and the salt shock was performed by adding pre-
warmed LSM medium supplemented with NaCl. As the control, the same amount of the me-
dium without NaCl supplementation was added to a culture. The c-di-AMP intracellular levels 
of were determined before and after diluting the cultures (see Materials and Methods). (D) 
Effect of NaCl on the CdaR-dependent c-di-AMP production in L. monocytogenes. (E) Sche-
matic illustration of the E. coli strain LB2003 lacking the native potassium transporters to study 
the effect of CdaR variants, GlmM, and CdaR in combination with GlmM on the CdaA-de-
pendent production of c-di-AMP that inhibits potassium uptake via KimA and thus growth. (F) 
The derivatives of the E. coli strain LB2003 carrying the plasmid pBP384 (KimA) in combi-
nation with either pBP370 (CdaA), pBP373 (CdaA D171N), pBP387 (CdaA-CdaR), pBP389 
(CdaA-GlmM), pBP388 (CdaA-CdaR-GlmM), pBP260 (CdaA-CdaR ΔTM), pBP261 (CdaA-
CdaR ΔYbbR4), pBP262 (CdaA-CdaR ΔYbbR3-4), pBP263 (CdaA-CdaR ΔYbbR2-4), or 
pBP264 (CdaA-CdaR ΔYbbR1-4) were grown at 37°C in M9 minimal medium supplemented 
with 350 µM KCl. 0.005 % L-arabinose and 50 µM IPTG were added to induce the expression 
of the cdaA genes/operons and the kimA gene, respectively. Data points represent biologically 




FIG 7 Control of CdaA-dependent c-di-AMP production by GlmM. (A) Sequence alignment 
of a part of GlmM and the overall sequence identities of the homologs from L. monocytogenes 
EGD-e (UniProt: Q8Y5E6), B. subtilis 168 (UniProt: O34824), S. aureus COL (UniProt: 
Q5HE43), L. lactis MG1363 (UniProt: A2RIG0), S. pneumoniae (UniProt: Q04JI8), and E. 
coli K-12 MG1655 (UniProt: P31120). The L. lactis MG1363 GlmM I154F variant was shown 
to inhibit CdaA stronger in vivo (Zhu et al., 2016). The residues that were exchanged in L. 
monocytogenes GlmM are labelled with blue arrows. (B) Control of CdaA activity by GlmM 
and the GlmM variants Y153A, F154I and F154A in vitro. The reactions were started by adding 
10 µM Δ100CdaA, incubated for 1 h at 30°C and stopped by heating for 5 min at 95°C as 
described previously (Heidemann et al., 2019). The reaction buffer contained 10 mM MnCl. 
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(C) Growth of the L. monocytogenes ΔglmM mutant strains synthesizing different GlmM en-
zymes and effect of GlmM depletion. The strains BPL45 (wild type + empty vector (EV)), 
BPL63 (ΔglmM + E. coli GlmMEco), BPL64 (ΔglmM + native GlmM), and BPL65 (ΔglmM + 
GlmM F154I) were grown in BHI medium without and with 1 mM IPTG (see Materials and 
Methods section for details). Data points indicate means of replicates. (D) Effect of NaCl on 
the GlmM-dependent c-di-AMP production in the L. monocytogenes strains BPL45 (wild type 
+ empty vector (EV)), BPL63 (ΔglmM + E. coli GlmMEco), BPL64 (ΔglmM + native GlmM), 
and BPL65 (ΔglmM + GlmM F154I). The experiment was carried out as described in the leg-
end to Fig. 6C. Data points represent biologically independent replicates (n = 3). Bars indicate 
means of replicates and the standard deviations are shown. 
 
 
FIG 8 Schematic illustration of c-di-AMP signaling in L. monocytogenes. c-di-AMP was 
shown to bind to the sensor kinase KdpD of the KdpDE two-component system, which might 
be involved in controlling the expression of the putative kdpABC potassium transporter genes 
(Gibhardt et al., 2019). c-di-AMP can be secreted via multi drug resistance (MDR) proteins 
(Woodward et al., 2010; Schwartz et al., 2012). 
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Table 1. Theoretical and calculated masses of the Δ100CdaA, GlmM and of the complex. 
Proteins Theoretical mass [kDa] Calculated mass [kDa] 
Δ100CdaA-GlmM complex 134.7 105.0 ± 2.18 % 
Δ100CdaA dimer 37.8 36.27 ± 1.7 % 




Additional supporting information may be found in the online version of this article at the 
publisher’s website. 
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Table S1. Primer 
Primer Sequencea (5’ - 3’) Plasmid, 
purpose 
FC146 CGATGCGTTCGCGATCCAGGC  Sequencing 
FC147 CCAGCCTGATGCGATTGCTGCAT  Sequencing 
FC148 GTCACCCGGATTGCGGCGG  Sequencing 
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aRestriction sites are underlined. 
 
  
RB10 TTTACCTGGTGTGGAGATAACTCC glmM se-
quencing 
RB11 AAAGATGGTTATCAAGCTGGAACACC Integration 
of pBP1002 
RB12 TTTTCGTTTTCCACGCTTGATCTGC Integration 
of pBP1002 
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Table S2. Bacterial strains and plasmids 
 
Bacterial strains 
Genotype; construction Reference 
Escherichia coli   
BL21(DE3) F– ompT gal dcm lon hsdSB(rB–mB–) λ(DE3 [lacI 
lacUV5-T7p07 ind1 sam7 nin5]) [malB+]K-12(λS) 
Stratagene 
BTH101 F- cya-99 araD139 galE15 galK16 rpsL1 (Strr) 
hsdR2 mcrA1 mcrB1 
Euromedex 
DH5α  f80dlacZ DM15 recA1 endA1 gyrA96 relA1 thi-1 




LB2003 F- aroE rpsL metE thi gal rha kup1 (trkD1) 
∆kdpABC5 ∆trkA aroE+ 
(1) 








EGD-e Serovar 1/2a strain Laboratory col-
lection 
BPL16 ΔcdaR attB::Phelp-lacO-cdaR lacI neo (2) 
BPL45 attB::Phelp-lacO-mcs lacI neo; pIMK3 into EGD-e This study 
BPL46 ΔcdaR attB::Phelp-lacO-mcs lacI neo; pIMK3 into  
LMJR45 
This study 
BPL47 ΔcdaR attB::Phelp-lacO-cdaR ΔTM lacI neo; 
pBP255 into LMJR45 
This study 
BPL51 ΔcdaR attB::Phelp-lacO-cdaR ΔTM lacI neo; 
pBP259 into LMJR45 
This study 
BPL60 attB::Phelp-lacO-glmMEco lacI neo; pBP1000 into 
EGD-e 
This study 
BPL61 attB::Phelp-lacO-glmM lacI neo; pBP1001 into 
EGD-e 
This study 
BPL62 attB::Phelp-lacO-glmM T460A lacI neo; pBP1003 
into EGD-e 
This study 
BPL63 ΔglmM attB::Phelp-lacO-glmMEco lacI neo; 
pBP1002 into BPL60 
This study 
BPL64 ΔglmM attB::Phelp-lacO-glmM lacI neo; pBP1002 
into BPL61 
This study 
BPL65 ΔglmM attB::Phelp-lacO-glmM T460A lacI neo; 
pBP1002 into BPL62 
This study 
BPL77 ΔcdaA (3) 
LMJR45 ΔcdaR (2) 
   
Plasmids Construction and purpose Reference 
GlmM_Y153A glmM from plasmid pBP366 with 
GlmM_Y153A_F/GlmM_Y153A_R as described 
previously (8); expression of His-GlmM Y153A in 
E. coli BL21(DE) 
This study 
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GlmM_F154A glmM from plasmid pBP366 with 
GlmM_F154A_F/GlmM_F154A_R as described 
previously (8); expression of His-GlmM F154A in 
E. coli BL21(DE) 
This study 
GlmM_F154I glmM from plasmid pBP366 with GlmM_F154I_F/ 
GlmM_F154I_R as described previously (8); ex-
pression of His-GlmM F154I in E. coli BL21(DE) 
This study 
pBAD33 PBAD-mcs araC cat; expression of proteins in E. coli (4) 
pBP33 Expression of Strep-Δ100CdaA in E. coli 
BL21(DE) 
(5) 
pBP223 cdaR from L. monocytogenes EGD-e with 
JR28/JR56 via BamHI/SacI into pGP172; 
expression of Strep-CdaR in E. coli BL21(DE) 
This study 
pBP224 cdaR from L. monocytogenes EGD-e in pUT18 (2) 
pBP225 cdaR from L. monocytogenes EGD-e in pUT18C (2) 
pBP226 cdaR from L. monocytogenes EGD-e in p25-N (2) 
pBP227 cdaR from L. monocytogenes EGD-e in pKT25 (2) 
pBP232 cdaA from L. monocytogenes EGD-e in pUT18 (2) 
pBP233 cdaA from L. monocytogenes EGD-e in pUT18C (2) 
pBP234 cdaA from L. monocytogenes EGD-e in p25-N (2) 
pBP235 cdaA from L. monocytogenes EGD-e in pKT25 (2) 
pBP250 cdaR from L. monocytogenes EGD-e with 
JH121/JH122 via BamHI/KpnI into pKTop; ex-
pression of CdaR in E. coli DH5α 
This study 
pBP251 cdaR ΔybbR from L. monocytogenes EGD-e with 
JH121/JH124 via BamHI/KpnI into pKTop; ex-
pression of CdaR ΔYbbR in E. coli DH5α 
This study 
pBP252 cdaR ΔTM from L. monocytogenes EGD-e with 
JH123/JH122 via BamHI/KpnI into pKTop; ex-
pression of CdaR ΔTM in E. coli DH5α 
This study 
pBP253 prkA from L. monocytogenes EGD-e with 
JH126/JH127 via BamHI/KpnI into pKTop; ex-
pression of PrkA in E. coli DH5α 
This study 
pBP254 prfA from L. monocytogenes EGD-e with 
JH128/JH129 via XbaI/KpnI into pKTop; expres-
sion of PrfA in E. coli DH5α 
This study 
pBP255 cdaR ΔTM from L. monocytogenes EGD-e with 
JH130/JH22 via NcoI/SalI into pIMK3; expression 
of CdaR ΔTM in L. monocytogenes 
This study 
pBP259 cdaR ΔYbbR 1-4 from L. monocytogenes EGD-e 
with JH21/JH131 via NcoI/SalI into pIMK3; ex-
pression of CdaR ΔYbbR 1-4 in L. monocytogenes 
This study 
pBP260 cdaA-cdaR ΔTM from L. monocytogenes with 
JH51/JH135 and JH136/JH103 via XbaI/PstI into 
pBAD33; expression of CdaA and CdaR ΔTM in 
E. coli LB2003 
This study 
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pBP261 cdaA-cdaR ΔYbbR 4 from L. monocytogenes with 
JH51/JH138 via XbaI/PstI into pBAD33; expres-
sion of CdaA and CdaR ΔYbbR 4 in E. coli 
LB2003 
This study 
pBP262 cdaA-cdaR ΔYbbR 3-4 from L. monocytogenes 
with JH51/JH139 via XbaI/PstI into pBAD33; ex-
pression of CdaA and CdaR ΔYbbR 3-4 in E. coli 
LB2003 
This study 
pBP263 cdaA-cdaR ΔYbbR 2-4 from L. monocytogenes 
with JH51/JH140 via XbaI/PstI into pBAD33; ex-
pression of CdaA and CdaR ΔYbbR 2-4 in E. coli 
LB2003 
This study 
pBP264 cdaA-cdaR ΔYbbR 1-4 from L. monocytogenes 
with JH51/JH137 via XbaI/PstI into pBAD33; ex-
pression of CdaA and CdaR ΔYbbR 1-4 in E. coli 
LB2003 
This study 
pBP359 glmM from L. monocytogenes EGD-e with 
FC336/FC337 via XbaI/KpnI into pUT18; B2H 
analysis 
This study 
pBP360 glmM from L. monocytogenes EGD-e with 
FC336/FC337 via XbaI/KpnI into pUT18C; B2H 
analysis 
This study 
pBP361 glmM from L. monocytogenes EGD-e with 
FC336/FC337 via XbaI/KpnI into p25-N; B2H 
analysis 
This study 
pBP362 glmM from L. monocytogenes EGD-e with 
FC336/FC337 via XbaI/KpnI into pKT25; B2H 
analysis 
This study 
pBP366 glmM from L. monocytogenes with FC334/FC335 
via BsaI/XhoI into pET SUMOadapt 
This study 
pBP369 glmM from L. monocytogenes with JR72/JR73 via 
BamHI/XhoI into pGEX-6P1 
This study 
pBP370 Expression of CdaA in E. coli LB2003 (3) 
pBP373 Expression of CdaA D171N in E. coli LB2003 (3) 
pBP384 Expression of KimA in L. monocytogenes (3) 
pBP387 cdaAR from L. monocytogenes with JH51/JH103 
via XbaI/PstI into pBAD33; expression of CdaAR 
in E. coli LB2003 
This study 
pBP388 glmM from L. monocytogenes with JH104/JH105 
via HindIII/PstI into pBP387; expression of 
CdaAR-GlmM in E. coli LB2003 
This study 
pBP389 glmM from L. monocytogenes with JH104/JH105 
via HindIII/PstI into pBP370; expression of CdaA-
GlmM in E. coli LB2003 
This study 
pBP1000 glmM from E. coli W3110 with RB3/RB4 via 
PstI/NcoI into pIMK3; expression of GlmM in L. 
monocytogenes  
This study 
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pBP1001 glmM from L. monocytogenes EGD-e with 
RB1/RB2 via PstI/NcoI into pIMK3; expression of 
GlmM in L. monocytogenes 
This study 
pBP1002 Up- and downstream fragments of glmM with 
RB6/RB7 and RB8/RB9 via EcoRI/BamHI into 
pMAD; deletion of glmM in L. monocytogenes 
This study 
pBP1003 glmM T460A from L. monocytogenes EGD-e with 
RB1/RB2/RB5 via PstI/NcoI into pIMK3; expres-
sion of GlmM F154I in L. monocytogenes 
This study 
pET SUMOadapt PT7-lacO 6x His SUMO thrombin site mcs aphA3 (7) 
pGEX-6P-1 Plac-lacO bla; expression of GST-tagged proteins in 
E. coli BL21(DE) 
GE Healthcare 
pGEXpBP33 Expression of GST-tagged Δ100CdaA in E. coli 
BL21(DE) 
(8) 
pGP172 PT7-mcs bla; expression of N-terminally Strep-
tagged proteins in E. coli BL21(DE) 
(9) 
pIMK3 Phelp-lacO-mcs lacI neo; expression of proteins in 
L. monocytogenes 
(10) 
pKT25 Plac-cyaT25-mcs aphA3; protein-protein interaction 
analysis, B2H assay 
(11) 
pKT25-zip Plac-cyaT25-yeast GCN4 leucine zipper aphA3; 
protein-protein interaction analysis, B2H assay 
(11) 
pKTop Plac-mcs-phoA66-1416-lacZ12-180 aphA3; topology analysis 
of membrane proteins 
(12) 
pMAD bla ermC bgaB; construction of L. monocytogenes 
mutant strains 
(13) 
p25-N Plac-mcs-cyaT25 aphA3; Protein-protein interac-
tion analysis, B2H assay 
(14) 
pUT18 Plac-mcs-cyaT18 bla; protein-protein interaction 
analysis, B2H assay 
(11) 
pUT18C Plac-cyaT18-mcs bla; protein-protein interaction 
analysis, B2H assay 
(11) 
pUT18C-zip Plac-cyaT18-yeast GCN4 leucine zipper bla; pro-
tein-protein interaction analysis, B2H assay 
(11) 
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4.1 Abstract  
The second messenger c-di-AMP is importantly involved in a plethora of different cellular 
functions mainly in regulating the bacterial osmolyte homeostasis. Over the years diverse c-di-
AMP binding proteins were identified like RCK_C domains, USP-like domains or CBS do-
mains. Here we report crystal structures of the CBS domain containing protein DarB in its apo-
state and in complex with either c-di-AMP, 3’3’cGAMP and AMP. We suggest a specific bind-
ing of c-di-AMP to DarB and a putative regulatory function of DarB which is most likely me-
diated directly through the bound c-di-AMP.  
 
4.2 Introduction  
The cystathionine b-synthase (CBS) domain is a small protein motif consisting of ca. 60 amino 
acids. It was first identified in several archaeal proteins and the name-giving human cystathi-
onine b-synthase (Bateman 1997). Up to now it was found in all kingdoms of life in a plethora 
of proteins that exhibit a large variety of functions (Baykov et al. 2011; Ereño-Orbea et al. 
2013). Some of these proteins consist only of CBS domains, while in many other proteins the 
CBS domains are fused to other domains. Many CBS domains possess regulatory function of 




enzymes and membrane transporters which depends on a ligand bound to the CBS domain 
(Anashkin et al. 2017). Most CBS domains are known to bind AMP or ATP, other adenosine 
derivatives like NADH and SAM or the even larger cyclic di-AMP (c-di-AMP) (Schuster et 
al. 2016; Huynh et al. 2017). c-di-AMP is a bacterial second messenger involved in many cel-
lular processes as it binds to several different proteins as well as to RNA riboswitches (for 
review sew (Corrigan R. M. and Gründling 2013; Commichau et al. 2015a). c-di-AMP is the 
only second messenger in bacteria known to be essential, since it regulates the activity of pro-
teins required for potassium and osmolyte homeostasis (for review see (Commichau et al. 
2017)) It was reported previously that binding of c-di-AMP to the RCK_C domains of potas-
sium ion transporters blocks potassium import (Corrigan et al. 2013; Bai et al. 2014; Kim et al. 
2015). This nucleotide based second messenger does not only bind to RCK_C domains, but 
also to other receptors, e.g. PII-like signal transduction protein (Gundlach et al. 2015b), 
KupA/B (Quintana et al. 2019), USP-like domains (Moscoso et al. 2016) and CBS domains 
(Sureka et al. 2014). Binding of c-di-AMP to the CBS domains of the carnitine transporter 
OpuC leads to an inhibition of the carnitine uptake (Schuster et al. 2016; Huynh et al. 2017). 
The Mg2+ transporter MgtE is another CBS domain protein, which binds c-di-AMP and is also 
involved in osmolyte transport (Gundlach et al. 2019).  
 
All CBS domains share the same topology (b1-a1-b2-b3-a2), but they often display only low 
sequence conservation within protein families, or even within one protein. The first two of the 
three b-strands are in a parallel orientation, while the third one is in an antiparallel orientation 
relative to the first two. The b-strands b2 and b3 are flanked by two a-helices (a1 and a2). 
Usually, CBS domains occur as tandem repeats associated in the form of a Bateman module or 
a CSB pair (for review see (Baykov et al. 2011; Ereño-Orbea et al. 2013)) . This association is 
often stabilized by the region positioned N-terminally to the conserved CBS motif containing 
a third a-helix (a0) which clamps the two CBS domains in a tandem repeat. There are three 
different types of homodimers formed by CBS domains, classified as parallel (head-to-head 
assembly), antiparallel (head-to-tail assembly) and V-shaped. The head-to-head assembly rep-
resents the most common assembly (Ereño-Orbea et al. 2013) which exhibits as the heat-to-tail 
assembly with a disk-like shape containing four CBS domains related by an internal D2 pseudo-
symmetry (the so-called CBS module). The tandem repeat of two CBS domains contains two 
canonical adenosine binding sites, hence, a dimeric protein with four CBS domains could bind 
up to four adenosine derivatives.  
 
Recently, the protein DarB (previously denoted as YkuL) was identified as c-di-AMP binding 
protein in B. subtilis (Gundlach et al. 2019). DarB consists of 147 amino acids, and comprises 
two CBS domains, but no other domains. The cellular function of DarB is so far unknown. 
Here we demonstrate that DarB specifically binds c-di-AMP with a dissociation constant in the 
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nano-molar range, and AMP with much lower affinity. DarB also binds 3´3´cGAMP in vitro, 
however, as cGAMP does not exist in B. subtilis, this interaction might have no physiological 
relevance. In order to understand the specificity and affinity for different ligands, we deter-
mined four crystal structures of DarB (YkuL) in its apo from and its ligand bound form either 
with c-di-AMP, 3´3´cGAMP, or AMP, respectively. The four CBS domains of the homo-di-
meric DarB bind two molecules of c-di-AMP, however, only one adenine of each c-di-AMP is 
specifically recognized by DarB, while the remaining adenines protrude out of the donut-like 
protein. No conformational changes occur in DarB upon c-di-AMP binding, hence, a putative 
regulatory function of DarB must directly be caused by the bound c-di-AMP, most likely by 
the protruding adenine. 
 
4.3 Results 
4.3.1 Nucleotide Binding and Specificity of DarB  
The CBS domain containing protein DarB from B. subtilis, a protein of unknown function and 
previously denoted as YkuL, was recently identified as c-di-AMP binding protein (Gundlach 
et al. 2019). Since CBS domains are known to bind a plethora of adenine-containing nucleo-
tides, ITC measurements with different mono- and di-nucleotides were performed. The results 
confirmed the tight binding of c-di-AMP with a Kd in the nM range (27.0 nM ± 1.98 nM) 
(Figure 1). No binding was detected for 2´3´cGAMP, c-di-GMP, ATP, SAM, NAD+ and co-
enzyme A (Figure S1). Interestingly, 3´3´cGAMP binds to DarB with a Kd in the low µM range 
(1.17 µM ± 0,97 nM), and also a weak interaction with AMP was observed (Figure 1 and S1. 
The direct comparison of binding constants between 3´3´cGAMP and c-di-AMP shows that 
DarB binds the cyclic homo-di-nucleotide with an approximately 40-fold higher affinity than 
the cyclic hetero-di-nucleotide. However, since 3´3´cGAMP is absent in B. subtilis, the binding 
to DarB is of no physiological relevance.         
 
4.3.2 Overall structure of the c-di-AMP binding protein DarB 
DarB was crystallized in the space group P212121 with two DarB molecules occupying the 
asymmetric unit. The crystal structure of the ligand free DarB (apo-DarB) was determined at 
1.84 Å resolution (Table 1) and superposes well with the deposited but unpublished structure 
of DarB/YkuL (PDB id:1YAV), as indicated by the root mean square deviation (r.m.s.d.) of 
0.533 Å between all Ca atoms. The previously deposited structure of DarB has a bound sulfate 
ion and is represents a different crystal form.  




The DarB monomer occurs as a tandem repeat composed of two CBS domains (CBS1 and 
CBS2), each possessing the canonical babba fold, and an N-terminal region that contains a 
short a-helix, and in case of CBS1 also a short b-strand (Figure 2A). The N-terminal region 
preceding the CBS1 spans over the two CBS domains and clamps them together, as the N-
terminus of the polypeptide chain is close to the C-terminus of the CBS2. The N-terminal short 
b-strand (b0) of CBS1 packs against b-strand b6 of CBS2, extends the b-sheet of CBS2 as 
fourth strand and thereby stabilizing the arrangement of the two CBS domains. The core of the 
protein is formed by the b-sheets of CBS1 and CBS2. These two b-sheets are oriented parallel 
to each other and are flanked on each side by the a-helices (blue). Like the N-terminal region, 
the linker connecting CBS1 and CBS2 also contains an a-helix (a0-1) followed by the canon-
ical CBS fold of CBS2 (b4-a4-b5-b6-a5).  
The two molecules in the asymmetric unit form a donut-shaped homodimer related by a two-
fold non-crystallographic symmetry. The dimer interface buries 1402.8 Å of the accessible 
surface area (17.5 %) and is stabilized by 7 hydrogen bonds between a-helices 1 and 1’ as well 
as a-helices 4 and 4’. According to the CBS protein classification DarB forms a dimer in a 
parallel head-to-head assembly (Figure 2B). The donut shaped DarB dimer has a rather nega-
tively charged outer surface, while the surface of the central pore is positively charged (Figure 
2C).  
 
4.3.3 Structure of DarB_c-di-AMP complex 
DarB was also crystallized in presence of nucleotides that were identified by ITC measure-
ments to bind to DarB (see above). First, DarB was crystallized in presence of c-di-AMP. The 
obtained crystals belong to the same space group as the ligand-free DarB crystals but differ 
slightly in unit cell dimensions. The structure of the c-di-AMP - DarB complex was determined 
at 1.7 Å resolution (Table 1). The two DarB molecules in the asymmetric unit form the donut-
shaped dimer like the apo DarB. Upon rigid body refinement using the apo DarB structure as 
the model, the difference electron density map clearly revealed the presence of two c-di-AMP 
molecules bound inside the DarB dimer (Figure S2).  
The nucleotide binding site is formed by the loop region connecting a1 and b2 as well as b-
strand 2 of CBS1, a-helix 4 and b-strands 5 and 6 of CBS2 and a-helix 4 of the CBS2 of the 
opposite monomer (B) (Figure 3A). Residues Lys23, Ala25, Tyr45, Thr46, Ala47, Arg132 of mon-
omer A, and Arg131´ of monomer B are involved in c-di-AMP binding (Figure 3B). The N6 of 
the adenine-1 (Ade1) forms a hydrogen bond to the main chain carbonyl O atom of Lys23, and 
N1 to the main backbone N atom of Ala25. Furthermore, Tyr45 positioned in the loop a1-b2 
stacks against the adenine by p-p in an almost coplanar orientation. Surprisingly, the second 
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adenine (Ade2) does not show any direct interactions with the protein. It protrudes from the 
protein ring and is surrounded by several water molecules, of which two are mediating contacts 
between adenine-2 and the protein. The 2´-OH of the ribose attached to Ade1 is hydrogen 
bonded to the carbonyl O atom of Ala47. The 2´-OH and the 3´-OH of the second ribose (aden-
osine-2) form hydrogen bonds to side chain of Arg131´ of the other monomer. The phosphate of 
adenosine-1 forms hydrogen bonds with the main chain N of Arg132, while the phosphate of 
adenosine-2 forms two hydrogen bonds with the side chain OH and the main chain amide of 
Thr46. 
The structure of the DarB_c-di-AMP complex superposes well with the ligand-free structure 
and the DarB structure with bound sulfate (PDB code: 1YAV), as indicated by the r.m.s.d. 
between all Ca atoms of 0.57 Å and 0.53 Å, respectively. Hence, binding of c-di-AMP does 
not induce any major conformational changes in DarB. Some minor structural changes occur 
in the central pore of the protein dimer. In the ligand-free state, the central pore of the donut is 
constricted in comparison to the c-di-AMP-bound state. This structural change is due to a 
movement of the loop connecting a1 and b2 which leads to a repositioning of Thr46. Upon c-
di-AMP binding this loop becomes less flexible as Thr46 forms a hydrogen bond with the phos-
phate of the ligand and is therefore fixed in its position. Another difference between apo and 
ligand-bound state concerns the side chain of Tyr45 which is disordered in the ligand-free state. 
When c-di-AMP is bound Tyr45 is caught in one conformation by the p-p stacking interaction 
with the adenine base. 
 
4.3.4 Structure of DarB_AMP complex 
Since the ITC experiments showed also a weak binding of AMP to DarB, crystallization trials 
of DarB in presence of AMP were performed. The obtained crystals diffracted to a resolution 
of 1.64 Å and belonged to the same space group as observed for the DarB-c-di-AMP and apo-
DarB structures. The difference electron density maps demonstrate two AMP molecules bound 
in the position corresponding to the two adenosine-1 moieties in the c-di-AMP complex struc-
ture (Figure S3).  
Hence, the protein-AMP contacts are the same as for the corresponding AMP of c-di-AMP 
(Figure 4). The comparison of the two nucleotide binding sites in the DarB-AMP complex 
unveiled that in one of the monomers the side chain of Arg132 binds the phosphate of AMP, 
while in the other monomer Arg132’ is rotated outwards of the binding pocket and forms a salt 
bridge with the Asp9 of a symmetry-related protein molecule leading to the loss of the contact 
with AMP phosphate.  
 




4.3.5 Structure of DarB_3´3´cGAMP complex 
In addition, the ITC experiments revealed that the hetero dinucleotide 3´3´cGAMP is also 
bound by DarB, but not the related 2´3´cGAMP. The DarB crystals obtained in presence of 
3´3´cGAMP belong also to the space group P212121 and contain two protein monomers in the 
asymmetric unit as described for DarB in complex with c-di-AMP. The crystal structure was 
determined at 1.5 Å resolution, and the difference electron densities showed the presence of 
two 3´3´cGAMP molecules bound similar as described for c-di-AMP (Figure S4). The binding 
of the adenine in 3´3´cGAMP is identical to that of Ade1 of c-di-AMP, while the guanine is 
protruding out of the protein ring like the Ade2 in the c-di-AMP complex. Surprisingly, the 
difference electron density maps indicated the presence of two additional 3´3´cGAMP mole-
cules adjacent to one of the two canonically bound 3´3´cGAMP, here denoted as cGAMP-2 
(Figure S4). The third 3´3´cGAMP (cGAMP-3) molecule binds to cGAMP-2 by p-p stacking 
interaction between the guanines, hydrogen bonds between the guanine NH2 group of cGAMP-
3 with a phosphate of cGAMP-2, and vice versa between the guanine NH2 group of cGAMP-
2 with a phosphate of cGAMP-3, and between the guanine N1 of c-GAMP-3 and the Tyr45 
OH group. The fourth 3´3´cGAMP molecule (cGAMP-4) is also bound by p-p stacking inter-
action of its adenine with the guanine of cGAMP-2, hence the guanine of cGAMP-2 is sand-
wiched between the guanine of cGAMP-3 and the adenine of cGAMP-4 (Figure 5). cGAMP-
4 is also bound by several hydrogen bonds to the protein, between the phosphates and the side 
chains of Lys23, Lys136, Arg132, and between the guanine and the main chain carbonyl O of 
Phe17 and Met18.  
Notably, the weaker electron density for cGAMP-3 and cGAMP-4 corresponds to a lower oc-
cupancy of 58 % and 59 %, respectively, meaning that a third and fourth 3´3´cGAMP is bound 
to only ca. 60 % of the DarB molecules in the crystal. These additional 3´3´cGAMP molecules 
are not involved in crystal contacts with neighboring protein molecules, hence, their binding is 
most likely not a crystallization artefact. However, the additional 3´3´cGAMP molecules are 
only found on one side of the donut shaped DarB dimer. On the other side the corresponding 
binding sites for the additional 3´3´cGAMP molecules are partially occupied by a neighboring 
protein molecule. 
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4.4 Experimental procedures 
4.4.1 Plasmid construction  
The selected gene darB was amplified using chromosomal DNA of B. subtilis 168 as template 
and appropriate nucleotides that attached BsaI and XhoI restriction sites to the fragments and 
cloned between the BsaI and XhoI sites of the expression vector pET-SUMOadapt. The result-
ing plasmid was pGP2972.  
 
4.4.2 Protein expression and purification  
E. coli Rosetta (DE3) was transformed with the plasmid pGP2972 encoding 6x-His-SUMO-
DarB. Expression of the recombinant proteins was induced by the addition of isopropyl 1-thio- 
β-D-galactopyranoside (final concentration, 1 mM) to exponentially growing cultures (A600 of 
0.8) of E. coli carrying the relevant plasmid. Cells were lysed by three passes at 18,000 p.s.i. 
through an HTU DIGI-F press (G. Heinemann, Germany). After lysis (50 mM Tris/HCl pH 
7.5, 150 mM NaCl), the crude extract was centrifuged at 100,000 xg for 60 min and then passed 
over a Ni2+-nitrilotriacetic acid column (IBA, Germany). The protein was eluted with an imid-
azole gradient. After elution, the fractions were tested for the desired protein using 15 % SDS- 
PAGE. The relevant fractions were combined, and the SUMO tag was removed with the 
SUMO protease while overnight dialysis. The cleaved SUMO moiety and the protease were 
removed using a Ni2+-nitrilotriacetic acid column. The protein concentration was determined 
according to the method of Bradford (Bradford 1976) using the Bio-Rad dye binding assay and 
bovine serum albumin as standard (BioRad, Germany).  
 
4.4.3 Isothermal Calorimetry (ITC) 
All ITC experiments were performed on a VP-ITC microcalorimeter (MicroCal Inc., North-
ampton, MA, USA). Prior the ITC measurements the buffer of the protein solution was ex-
changed using the “Zaba” spin desalting columns (Thermo Scientific) to 50 mM Tris/HCl pH 
7.5, 200 mM NaCl. The nucleotides were individually dissolved in the exact same buffer (c-
di-AMP, c-di-GMP, 3´3´c-GMP-AMP, 2´3´c-GMP-AMP, AMP, NADH, SAM, Co-A and 
ATP). Measurements were carried out with 10 µM DarB in the sample cell and 100 µM nucle-
otide in the titration syringe. All experiments were carried out at 20 °C and a stirring speed of 
307 rpm. All parameters for the titration series are given in Tab.3. The data analysis was carried 




out using the MicroCal PEQ-ITC Analysis, Malvern Panalytical software. The protein and lig-
and concentration were determined by using either the Bradford assay (Bradford 1976) or a 
Nanodrop spectrophotometer (NANODROP 2000 Spectrometer, Thermo Scientific).   
 
4.4.4 Crystallization and Cryoprotection  
The sitting-drop vapour diffusion method was applied for crystallization. The initial crystalli-
zation trials were performed at 20 °C using the protein at a concentration of 4.0 mg/ml. For 
crystallizing the DarB apo the initial droplet size (0.25µM; 1:1 ratio) was increased to 2 µl 
using a 1:1 protein-to-reservoir ratio. Rectangular shaped crystals grew over night in 0.2 M 
calcium acetate, 0.1 M MES pH 6.5, 15 % w/v polyethylene glycol 8000. For crystallization 
of DarB c-di-AMP complex the protein was supplemented with a 6-fold excess of ligand (Jena 
Bioscience, Germany). The best diffracting crystals grew after approximately 24 hours in 0.2 
M calcium chloride dehydrate, 0.05 M HEPES sodium pH 7.5, 28 % v/v polyethylene glycol 
400 and 0.002 M spermine (Hampton Research, USA) in a 1:1 ratio (0.25µl:0.25µl of pro-
tein/reservoir).  
Both crystal types were soaked in a sucrose saturated reservoir solution for cryoprotection and 
flash cooled before data collection.  
DarB was also crystallized in presence AMP or 3´3´cGAMP. A protein concentration of 4.5 
mg/ml DarB supplemented with either an 8.5-fold excess AMP or a 6.0-fold excess of 
3´3´cGAMP in a 1:1 protein-to-reservoir ratio. In case of AMP best diffracting crystals were 
obtained after one month, while DarB- 3´3´cGAMP containing crystals were already obtained 
after 24 h in 0.1 M Tris/HCl pH 8.5, 32 % w/v polyethylene glycol 4000 and 5 % v/v glycerol 
respectively. No additive was added to the reservoir solution for cryoprotection.  
 
4.4.5 X-ray data collection and processing  
The diffraction images were recorded at PETRAIII EMBL beamlines P13 (DarB_APO and 
DarB_c-di-AMP) and P14 (DarB_AMP and DarB_3´3´cGAMP) and processed with the XDS 
package (Kabsch 2010a; Kabsch 2010b). The data collection and processing statistics are sum-
marized in Tab.1. For all crystals an orthorhombic lattice with similar unit cell parameters was 
determined. The crystals of apo DarB and in complex with AMP exhibits unit cell parameters 
of a = 38.670 Å, b = 67.760 Å, c = 103.960 Å, and a = 41.310 Å, b = 69.260 Å, c = 105.420 
Å, respectively. The crystals in complex c-di-AMP and 3´3´cGAMP exhibit cell constants of a 
= 42.150 Å, b = 65.410 Å, c = 104.850 Å and a = 41.840 Å, b = 65.130 Å, c = 104.210 Å 
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respectively. The cell content analysis of all four structures indicated the presence of two mon-
omers occupying the asymmetric unit (apo: Vm=2.07 Å3/Da, corresponding solvent content, c-
di-AMP Vm = 2.15 Å3/Da, corresponding solvent content of 42.81 %, 3´3´cGAMP: Vm=2.15 
Å3/Da, corresponding solvent content 42.73 %, and AMP: Vm=2.27 Å3/Da, corresponding sol-
vent content 45.89 %). 
 
4.4.6 Structure Determination and Refinement  
The initial phases of DarB_c-di-AMP were obtained by molecular replacement with PHASER 
(McCoy et al. 2007) using the DarB structure of B. subtilis (PDB code 1YAV) as a search 
model. All other structures (DarB_apo, DarB_3´3´cGAMP and DarB_AMP) are isomorphous 
to the DarB_c-di-AMP crystal structure. Therefore, rigid body refinement followed by manual 
modelling in Coot (Emsley et al. 2010) utilizing 2mFo-DFc and mFo-DFc electron density 
maps was performed. Reciprocal space refinement has been conducted with Refmac5 (Winn 
et al. 2011) and PHENIX. In order to monitor the progress of refinement using the Rfree a ran-
dom set of 5 % reflections was excluded from the refinement. The structure of apo DarB was 
determined at a resolution of 1.84 Å and to Rwork of 20.23% and Rfree of 25.09 %. The final 
structure of DarB in complex with c-di-AMP was determined at a resolution of 1.70 Å to Rwork 
of 18.29 % and Rfree of 20.97 %. Finally, the structures of DarB in complex with AMP and 
3´3´cGAMP were determined at 1.64 Å (Rwork of 18.88 % and Rfree of 22.18 %) and 1.50 Å 
(Rwork of 15.33 % and Rfree of 19.20 %) resolution, respectively. Atomic models have been 
verified against omit maps as calculated with PHENIX suite. The presence of bound ligands 
has been confirmed by calculation of omit maps using phenix.polder program (Liebschner et 
al. 2017). Figures have been generated using an open source version of pymol (Schrödinger 
2010). 
  




4.5 Discussion  
In the recent years more and more proteins were identified to bind the essential second mes-
senger c-di-AMP. Most of these proteins are known to be involved in processes essential for 
bacteria survival, e.g.: the potassium or osmolyte homeostasis (Woodward et al. 2010; Luo Y 
and Helmann 2012; Mehne et al. 2013; Gundlach et al. 2015a; Commichau et al. 2017; 
Gundlach et al. 2017a; Gundlach et al. 2017b; Commichau et al. 2019). Some of these proteins 
share two distinct and conserved domains, the RCK_C and CBS domains, which are responsi-
ble for binding c-di-AMP (Gundlach et al. 2019). In this study we structurally and biochemi-
cally analyzed the c-di-AMP binding receptor B (DarB) which was previously described as a 
CBS domain containing protein with the ability to bind c-di-AMP. So far, a functional link 
between c-di-AMP binding of DarB and a physiological relevance in the bacterial cell has not 
been observed.  
Our results confirmed a tight and specific binding of c-di-AMP to each DarB monomer in the 
nanomolar range. Although the hetero di-nucleotide 3’3’cGAMP is absent in B. subtilis which 
indicates no physiological relevance it binds to DarB with an affinity in the micromolar range. 
The first crystal structure of DarB from B. subtilis was already deposited in the PDB in 2004. 
It has crystallized as a donut-shaped dimer revealing a typical CBS domain fold with two do-
mains forming a head-to-head assembly. In contrast, the structurally and biochemical charac-
terized CBS domain subunit from the carnitine transporter OpuC also binds c-di-AMP, yet the 
CBS modules are oriented in an antiparallel manner (head-to-tail assembly) (Ereño-Orbea et 
al. 2013; Schuster et al. 2016).  
In order to get further structural insights into the specificity and affinity for different ligands 
four crystal structures were determined: DarB in its apo-form and in complex with either c-di-
AMP, 3’3’cGAMP or AMP. Structural comparisons of different CBS domain containing pro-
teins suggested the presence of two canonical adenosine binding sites in a CBS module (Scott 
et al. 2004). In most structurally analyzed CBS modules only one binding site is occupied by 
a ligand which is explained by the amino acid composition. 
In all ligand bound DarB structures each monomer had one nucleotide bound in one of the two 
canonical nucleotide binding sites which are chemically not identical. A DarB dimer has two 
cattycorner binding sites due to its head-to-head assembly, while in the OpuC dimer these 
binding sites are parallel to each other. This could explain why in case of DarB, only one ade-
nine base (Ade1) of c-di-AMP is directly bound by the protein in each monomer, while the 
second adenine (Ade2) protrudes from the protein. However, in OpuC the parallel positioning 
of the binding sites might favor the binding of only one c-di-AMP molecule in an elongated 
manner in which both adenine base, Ade1 and Ade2 are bound.  
In order to get further insights on the function of proteins that are structurally very similar to 
DarB and to find structural homologous a DALI search was performed (Holm and Rosenström 
2010). The DALI search using only one monomer of DarB unveiled a plethora of different 
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proteins. 25 Protein structures were chosen with a Z-score above 13.5. All structures superim-
pose with an r.m.s.d between 1.3 and 2.9 Å. Seven of the 25 structures show an adenine deriv-
ative in the nucleotide binding site and these structures were used for further structural analysis 
(Tab. 2).  
Structural comparison of the c-di-AMP binding site in DarB with the nucleotide binding sites 
of the seven CBS domain containing proteins unveiled high overall 3D similarity but also very 
conserved surrounding of bound ligand molecules. As pointed out previously CBS modules 
consist of two putative nucleotide binding sites which despite their structural similarity differ 
significantly in composition of amino acids and hence are chemically not equivalent (reviewed 
in (Ereño-Orbea et al. 2013)). This is the most plausible explanation why a DarB dimer binds 
only two nucleotides.  
 
A structural comparison of the binding sites revealed that two amino acids: leucin 23 and ala-
nine 25, which are positioned in the loop region (pink) proceeding the canonical CBS fold of 
CBS1, are crucial for ligand binding. These residues favor adenine over guanine derivatives as 
described for different CBS domain containing proteins (Rudolph et al. 2007; Ereño-Orbea et 
al. 2013). The results of the structural analysis are consistent with the biochemical and struc-
tural data. The binding pocket of DarB is specific for adenine binding, which is supported by 
the fact, that only the adenine base of the hetero di- nucleotide 3’3’cGAMP is bound deep in 
the binding pocket while the guanine base protrudes out of the protein.  
We suggested that the binding is specific to c-di-AMP although also AMP binds to DarB, yet 
with low affinity. Probably the existence of 3’3’ phosphate-sugar ring, present in both c-di-
AMP and 3’3’cGAMP, is responsible for higher specificity of DarB to dinucleotides.  
However, the question to answer is why 3’3’cGAMP binds with a lower affinity than c-di-
AMP even though both molecules are coordinated by the same amino acids and also intera-
tomic interactions are of similar lengths. Structural analysis exhibit that the outpointing gua-
nine base is rotated towards the protein core. A closer look to the structure unveiled the pres-
ence of a conserved water molecule in all available DarB structures (apo_DarB, 
DarB_cdiAMP, DarB_AMP, DarB_3’3’cGAMP). This water molecule causes a steric clash 
with N2 amine group of the guanine base and is most likely responsible for the observed change 
in orientation of the guanine base when compared to Ade2 of c-di-AMP. In addition, the out-
pointing purine base is indirectly coordinated through water molecules. Therefore, we suggest 
that the decreased binding affinity of hetero dinucleotide is due to the approximately 41-degree 
rotation of the purine base leading to a conformation which is most likely energetically less 
optimal. Surprisingly in the other nucleotide binding site the outpointing base of the 
3’3’cGAMP is oriented in a similar way as the adenine base (Ade2) in the c-di-AMP-DarB 
structure and unveils the positioning of two further dinucleotides in a coplanar assembly to the 
guanine base. These additional 3’3’cGAMP molecules are bound in a positively charge patch 




on the protein surface (Fig. 4). Interestingly, cyclic dinucleotides have been described previ-
ously to form dimeric assemblies. While c-di-GMP was reported to form dimers in order to 
bind to the I-site of its synthesizing enzyme (diguanylate cyclases) to inhibit its activity, so far, 
no biological relevance has been described for c-di-AMP dimers (Blommers et al. 1988; 
Manikandan et al. 2014). This assembly is not a crystal lattice artefact, since it is not stabilized 
by crystal contacts. Hence, we wondered whether DarB might also be able to bind RNA as 
described in other studies for CBS domain proteins (McLean et al. 2004). The relative orienta-
tion of the nucleotide bases resembles the classical orientation of the nucleotide bases in DNA 
or RNA what strongly argues towards the ability of RNA binding (Fig. 4 and S4). It is com-
monly known that RNA molecules prefer to bind to positively charged amino acids (Ellis et al. 
2007; Chen and Lim 2008). 
The physiological function of DarB is still unclear as well as its putative interaction part-
ner/partners. 
In a plethora of different studies, it was argued that c-di-AMP is an essential nucleotide for 
bacteria that carry a c-di-AMP synthesizing enzyme (diadenylate cyclase). Therefore, di-
adenylate cyclases seem to be an attractive target for the development of new antibiotic drugs 
(Corrigan R. M. and Gründling 2013; Rosenberg et al. 2015; Commichau et al. 2019; 
Heidemann et al. 2019). The identification of c-di-AMP interaction partners might help to un-
derstand why c-di-AMP is essential and where potential resistances might develop.  
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Table and Figures  
Table 1: Crystallographic data collection and refinement statistics 




Crystallographic data         























Unique reflections 24397 32669 37896 50229 
Redundancy  5.1(5.3) 7.0(7.3) 13.25(13.52) 12.95 (13.34) 
Completeness (%) 99.1 (99.7) 99.8 (99.8) 99.8(99.8)  99.9 (100) 
Space group P212121 P212121 P212121 P212121 
a (Å) 38.67 42.15 41.31 41.49 
b (Å) 67.76 65.41 69.26 69.92 
c (Å) 103.96 104.85 105.42 105.78 
Rmerge (%) 5.8 (64.0) 5.2 (92.0) 2.9 (68.0) 3.9 (63.2) 
I/𝜎 (I) 16.81 (2.51) 24.45 (2.41) 40.44 (4.12) 31.06 (4.2) 
CC1/2 99.8 (87.3) 99.9 (88.6) 100 (97.4) 100 (94.2) 
Refinement statistics          
Rwork/Rfree  0.2023/0.2509 0.1828/0.2105 0.1885/0.2204 0.1532/0.1907 
No. of atoms 2418 2586 2488 2780 
Average B factor 
(Å2) 
36.53 30.90 44.34 31.42 
Root mean square de-
viation 
        
Bonds Å 0.005 0.007 0.011 0.009 
Angles (degree) 0.775 1.062 1.138 1.145 
Ramachandran 
plot 
    
Favoured (%) 98.15 99.26 98.51 98.18 
Allowed (%) 1.85 0.74 1.49 1.82 
Outliers (%) 0.00 0.00 0.00 0.00 
PDB codes 6YJ8 6YJA 6YJ7 6YJ9 
 
  




Tabelle 2: DALI search for structural homologs with bound ligand 
PDB 
code 
Protein Ligand Organism Function  %id  Z-score 
1YAV DarB/YkuL c-di-AMP Bacillus subti-
lis 
Unknown 100 A 22.8/ B 
22.4 
2YZQ PH1780 SAM Pyrococcus 
horikoshii 
Unknown 19 14.5 
2RC3 NE2398 NAD Nitrosomonas 
europaea 
Unknown 14 14.6 


















unknown 14 14.1 













Tabelle 3: Parameters used for the ITC titration series 




Spacing [sec.] Filter period 
[sec.] 
1 5 10 360 2 
2-19 15 30 360 2 
 
  








Figure 1: Nucleotide binding measured by means of ITC. A) The nucleotide-based second messenger c-di-
AMP specifically binds to DarB with a KD of 27.0 nM ± 1.98 nM. B) The hetero di-nucleotide 3’3’ cGAMP binds 
to DarB with an approximately 40-fold lower affinity in comparison to c-di-AMP.   
  
A B 






Figure 2: Crystal structure of DarB. A) The monomer structure of DarB is depicted in cartoon mode (helices: 
blue, b-strands: yellow, linker region: red, loop region: gray). Each DarB monomer occurs as a tandem repeat 
which is composed of two CBS domains (CBS1 and CBS2), possessing canonical babba fold. B) DarB forms a 
donut-shaped dimer with the N- and C-termini close to each other which is according to the CBS protein classifi-
cation a parallel head-to-head assembly. C) The electrostatic surface potential of DarB exhibits that the outer 













Figure 3: Crystal structure of DarB with two nucleotide binding sites. A) Cartoon representation of the donut-
shaped homo-dimeric DarB with two bound c-di-AMPs. Monomer A is colored in dark blue; Monomer B is 
colored in light blue. The two c-di-AMP molecules are depicted in ball and stick mode (carbon: yellow, phosphate: 
orange, nitrogen: blue, oxygen: red). B) A detailed view of the nucleotide binding site in monomer A and B, 
showing amino acids involved in the c-di-AMP binding. Only one adenine base is coordinated by amino acids, 
while the other protrudes out of the protein core and coordinated through water molecules. The dashed lines 












Figure 4 Crystal structure of DarB in complex with AMP. A) Cartoon representation of the DarB with two 
bound AMPs. Monomer A is colored in dark blue; Monomer B is colored in light blue. The two AMP molecules 
are depicted in ball and stick mode (carbon: yellow, phosphate: orange, nitrogen: blue, oxygen: red). B) A detailed 
view of the nucleotide binding in molecule A and B. The dashed lines indicate distances between the protein and 











Figure 5: Crystal structure of DarB in complex with 3’3’cGAMP. In this structure two additional 3´3´cGAMP 
molecules are bound to DarB adjacent to one of the two canonically bound 3´3´cGAMP. The additional 
3’3’cGAMP molecules are bound along the positive patch one the protein surface and interact via π-π stacking 
with the protruding guanine of the 3’3’cGAMP located in the c-di-AMP binding site. The nucleotides are depicted 
in ball and stick mode (phosphate: orange, nitrogen: blue, oxygen: red, canonical 3’3’cGAMP: carbon: yellow; 
non-canonical 3’3’cGAMP: carbon: grey) 
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Supporting Figure S1: Nucleotide binding studies. A) CBS domain containing proteins are known to bind a 
diversity of adenine derivatives like, ATP, NADH or AMP. The binding of various nucleotides was measured by 
means of ITC. The nucleotide AMP binds with a very low affinity to DarB. B) No other nucleotide binding than 
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Supporting Figure S2: Fo-Fc omit electron density maps of the two c-di-AMP molecules bound to DarB. C-
di-AMP is depicted in ball-stick mode. The mFo-DFc omit electron density map (blue mesh) is contoured at a 
sigma level of 3.0. 
 
Figure S3 
    
 
 
Supporting Figure S3: Fo-Fc omit electron density maps of the two AMP molecules bound to DarB. AMP is 
depicted in ball-stick mode (carbon: yellow, phosphate: orange, nitrogen: blue, oxygen: red). The mFo-DFc omit 
electron density map (blue mesh) is contoured at a sigma level of 3.0.  
cdiAMP-1 cdiAMP-2 
AMP-1 AMP-2 






Supporting Figure S4: Crystal structure of DarB with bound 3’3’cGAMP at 1.64 Å resolution. Cartoon 
representation of the homo-dimeric DarB with two bound 3’3’cGAMP in the c-di-AMP binding site. Adjacent to 
one of the two canonical 3’3’cGAMP molecules, two additional 3’3’cGAMP molecules (cGAMP-3 and cGAMP-
4) are present. The nucleotides are depicted in ball and stick mode (phosphate: orange, nitrogen: blue, oxygen: 
red, canonical 3’3’cGAMP: carbon: yellow; non-canonical 3’3’cGAMP: carbon: grey). The mFo-DFc omit elec-
tron density map (blue mesh) is contoured at a sigma level of 3.0.  
  









Supporting Figure S5: Fo-Fc omit electron density maps of the four 3‘3‘cAMP molecules bound to DarB. 
AMP is depicted in ball-stick mode (phosphate: orange, nitrogen: blue, oxygen: red, canonical 3’3’cGAMP: car-
bon: yellow; non-canonical 3’3’cGAMP: carbon: grey). The mFo-DFc omit electron density map (blue mesh) is 
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5.1 Introduction  
In the recent years the importance of developing new antibiotic drugs has increased due to the 
rising number of multidrug resistant bacterial species. Bacteria are getting less susceptible or 
completely resistant to antibiotics what reduces the repertoire of available drugs used to control 
bacterial infections (WHO 2017). According to the German federal government every year 
400,000 to 600,000 people become severe bacterial infections in Germany that need to be 
treated in hospitals. Statistics show that already 10,000 to 15,000 patients die annually due to 
the lack of effective antibiotics (German Federal Government 2020). One major challenge of 
antibiotic research is the identification of new targets. A pivotal aspect of a promising target is 
its conservation and essentiality for the survival of a wide range of bacterial species. Its inhi-
bition should hamper bacterial growth. Furthermore, the lack of structural and functional ho-
mology of identified target proteins to proteins of the mammalian host is of great importance 
in order to avoid side effects as well as to ensure the “drugability” of the chosen target (Silver 
2011). 
In 2008 the bacterial second messenger cyclic di-AMP (c-di-AMP) was discovered which 
opened new perspectives in antibiotic research as it fulfills these requirements (Witte et al. 
2008). It quickly became clear that c-di-AMP is rather unique compared to other known sec-
ondary metabolites. Several studies reported the presence of c-di-AMP in a wide range of dif-
ferent bacterial species, mainly in Gram-positive but in part also Gram-negative bacteria and 
archaea (Romling 2008; Corrigan R. M. and Gründling 2013). Many of these bacteria are 
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known to be human pathogens e.g. Listeria monocytogenes, Staphylococcus aureus or Myco-
bacterium tuberculosis (Woodward et al. 2010; Corrigan et al. 2011; Bai et al. 2012). c-di-
AMP is described as the only known essential second messenger in bacteria so far, since it is 
involved in regulating the bacterial osmolyte and potassium ion homeostasis (Bai et al. 2013; 
Blötz et al. 2017; Gundlach et al. 2017b; Gundlach et al. 2019). Loss of function mutation in 
the genes of the c-di-AMP synthesizing enzymes, the diadenylate cyclases (DACs) is lethal to 
the bacterial cell. Interestingly, DACs are absent in mammalian cells and therefore c-di-AMP 
cannot be detected in humans (Rosenberg et al. 2015).  
DACs catalyze the cyclisation of two ATP molecules into c-di-AMP in a metal ion dependent 
manner (Witte et al. 2008; Müller et al. 2015). Up to now five different classes of DACs are 
known, named DisA, CdaA, CdaS, CdaM, and CdaZ (Romling 2008; Corrigan R. M. and 
Gründling 2013; Blötz et al. 2017; Commichau et al. 2019). All of them share the highly con-
served diadenylate cyclase domain (DAC domain) accompanied by different types of regula-
tory domains (Commichau et al. 2019). Some bacteria like Bacillus subtilis carry more than 
one class of DACs while most bacteria that are known to synthesize c-di-AMP possess only 
one, either the DAC class DisA or CdaA. The latter is described as the most prevailing DAC 
domain containing protein among different bacterial species (Commichau et al. 2019). 
Three DACs have been structurally characterized, the DNA scanning protein DisA, the mem-
brane bound protein CdaA which is expressed at high extracellular K+ ion concentration and 
CdaS which is known to be exclusively expressed during spore germation in the order Bacil-
lales (Witte et al. 2008; Corrigan Rebecca M and Gründling 2013; Mehne et al. 2013; Mehne 
et al. 2014; Rosenberg et al. 2015; Heidemann et al. 2019). Since CdaA is the prevailing DAC 
it provides a promising starting model for antibiotic research. 
CdaA is a membrane bound protein consisting of an N-terminal three a-helical transmembrane 
domain followed by a linker region connecting the membrane domain and the active cyclase 
domain. The DAC domain shows an overall globular fold with a central b-sheet of seven par-
allel and antiparallel b-strands (b1-b7) which is flanked by five a-helices. The active site is 
formed by a-helix 4, the b-strands 1 and 5 as well as several loops connecting a1 and b1, a3 
and b3, a4 and b4, and b5 and b6 (Fig. 1A). In order to form c-di-AMP the two ATP molecules 
need to be in close vicinity. This is ensured by two with ATP loaded CdaA monomers facing 
each other (Fig.1B) (Rosenberg et al. 2015; Heidemann et al. 2019). A comparison of DisA 
and CdaA unveiled differences concerning the accessibility of the active site (Witte et al. 2008; 
Heidemann et al. 2019). While DisA contains stably associated catalytically active dimers, it 
was suggested that the active dimer of a CdaA exists only transiently which makes its nucleo-
tide binding site easier accessible to potential inhibiting substances and thus promising target 
for drug discovery (Heidemann et al. 2019). 
A common approach and a powerful tool of drug development is the fragment-based drug dis-
covery which was firstly applied in 1996 (Shuker et al. 1997; Congreve et al. 2008; Schulz et 
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al. 2011). Those fragments are usually small molecules typically with a molecular mass under 
300 Da which allows to cover a broader range of chemical space (Murray and Rees 2009; 
Barelier et al. 2014; Lamoree and Hubbard 2017). 
This is a major difference compared to the approach of high throughput screening where a 
library is composed of millions of different compounds. In fact, these fragments provide a good 
starting point for building target specific drug-like compounds. However, since fragments are 
rather small, they only provide a small attack surface to the protein which leads to weak inter-
actions that are difficult to obtain with conventional crystallographic analysis methods. X-ray 
crystallography has been used intensively as a sensitive detection method for fragment screen-
ing in order to identify weak binders (Congreve et al. 2008; Schiebel et al. 2016). Crystallo-
graphic fragment screening copes with the limitation of the weak binding affinities of frag-
ments as high concentrations can be employed during the experiment. As a drawback of crystal 
lattice averaging, an electron density map of a partially occupied binding sites reveals features 
corresponding to bound and unbound state. In fact, this may completely obscure the evidence 
for the ligand bound state or at least makes a distinct identification difficult, if relying on con-
ventional identification methods (Pearce et al. 2017b). In order to overcome the problem of 
uninterpretable density and to increase the contrast of the signal to noise ratio corresponding 
to the weakly bound ligand the Pan-Density Dataset Analysis (PanDDA) method was em-
ployed. This method is based on the voxel analysis approach requiring multiple crystallo-
graphic data sets (Ashburner and Friston 2000; Pearce et al. 2017b). It allows the contrasting 
of bound and unbound state against each other and enables unveiling of weakly bound ligands 
or other structural differences. After the identification of a dataset with significant differences, 
i.e. a potential bound ligand, the superimposed non-bound (ground) state density maps are sub-
tracted from the bound electron density map revealing the partially occupied ligand state. The 
resulting density map is called event map. The event map represents only the bound state in 
the crystal which can be used for ligand modeling (Pearce et al. 2017b; Pearce et al. 2017c; 
Pearce et al. 2017a). 
Luckily, in our first study we were able to obtain a new crystal form of apo-CdaA which dif-
fracted to a reasonable resolution and more important the crystal packing seemed suitable for 
a fragment screening campaign (Heidemann et al. 2019). Two ∆100CdaA molecules are pre-
sent in the asymmetric unit forming a non-catalytic dimer with outwards facing active sites 
(Fig. 1C). According to the crystal packing at least the active sites of one CdaA monomer 
seems to be accessible.  
Our crystallographic fragment screening analysis using the PanDDA method unveiled three 
different ligand binding sites on CdaA which can be used as a starting point for drug design of 
a novel antibiotic.  
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Figure 1: Crystal structure of ∆100CdaA. (A) Overall structure of the truncated ∆100CdaA. CdaA shows an 
overall globular fold with a slightly twisted b-sheet which is surrounded by 5 a-helices. The protein structure is 
depicted in cartoon mode in light grey. The bound ATP in the active site is depicted in ball and sticks mode 
(carbon in green, phosphates in orange, oxygens in red, and nitrogen in blue) (PDB: 4RV7; Rosenberg et al. 2015). 
(B) Representation of a ∆100CdaA dimer in its post-catalytic state with a c-di-AMP bound in the active site. Two 
face-to-face orientate CdaA nucleotide binding sites are forming the catalytic active dimer. The protein structure 
is depicted in cartoon mode in light and dark grey. The atoms in c-di-AMP are colour-coded as described for ATP 
bound structure (PDB: 6HVL; Heidemann et al. 2019). (C) Representation of the ∆100CdaA dimer formation in 
the asymmetric unit. ∆100CdaA shows a non-catalytic dimer with two outwards facing nucleotide binding sites 
which are antiparallel oriented to each other. The positioning of the active site is marked by two bound AMP 
molecules. The atoms in AMP are colour-coded as described for ATP (PDB: 6HVM; Heidemann et al. 2019).  
 
5.2 Experimental procedures  
5.2.1 Bacterial strains and Growth Conditions  
For overexpression of the protein Escherichia coli BL21 (DE3) was used. The E. coli strain 
was cultivated in 2 YT medium. 
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5.2.2 Protein expression and purification 
The protein expression and purification were performed according to the published procedure 
by Heidemann et al. 2019. The construct ∆100CdaA used is equipped with an N-terminal GST- 
tag and was generated as described before.  
The pGEX-6P-1-∆100CdaA plasmid was transformed into E. coli BL21 (DE3) and grown in 
1 L 2YT medium at 37 °C. after the cell culture reached an optical density (OD600) of ~ 0.6 the 
protein expression was induced by adding 1 mM IPTG and incubated over night at 16 °C. The 
harvested cells were disrupted with a microfluidizer (M-110S Microfluidizer, Microfluidics) 
and centrifugation at 15.600 xg for 30 min. Subsequent to centrifugation the lysate was loaded 
onto a Glutathione Sepharose column (GE Healthcare) in 1 M NaCl, 20 mM Tris/HCl pH 7.5, 
10 mM EDTA. The GST-tagged target protein was eluted from the column with the addition 
of 40 mM reduced glutathione. The eluate was incubated over night with PreScission protease 
(ration 1:100 (w/w)) in a cellulose tubing during dialysis (buffer: 300 mM NaCl, 20 mM 
Tris/HCl pH 7.5) at 4 °C. In order to sperate the cleaved-off GST-tag from the protein a second 
glutathione sepharose purification step was included. 
 
5.2.3 Crystallization  
The sitting-drop vapour-diffusion method was applied for crystallization. The original pub-
lished crystallization condition of the apo CdaA form was optimized in order to be more suited 
for fragment screening (Heidemann et al. 2019). The crystallization trails were performed at 
20 °C at a protein concentration of 6 mg/ml ∆100CdaA in 2 µl droplets and 1:1 protein-to-
reservoir ratio. In order to facilitate crystal growth, micro seeding has been performed. Thin 
crystal plates were obtained overnight in 3.7 M NaCl, 0.1M Na-HEPES pH 8.5 and 3 % DMSO. 
The ideal DMSO concentration was determined by preceding stability tests.  
 
5.2.4 Fragment soaking, data collection and structure determination 
For fragment screening the two following fragment libraries were used: HZB 96 fragment 
screen (Helmholz Zentrum Berlin) (Huschmann et al. 2016) and the commercially available 
Frag Xtal Screen (Jena BioScience). Each fragment screen plate provides 96 different frag-
ments that are spotted in the two protein wells of a crystallization plate. In order to solubilize 
the dried fragments 0.5 µl crystallization reservoir was pipetted to one of the two wells for each 
fragment, resulting in nominal fragment concentrations of 100 mM. The second well was sup-
plemented with the saturated sucrose cryo-buffer (Heidemann et al. 2019). The crystallization 
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plates were sealed with crystallization foil and stored at 20 °C overnight, allowing the frag-
ments to solubilize. Subsequently, two crystals were transferred to each well with solubilized 
fragment. All crystals were soaked overnight in fragment solution and cryo-protected in the 
second drop prior to plunging them into liquid nitrogen. 
Diffraction images were collected at PETRA III EMBL beamlines P13 and P14 (DESY, Ham-
burg, Germany) as well as at MASSIF-3 beamline (ESRF, Grenoble, France). All images were 
automatically processed with the XDS package (Kabsch 2010b; Kabsch 2010a). The processed 
data were automatically refined by using their customized refinement pipeline (fspipeline, 
Helmholtz-Zentrum Berlin) (Schiebel et al. 2016). The refined structural models were than 
used as input for PanDDA (Pearce et al. 2017c). Identified ligands or conformational changes 
triggered by ligand binding were modeled in an event map and merged with the unbound pro-
tein state of the crystal. 
 
5.3 Results and Discussion 
A bottle neck of antibiotic research is the identification of new drug targets specific for the 
causative organism and not for the host. Recent discovery of c-di-AMP opened the field to a 
potential new class of antibiotics, targeting c-di-AMP synthesizing enzymes which are absent 
in humans but present in a variety of pathogenic bacteria (Song et al. 2005; Woodward et al. 
2010; Corrigan et al. 2011; Bai et al. 2012).  
In order to identify molecules that bind to a new potential drug target the approach of fragment 
screening in combination with X-ray crystallography as a sensitive detection tool is often used. 
Fragments provide a good starting point to build a target specific drug.  
In a previous study we presented a stable crystallization system of apo-∆100CdaA with rea-
sonable diffracting crystals at around 1.7 Å – 2.2 Å resolution, respectively (Heidemann et al. 
2019). In the asymmetric unit two ∆100CdaA monomers are present forming a non-catalytic 
dimer with two outwards facing active sites. The two active sites are exposed to the solvent 
making them accessible for fragment binding. However, in one of the two active sites the Tyr187 
which is known to lock ATP in the binding pocket is blocked by the N-terminus of a-helix 1 
of a symmetry mate which could hamper fragment binding.  
Two 96-fragment libraries were used for initial screening and around 200 datasets were col-
lected subsequently for 91 individual fragments (Tab. S3). Around 50 % of soaked crystals did 
not diffract or dissolved during soaking. Two crystals were soaked for each fragment condition. 
In order to perform a successful fragment screening, it is of great importance to work with high 
resolution datasets. The distribution of the resolutions of all collected datasets is represented in 
Figure S1.  
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Figure 2: Chemical structures of all fragments. Representation of all fragments that gave a positive signal by 
data analysis. The colours show the positioning of the fragment in one of the 3 binding pockets as seen in figure 
3. 
Following automated re-
finement with the fspipe-
line (Schiebel et al. 2016), 
the output models and maps 
were submitted to PanDDA 
using by the PanDDA de-
fault settings. Initially only 
one fragment was identi-
fied by the conventional 
analysis (Fragment E05, 
Jena BioScience), resulting 
in a hit rate of about 1 %. 
By using the PanDDA 
method the hit rate could be 
increased by almost a ten-
fold. Eight additional frag-
ments were identified, in-
creasing the hit rate of unique fragment hits to 10 %. Fragments JBS_B04 and JBS_E01 could 
be detected at two different binding sites in the protein. The crystallographic data are summa-
rized in table S 1 & 2) and each ligand hit is represented in its chemical structure in figure 3. 
In summery three different fragment binding site could be identified which are referred to as 
Figure 3: Fragment binding sites. Overall structure of CdaA with three dif-
ferent fragment binding sites highlighted different colours: The first set of 
fragments is positioned to the nucleotide binding site (green). In close vicinity 
to the ATP binding pocket the second set of fragments was observed (red). 
The third set of bound fragments was identified to be bound between the N-
terminal a-helix 1 and the C-terminal a-helix 5 (blue). 
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binding site I (green), II (red) and III (blue) by using the PanDDA method. With respect to the 
three binding sites a clear preference is obtained in binding site I and II. Most of the ligands 
are bound to the upper part of the ATP binding pocket were the purine base is positioned (bind-
ing site I) or in the vicinity of the binding site between helix a2 and a4 as well as the loop 
region b4-a4 (binding site II) (Fig. 1A and 3). A third set of fragments is positioned between 
the N-terminal a-helix 1 and C-terminal a-helix5 (Fig. 3) which is referred to as binding site 
III. 
In total four unique fragment hits were identified to be bound to the nucleotide binding pocket 
(binding site I) of CdaA. One of these hits is GMP (Fragment 83, HZB Screen) which is a 
rather impractical candidate for further drug design since GMP is an intermediate of guanine 
derived metabolites and thus highly abundant in the cell. However, in case of CdaA the ribose 
of the GMP molecule is bound at the adenine base binding site of the ATP. Through steric 
hinderance the purine base of the GMP is not able to bind at the same position as the adenine 
base of the ATP and protrudes out of the binding pocket (Fig. 4A). It might be worth to check 
data banks for GMP modifications to test in a subsequent step by in silico docking experiments 
to find binding positions of a modified GMP. Nevertheless, it is indispensable to consider early 
on that the altered GMP will not bind to GDP or GTP binding pockets of other proteins but 
specifically binds to CdaA. A higher affinity of a GMP modified follow-up to CdaA might 
hamper ATP binding as well as the formation of a dimer. 
As mentioned previously three further fragments were detected to bind to the nucleotide bind-
ing site (B04, D07, H04; Jena Bioscience) (Fig 4 B-F). 
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Figure 4: Representation of fragments bound to the nucleotide binding pocket in CdaA and their corre-
sponding results of the Z-scoring approach shown as a map in column one and the PanDDA event map in 
column 2. The ∆100CdaA structure is depicted as ribbon cartoon (grey) and the bound ligands are represented in 
balls and sticks (carbon in green, oxygen in red and nitrogen in dark blue). The fragments (HZB_083, JBS_B04a/c, 
JBS_D07 and JBS_H04) and all amino acids involved in ligand binding are shown in column A-E. Polar interac-
tions to 3.2 Å are marked by dashed lines. Binding of the fragments lead to a conformational change of Tyr187 
side chain locking the fragment in the binding pocket. Differences to the ground state analysed by the voxel 
analysis approach are represented as a Z-map (transparent surface representation in light orange, Z=2). The 
PanDDA event map (blue 2 s; A.1 BDC=0.14, B.1 BDC= 0.35, C.1 BDC= 0.29, D.1 BDC= 0.4, E.1 BDC= 0.54) 
shows clear evidence for a bound ligand in the upper part of the ATP binding pocket.  
 
Interestingly two fragments embody an aromatic ring (B04 and D07). In each case this ring is 
bound to the coordination area of the six-ring of the ATP purine base (Fig. 4 B, C and D). All 
fragments bound to the nucleotide binding site, except the GMP, lead to a rotation of the tyro-
sine 187 side chain towards the fragment, locking it in the binding pocket by p-p stacking 
interaction (Fig. 4B-E). This movement of the tyrosine towards the active site of CdaA was 
described previously up on ATP binding (Heidemann et al. 2019). That means these fragments 
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are locked to the active site in the nucleotide binding pocket. All three fragments seem prom-
ising to be used for further follow-up compound studies as their binding introduces a confor-
mational change of an essential amino acid for ATP binding. It should also not go unnoticed 
that this set of fragments do not bind along the ATP or c-di-AMP coordination site (for review 
ATP or c-di-AMP coordination (Rosenberg et al. 2015; Heidemann et al. 2019)) and are rather 
pointing out of the binding pocket and thus might block the ability of forming catalytic dimers.  
 
Figure 5: Representation of all Fragments not bound to the nucleotide binding pocket. I-K shows fragments 
bound in close vicinity to the ATP binding pocket. F-G shows fragments bound via π-stacking between N-terminal 
a-helix 1 and C-terminal a-helix 2. The corresponding results of the Z-scoring approach are shown as a map 
representation in column one and the PanDDA “event map” is illustrated in column 2. The ∆100CdaA structure 
is depicted as ribbon cartoon (grey) and the bound ligands are represented in balls and sticks (carbon in green, 
oxygen in red and nitrogen in dark blue). Polar interactions to 3.2 Å are marked by dashed lines. Binding of the 
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fragments lead to a conformational change of Tyr187 side chain locking the fragment in the binding pocket. Dif-
ferences to the ground state analysed by the voxel analysis approach are represented as a Z-map (transparent 
surface representation in light orange, Z=2). The PanDDA event map (blue 2 s; F.1 BDC= 0.35, G.1 BDC= 0.40, 
H.1 BDC= 0.43, I.1 BDC= 0.38, J.1 BDC= 0.50, JK1 BDC= 0.46) shows clear evidence for ligand binding. 
 
In fact, further development could lead to a novel kind of inhibitor that are not based on ATP 
mimicry which could also help to create a very specific inhibitor with less side effects.  
In the lead discovery of fragments there are several ways of proceeding with a hit: for instance, 
fragment growing, linking and merging. In case of binding site I fragment growth seems to be 
a suitable approach to follow (GMP, B04, D07, H04, Fig. 4) (Hubbard 2016).  
Beside the first binding site, a second fragment binding spot, binding site II (C11, E01, E05; 
Jena Bioscience) was observed in close vicinity to the ATP binding pocket (Fig. 5 I-K). This 
binding site is formed by two a-helices, namely a2 and a4 as well as a loop region which 
embodies amino acids that contribute to nucleotide binding. All three compounds possess a 
ring structure which are interacting with a tyrosine (Tyr143 and Tyr187) of the protein. The ring 
structure is forming the central scaffold of all three fragments and could form the basis for 
ligand growth into the active site of CdaA. As described for fragments in binding site I, lead 
compounds could be built in a way that they either hinder the protein to form active dimers or 
that they have a strong influence on the catalytic tyrosine which could prevent ATP binding. 
The ring substituents point towards the N-terminus, away from the active site. An alteration or 
further growth of the substituents along the protein surface could increase polar interactions 
which in fact might increase the binding affinity and additionally the target specificity. As 
already pointed out target specificity is an important aspect to consider in order to reduce the 
interaction with other human proteins. Inhibition of essential human proteins could result in 
severe, toxic side effects which should be kept rather small. Due to its positioning this second 
set of fragments might be suited for both, for individual fragment growth but also fragment 
linking to the first set of fragments. The ligand binding site I and II are in close vicinity to each 
other, therefore it might be worth to consider searching for linkers connecting these fragments.  
The last set of fragments (binding site III) which were identified by fragment screening are 
located distant to the active site (B04, B06, C08, E01b) (Fig. 3A (red) and Fig. 5 F-H). While 
the fragment B04 was described above to be located in the active site of CdaA it was also 
detected at the N-terminal a-helix 1, entangled by the flexible region (Fig. 3A). It should be 
kept in mind that the working CdaA construct is a truncated version lacking the N-terminal 
membrane domain as well as an additional helix linking the membrane domain and the cyclase 
domain (predicted coiled-coil) (Rosenberg et al. 2015; Heidemann et al. 2019). If the additional 
helix is present and CdaA is located on the membrane this binding site might be shielded. It is 
not known what kind of influence the missing part has on the activity of the protein and whether 
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the fragment would still bind to the full-length CdaA. Therefore, this binding site is probably 
not the first choice for further optimization.  
The additional three fragments (B06, C08, E01b) that are grouped as binding site III are posi-
tioned between the N-terminal a-helix 1 and the C-terminal a-helix 5 (Fig. 5 J & H and Fig. 
1). The fragment was also described above to bind to binding site II, yet here we are concen-
trating on binding site III. 
If either B06, C08 and E01 bind to the protein a histidine (His110) changes the position of its 
site chain, interacting with the benzoic ring of the fragments via p-p stacking interaction. In 
these cases, it might also be difficult to predict the influence of the bound fragments on the 
protein activity because they are located distant from the active site and the dimeric interface. 
A comparison of all bound fragments revealed a certain structural feature on how the fragments 
are bound to the macromolecule. A key interplay in all cases are π-π aromatic or cation-π in-
teractions which geometrically arrange either in sandwich, T-shaped or parallel displacement 
formations (Sinnokrot et al. 2002). The availability of ring systems is a common characteristic 
of commercial drugs and also fragment libraries (Feher and Schmidt 2003; Ertl et al. 2006). 
Ring systems are often used as central scaffolds as they contribute to the basic shape, rigidity 
or flexibility of the molecule and keep substituents in their proper position and directly interact 
with the protein. They can be easily used for further development of lead compounds (Ertl et 
al. 2006). On the ground of similar scaffolds certain characteristic substituents of different 
overlaying fragment hits can be merged in order to form a more potent drug compound. 
With the results of this first fragment screening with CdaA we are planning to proceed with a 
follow-up campaign. Subsequent identification of lead compounds a templet-based in silico 
docking experiment will be performed. That means, after selecting larger compounds that share 
the core structure of the respective fragment hit, these follow-up compounds will be filtered by 
a docking algorithm which takes the binding pose of the fragment hit as a starting restraint into 
account. The resulting binding poses will be computationally scored and manually chosen for 
the next round of crystallographic experiments.  
We aim to modify the identified fragments in a way that they will bind with a higher affinity 
to CdaA and will in the long run influence c-di-AMP synthesis. 
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35112 14055 25538 26642 19433 18986 
Redun-
dancy  
6.5 (6.7) 7.4 (6.5) 8.2 (8.6) 7.9 (8.3) 8.0 (8.2) 12.9 (13.5) 
Completen-
ess (%) 
98.1 (97.4) 96.2 (94.9) 99.6(99.9) 99.4 (99.0) 99.8 (99.8) 99.8 (99.6) 
Space group P212121 P212121 P212121 P212121 P212121 P212121 
a (Å) 41.970 41.700 42.690 41.660 42.250 41.130 
b (Å) 64.680 64.460 64.850 64.750 64.920 64.710 
c (Å) 129.520 128.690 129.980 129.060 128.700 128.710 






































      














      
Bonds Å 0.010 0.014 0.011 0.012 0.012 0.011 
Angles 
(degree) 
1.047 1.473 1.104 1.281 1.184 1.189 
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15518 21084 23622 37303 32944 
Redun-
dancy  
13.0 (13.4) 8.1 (8.5) 8.2 (8.6) 8.3 (8.6) 8.3 (8.7) 
Completen-
ess (%) 
99.9 (100.0) 98.68 (98.7) 99.7 (99.8) 99.5 (99.1) 99.9 (99.9) 
Space 
group 
P212121 P212121 P212121 P212121 P212121 
a (Å) 44.220 40.320 39.79 41.750 43.740 
b (Å) 65.070 64.810 64.65 64.710 64.110 
c (Å) 130.330 129.580 130.02 129.040 129.790 
Rmerge (%) 8.9(89.9) 8.2 (199.1) 8.6(281.1) 5.5 (183.2) 5.5 (165.0) 
I/𝝈 (I) 3.73 (19.70) 1.4 (17.6) 1.02 (15.8) 1.5 (19.0) 1.4 (18.9) 
CC1/2 99.9 (95.3) 100.0 (69.7) 100.0 (61.1) 99.9 (78.5) 99.8 (75.4) 
Refinement 
statistics  
     
Rwork/Rfree  0.2302/0.2985 0.2635/0.3340 0.3143/0.3473 0.2184/0.2670 0.2157/0.2616 
Root mean squ-
are deviation 
     
Bonds Å 0.014 0.014 0.014 0.010 0.010 
Angles 
(degree) 
1.456 1.438 1.613 1.119 1.141 
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Supporting Figure S1: Histogram showing resolution distribution of all dataset. 69.6 % of all collected da-
tasets show reasonable diffraction between 1.7 and 2.2 Å resolution. 
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Table S3: Overview of all collected data sets.  
1 Fragment 
# 
























































































1.978 [A] 99.9% 7.3% 0.2138 
0.2375 
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4, 6, 6a- 
tetrahy-






















































1.835 [A] 99.9% 8.1% 0.2242 
0.2520 
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1.880 [A] 99.4% 7.8% 0.2315 
0.2650 
 












1.994 [A] 99.7% 8.1% 0.2348 
0.2579 
 




















1.949 [A] 99.3% 6.3% 0.2055 
0.2243 
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2.012 [A] 99.0% 5.7% 0.2102 
0.2384 
 









1.830 [A] 99.3% 7.8% 0.1971 
0.2288 
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99.2% 12.6% 0.2643 
0.3142 
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3.298 [A] 99.8% 21.9% 0.3464 
0.3810 
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37 C03  
















































































1.949 [A] 99.3% 6.3% 0.2055 
0.2243 
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3.120 [A] 95.7% 16.7% 0.2448 
0.2784 
 


























1.989 [A] 99.6% 9.7% 0.2136 
0.2398 
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2.467 [A] 98.6% 9.2% 0.2220 
0.2543 
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4, 6, 6a- 
tetrahy-































2.713 [A] 97.4% 31.5% 0.3228 
0.3440 
 








2.385 [A] 99.6% 24.1% 0.2805 
0.3266 
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1- c] [1, 2, 
4] triazine,  
3- (3, 4- 
difluoro-
phenyl) - 






























































4.876 [A] 99.5% 8.3% 0.1920 
0.2440 
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2.273 [A] 99.8% 4.3% 0.2024 
0.2307 
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3.553 [A] 98.5% 9.2% 0.2305 
0.2744 
 
Chapter 5: A crystallographic fragment screen unveils three different binding sites on the  



























































































2.216 [A] 99.5% 7.4% 0.2216 
0.2400 
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3.136 [A] 99.6% 7.8% 0.2665 
0.3128 
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2.063 [A] 99.8% 5.5% 0.2119 
0.2399 
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3- (3, 4- 
difluoro-
phenyl) - 
1, 4, 6, 7- 
tetrahydro 











































































2.002 [A] 99.8% 4.5% 0.2222 
0.2480 
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3.214 [A] 97.1% 6.9% 0.1963 
0.2431 
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2.112 [A] 99.8% 6.1% 0.2244 
0.2353 
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2.223 [A] 97.9% 4.7% 0.2058 
0.2341 
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2.060 [A] 99.7% 5.2% 0.2024 
0.2276 
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2.075 [A] 99.8% 6.4% 0.2399 
0.2790 
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2.118 [A] 98.6% 7.5% 0.2885 
0.3056 
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2.264 [A] 99.7% 7.7% 0.2561 
0.3021 
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2.131 [A] 98.8% 3.6% 0.1942 
0.2359 
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1.986 [A] 99.8% 4.6% 0.2033 
0.2319 
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Chapter 6: Discussion 
The ability of bacteria to cope with environmental changes is an essential selective advantage. 
Bacteria possess a plethora of transduction pathways in order to adapt rapidly to changes in 
nature (Goudreau and Stock 1998). In all kingdoms of live these intracellular signaling mole-
cules are often nucleotide-based second messengers. In bacteria c-AMP, (p)ppGpp and c-di-
GMP are the most comprehensively studied among the long list of known nucleotide-based 
signaling molecules (Pesavento and Hengge 2009).  
In 2008 the bacterial second messenger c-di-AMP “entered the fray” (Witte et al. 2008; 
Corrigan Rebecca M and Gründling 2013). Henceforth, the research interest on the c-di-AMP 
synthesis, degradation and function increased rapidly giving more remarkable insights into its 
importance for bacteria (Corrigan R. M. and Gründling 2013; Commichau et al. 2015a; 
Commichau et al. 2019). c-di-AMP is synthesized out of two ATP molecules by the so called 
diadenylate cyclases in a metal ion-dependent manner. The first discovered DAC is the DNA 
scanning protein DisA. DisA forms a stable associated homo octamer in vivo and in vitro com-
posed of two N-terminal “head-to-head” tetrameric rings which are accompanied by a C-ter-
minal signaling domain. The nucleotide binding site was identified directly between the inter-
face of these two N-terminal domains forming dimeric “head-to-head” assemblies which are 
characterized as the catalytic units. Each monomer of the four dimers is described as a DAC 
domain. (Witte et al. 2008; Müller et al. 2015). Five classes of c-di-AMP synthases with dif-
ferent regulatory domains have been identified so far (Romling 2008; Corrigan Rebecca M and 
Gründling 2013; Blötz et al. 2017; Commichau et al. 2019). However, most bacteria possess 
only one diadenylate cyclase either of the class DisA or CdaA, while the latter is the most 
prevailing DAC among all bacteria that synthesize c-di-AMP (Corrigan et al. 2013; 
Commichau et al. 2019). In several studies it was shown that the presence of c-di-AMP is 
essential for some bacteria under standard laboratory conditions (Gundlach et al. 2015a; 
Commichau et al. 2017; Gundlach et al. 2017a). Nonetheless, an extensive excess of c-di-AMP 
is equally harmful to the cell and therefore the level of c-di-AMP needs to be tightly regulated 
(Woodward et al. 2010; Luo Y and Helmann 2012; Mehne et al. 2013; Gundlach et al. 2015a; 
Commichau et al. 2017; Gundlach et al. 2017a; Gundlach et al. 2017b; Commichau et al. 2019). 
In comparison to other nucleotide-based second messengers, c-di-AMP is rather unique and 
opens new perspectives in antibiotic research (Corrigan R. M. and Gründling 2013; Rosenberg 
et al. 2015; Commichau et al. 2019; Heidemann et al. 2019). This work mainly focuses on the 
diadenylate cyclase class CdaA from the human pathogen L. monocytogenes which is the sole 
DAC in this organism. In this Chapter the CdaA functionality as well as a CdaA regulation 
model and the oligomerization state in the cell are discussed. Furthermore, a comparison of c-
di-AMP to the well-studied bacterial second messenger c-di-GMP will be presented. Finally, 
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the importance of new antibiotics development is discussed with the focus on diadenylate 
cyclases as promising targets for new antibiotic substances. The structural and biochemical 
characterization of the c-di-AMP binding protein DarB/YkuL from B. subtilis was also part of 
this work. However, it is not discussed in the following as it is a non-essential protein and is 
not part of the drug discovery campaign. 
 
6.1 CdaA Structure and function  
The structure of the DAC class CdaA from L. 
monocytogenes (∆100CdaA) was already pub-
lished in the beginning of 2015 (Rosenberg et al. 
2015). Based on the structural comparison of 
DisA and CdaA it was assumed that CdaA is 
able to synthetize c-di-AMP upon dimerization. 
Even though the crystal structure represented 
only an inactive monomer of CdaA which is in-
compatible with the formation of c-di-AMP, bi-
ochemical data confirmed the formation of a di-
mer in solution. The dimeric assembly has been 
observed also for truncated constructs ∆80CdaA 
and ∆100CdaA in vivo and in vitro (Fig. 6). The 
same study suggested that the CdaA activity is, 
as described for DisA, Mg2+ ion dependent. However, CdaA is only active in presence of Mn2+ 
or Co2+ ions and not active in presence of Mg2+ ions. Further experiments confirmed Mn2+ as 
the main CdaA cofactor by a coralyne-based assay (Heidemann et al. 2019). In addition, a 
significantly lower activity has been observed in presence of Co2+ ions but no activity in pres-
ence of Mg2+ ions. This is consistent with the previous results (Rosenberg et al. 2015). Utilizing 
this knowledge, we succeeded in crystalizing CdaA in its post-catalytic state with its product 
c-di-AMP bound. In addition, apo CdaA has been also crystallized. The ligand-free crystals 
were used for fragment screening (Heidemann et al. 2019) (Chapter 5).  
Interestingly, the asymmetric unit of both crystal forms contained two CdaA monomers form-
ing a non-catalytic dimer with outwards facing active sites. This assembly has also been ob-
served in different crystal forms under different crystallization conditions and for CdaA from 
different organisms (Heidemann et al. 2019; Tosi et al. 2019) (Fig. 7).  
In addition to structural data Tosi et al. reported that S. aureus DacA (described as CdaA in L. 
monocytogenes and B. subtilis) exhibits cyclase activity mainly in presence of Mn2+, Co2+ but 
also Mg2+ ions. This is surprising as the structural comparison of the active sites (lmoCdaA-
Figure 6: Schematic illustration of the domain or-
ganization of the different available CdaA L. mon-
ocytogenes constructs. CdaA consists of transmem-
brane (TM) domain made of three a-helices, 2 coiled-
coil domains and the active cyclase domain. The con-
struct ∆80CdaA lacks the TM domain while the con-
struct ∆100CdaA additionally lacks the following 
coiled-coil domain (modified from Rosenberg et al. 
2015).  
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sauDacA) unveiled an identical positioning of the amino acids involved in binding of both c-
di-AMP and the metal ion (Heidemann et al. 2019) (Chapter 2).  
The unexpected catalytic activity of Mg2+ ions could result from different experimental ap-
proaches which were used to determine the conversion of two ATP molecules into c-di-AMP. 
While Tosi et al. used a radio-thin-layer chromatography (radio-TLC) approach with labeled 
ATP (a-P32), we used the c-di-AMP-specific coralyne-based assay (Zhou et al. 2014). In order 
to investigate potential differences between CdaA of these two organisms, a GST-tagged, co-
don optimized CdaA from S. aureus was tested using the coralyne-based assay. The results 
suggested a similar metal dependence of CdaA/DacA from S. aureus and L. monocytogenes. 
However, an activity in presence of Mg2+ as shown by the radio-TLC method could not be 
confirmed (Chapter 8, Fig. 11). The observed discrepancy could result from differences in the 
purification protocol as well as the used construct (Tosi et al. 2019 = His-∆100CdaA). The 
ultimate prove would require the measurement of the GST-CdaA construct of S. aureus and L. 
monocytogenes with the sensitive radio-TLC method. 
 
Figure 7: Crystal structures of ∆100CdaA from different organisms and in different space groups. (A) 
Crystal structure of CdaA from L. monocytogenes (Space group: H32) (PDB code: 6HVL). (B) Crystal structure 
of CdaA from B. subtilis (Space group: P43212) (PDB code: 6HUW). (C) Crystal structure of CdaA from L. 
monocytogenes (Space group: P212121) (PDB code: 6HVM). (D) Crystal structure of CdaA from S. aureus (Space 
group: P212121) (PDB code: 6GYW). The asymmetric unit of all crystal forms contains two CdaA monomers 
forming a non-catalytic dimer with an interface between a-helix 3 (Fig. 4/ Introduction). A superposition of all 
CdaA structures available in the protein data bank (PDB) is represented in figure 13 (Chapter 8). All protein 
structures are depicted in cartoon mode, L. monocytogenes CdaA structures are colored light and dark blue, the 
CdaA structure from B. subtilis is colored light green and the one from S. aureus is colored in light brown.  
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6.2 Oligomerization state of CdaA in solution and its biological relevance  
The synthesis of c-di-AMP requires the formation of DAC dimers with face-to-face oriented 
active sites. This is known from structural analysis of DisA, which forms stable associated 
DAC dimers in solution. Comparison of the active sites of CdaA and DisA reveals a more 
crowded active site in CdaA which explains why the active CdaA dimer is only transiently 
formed (Heidemann et al. 2019) (Chapter 2). Therefore, unlike DisA, the catalytic CdaA dimer 
needs to disassemble in order to release c-di-AMP (Heidemann et al. 2019) (Chapter 2). 
In 2015 Rosenberg and colleagues published in vitro experiments (SEC-MALS data) that 
demonstrated the formation of CdaA dimers in solution. Yet this dimer formation was de-
scribed as the ability of CdaA to form catalytic active dimers, although it could not be experi-
mentally proven (Rosenberg et al. 2015). The formation of a CdaA dimer in solution was con-
firmed by us (Chapter 3, Fig. 4 and 5) and by Tosi et al. 2019. Therefore, the question was 
asked whether CdaA forms under non-catalytic conditions a catalytic dimer in solution or a 
non-catalytic dimer?  
The dimer in solution seems rather stable which is non-corresponded to the assumption that 
CdaA forms transient catalytic dimers (Heidemann et al. 2019). Previously the DAC class CdaS 
was proposed to form hexamers in solution. In this hexamer model the DAC domains form 
non-head-to-head dimer assemblies, similar to these described for CdaA/DacA (Mehne et al. 
2014; Tosi et al. 2019). However, no further experiments were performed in order to confirm 
that the hexamer assembly is the active form of CdaS and whether additional oligomerization 
is required to synthesize c-di-AMP (Mehne et al. 2014). In contrast, the DAC class DisA was 
shown to form octamer assemblies in in vivo and in vitro in order to form c-di-AMP. Therefore, 
Tosi et al. suggested that a non-catalytic CdaA/DacA dimer is present in solution (Witte et al. 
2008; Mehne et al. 2014; Müller et al. 2015).  
Our structural data and the crystal structures obtained by Tosi et al. suggested the formation of 
a CdaA dimer. This dimer in the crystal structures is non-catalytic with outwards facing active 
sites forming a dimeric interface between the two a-helices 3 and b-strand 2 which results in 
an extended twisted b-sheet (Fig. 4 and 8). This specific assembly of CdaA is not only obtained 
in crystals with different space groups but also by the crystallographic analysis of CdaA from 
different organisms like L. monocytogenes (6HVM, 6HVL, Heidemann J. et al. 2019), B. sub-
tilis (6HUW; Tosi T. et al. 2019) and S. aureus (6GYW; Tosi T. et al. 2019) (Fig. 7). 
Based on this prominent non-catalytic assembly seen in different crystal structures and the fact 
that other crystallographic characterized DACs were described to form higher oligomeric com-
plexes Tosi et al. suggested that this non-catalytic dimer formation has a biological relevance 
(Witte et al. 2008; Mehne et al. 2014; Müller et al. 2015). In order to address this question, 
mutations were introduced into the S. aureus interface of the non-catalytic dimer showing a 
negative effect on the CdaA activity (Tosi et al. 2019). All these biochemical and crystallo-
graphic data suggest that CdaA forms a non-catalytic dimer in solution.  
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The next question which needs to be considered is whether the assembly of a non-catalytic 
CdaA dimer can be present in the cell and whether CdaA is still able to form catalytic dimers. 
The structural analysis of the non-catalytic dimer clearly shows that the N-terminal part of each 
of the two a-helices 1, which are connected to the membrane domain by a 20 amino acid linker 
region, point in the same direction (Fig. 8). This is consistent with the fact that CdaA is bound 
to the membrane. As described in Chapter 2 CdaA from L. monocytogenes was successfully 
crystallized in its post-catalytic state with bound c-di-AMP. In the asymmetric unit a non-cat-
alytic dimer is present of which each monomer represents a different catalytic state. While 
monomer one forms a transiently existing catalytic dimer (2-fold axis, crystallographic assem-
bly), the second forms a non-catalytic dimer with the first one and in addition reveals an AMP 
molecule bound in the active site (Heidemann et al. 2019). Comparing the orientation of four 
monomers forming an active dimer reveals that the N-terminal helices of all DAC domains are 
pointing in the same direction (Fig. 8). This indicates that based on crystal structure two non-
catalytic dimers are needed to form one catalytic CdaA dimer. It might be an interesting aspect 
to think of, that the formation of catalytic CdaA dimers might be directly regulated by the 
cellular turgor which was described to be controlled through the presence and absence of c-di-
AMP (Commichau et al. 2017).  
It should be kept in mind that all crystallization experiments were performed with a truncated 
construct. Although further biochemical data suggested that the additional N-terminal a-helix 
(∆80CdaA) has no influence on the CdaA activity compared to ∆100CdaA the influence on the 
full-length CdaA has not been biochemically and structurally studied so far (Chapter 8, Fig. 
12). Structural and biochemical data on the full-length CdaA could help to better understand 
what CdaA full-length looks like and how it is functioning in the cell.  
One can only speculate of the biological relevance and whether CdaA is present as a non-
catalytic dimer in the cell and only forms catalytic dimers under c-di-AMP synthesizing con-
ditions. The formation of higher oligomers is well known for soluble and membrane bound 
proteins in living cells (Goodsell and Olson 2000). As well as the communication between 
active sites in oligomers through hydrogen bonds or allosteric effects could result for example 
in negative or positive cooperativity (Ferrell 2009). Whether this is also true for CdaA needs 
to be elucidated in future experiments. 





Figure 8: Suggested oligomerization state model of CdaA from L. monocytogenes. (A) Non-catalytic CdaA 
dimer of two CdaA monomers with an interface between a-helix 3 (monomer A: dark blue, monomer B: light 
blue). The N-terminal part of the two a-helices 1 of both CdaA monomers are pointing in the same direction 
which is consistent with the fact that the cyclase domain is linked by a 20 amino acid linker to a membrane. (B) 
Non-catalytic CdaA dimer which is rotated by 45 degree in comparison to (A). (C) A tetramer of CdaA molecules 
formed by two non-catalytic dimers exhibiting a catalytic dimer with bound c-di-AMP (non-catalytic dimer 1 is 
depicted in dark and light blue, non-catalytic dimer 2 is depicted in dark and light cyan). The catalytic dimer is 
formed by monomer A (dark blue) of the non-catalytic dimer 1 and monomer A (dark cyan) of the non-catalytic 
dimer 2. The N-terminal part of all four a-helices 1 point in the same direction. The protein structures are depicted 
in cartoon mode in light and dark blue as well as in light and dark cyan. c-di-AMP is depicted in stick mode 
(carbon in dark blue and cyan, phosphate in orange, oxygen in red, and nitrogen in blue) (PDB: 6HVL). 
 
6.3 CdaA regulation 
Even though the presence of c-di-AMP has been described to be essential for some bacteria, 
an overproduction of c-di-AMP was demonstrated to be harmful for the cell. Hence, c-di-AMP 
was named the “essential poison” which requires a tight control of its synthesis (Gundlach et 
al. 2015a; Huynh and Woodward 2016; Blötz et al. 2017).  
CdaA is present in a conserved gene cluster which encodes besides cdaA the regulatory protein 
CdaR and the glucosamine mutase GlmM (Mehne et al. 2013; Rismondo et al. 2016; Zhu et al. 
2016). Therefore, a functional relation between these three proteins was suggested. Indeed, a 
direct interaction between CdaA and CdaR as well as modulation of the CdaA activity were 
reported previously (Mehne et al. 2013; Gundlach et al. 2015a; Rismondo et al. 2016). In silico 
experiments suggested a positioning of CdaR extracellular (Corrigan Rebecca M and 
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Gründling 2013). This was confirmed in Chapter 3. Here it was also shown that CdaR interacts 
through the transmembrane domain with CdaA suggesting that the CdaA TM importantly con-
tributes to the activity of the DAC domain and also the transfer of a sensed signal by CdaR. 
The importance of the membrane domain was also demonstrated by mutations resulting in a 
decrease of CdaA activity (Zhu et al. 2016). It is suggested that CdaR is a signal receptor sens-
ing an external signal. So far, a signal sensed by CdaR and the signal transduction through the 
interacting TM domains of CdaR and CdaA is not known. In order to shed light on this un-
solved problem it is of great interest to identify the signal which is transduced to the DAC 
domain. Crystallographic and biochemical experiments might also help to further understand 
the mode of interaction between CdaR and CdaA and how the activity of DAC domain is mod-
ulated.  
The second protein encoded in the conserved gene cluster is GlmM. A direct interaction be-
tween CdaA and GlmM has been reported in B. subtilis, L. lactis and S. aureus (Gundlach et 
al. 2015a; Zhu et al. 2016; Tosi et al. 2019). In Chapter 3 an interaction between GlmM and 
CdaA was also confirmed in vivo and in vitro for L. monocytogenes. Furthermore, it was 
demonstrated that GlmM inhibits the c-di-AMP synthesis of CdaA under hyperosmotic stress 
preventing the cell from uncontrolled water loss through e.g. carnitine and betaine uptake (Zhu 
et al. 2016, Chapter 3). Zhu and colleagues discovered in L. lactis under hyperosmotic stress 
conditions a point mutation in GlmM at position 154 (I154 to F) leading to an osmoresistent 
strain. This strain showed a reduced c-di-AMP level in comparison to the wild type GlmM 
strain, suggesting an interaction between CdaA and GlmM. Sequence alignments of GlmM 
from related bacteria unveiled a phenylalanine in S. aureus, L. monocytogenes and B. subtilis 
at the position of an isoleucine (I154) in L. lactis wild type. As the L. lactis mutant strain carries 
also a Phe, it was suggested that this amino acid might play an important role in modulating 
CdaA and therefore might be involved in CdaA and GlmM interaction. Indeed, mutations of 
the phenylalanine to an isoleucine showed a similar effect in L. monocytogenes as the wildtype 
GlmM in L. lactis. Interestingly, the phenylalanine (Phe155) in the available S. aureus GlmM 
(PDB: 6GYZ) structure is exposed on the protein surface and could indeed be crucial for pro-
tein-protein interactions (Tosi et al. 2019).  
How could an interaction of GlmM with CdaA result in altering cyclase activity?  
The crystal structure of GlmM reveals, as suggested from biochemical data, a homodimer as a 
biologically active form. This oligomerization of two GlmM monomers results in a V-shaped 
structure, right above the dimeric interface is the previously discussed Phe155 exposed to the 
surface (Fig. 9). So far, no crystallographic data of a CdaA and GlmM complex are available. 
However, Tosi et al. performed SAXS experiments in which the ab initio SAXS molecular 
envelope suggested that, at least in solution, CdaA sits on top of the GlmM homodimer inter-
face. It was suggested that GlmM blocks the formation of higher CdaA oligomers which might 
be important for activity (described in 6.2). Nonetheless, these results seem to be inconsistent 
with the fact that only a single mutation (in L. monocytogenes Phe154 to Ile) leads to an increase 
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in the intracellular c-di-AMP level. The question to address is whether a single amino acid 
mutation in GlmM could have such a strong impact on the GlmM-CdaA complex formation 
and is able to perturbate the inhibition of the suggested higher CdaA oligomers. So far, no data 
are available describing the influence of the single mutation on the GlmM-CdaA binding af-
finity. In order to argue about the mode of GlmM-CdaA interaction additional experimental 
data would be required. Even though we know that GlmM inhibits CdaA as a reaction of hy-
perosmotic stress, the signal leading to a complex formation and thereby inhibition of c-di-
AMP synthesis still needs to be elucidated. 
Structural characterization of the GlmM-CdaA complex would be of great interest in order to 
understand CdaA inhibition on a structural level which in turn could be useful for a CdaA drug 
discovery campaign.  
 
Figure 9: Crystal structure of the Glucosamine mutase GlmM from S. aureus. (A) GlmM homodimer (mon-
omer 1: dark green, monomer 2: light green) with a V-shaped dimeric interface in which the two Phe155 are ex-
posed on the protein interface. The protein is depicted in a cartoon mode in light and dark green. The two phenyl-
alanine are shown in stick mode (carbon in light and dark green, oxygen in red and nitrogen in blue). These two 
Phe155 were shown to negatively influence CdaA activity and its position is indicated by the two red stars. (B) A 
detailed view of the two Phe155 exposed on the protein surface (PDB code: 6GYZ) (Tosi et al. 2019). 
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6.4 DAC and DGC comparison  
Besides the bacterial second messenger c-di-AMP 
diverse cyclic nucleotides are known, like the 
closely related c-di-GMP. c-di-GMP was already 
discovered in 1987 by Benziman and coworkers 
which is together with c-AMP and (p)ppGpp prob-
ably the most comprehensively studied nucleotide-
based second messenger (Ross et al. 1990; 
Pesavento and Hengge 2009).  
The synthesis of c-di-GMP requires two GTP mol-
ecules positioned in close proximity in order to fa-
cilitate a nucleophilic attack of the 3’OH group of 
one GTP on the a-phosphate of the other GTP mol-
ecule, leading to their cyclization and the release of 
two pyrophosphates. This reaction is ensured by di-
merization of two GGDEF domains of the so called 
diguanylate cyclases (DGC) that is metal ion-de-
pendent, as it is known for the diadenylate cyclases 
(Romling et al. 2013). However, not all GGDEF 
domain-containing proteins necessarily possess 
DGC activity (Suzuki et al. 2006; Bordeleau et al. 
2011). It was mentioned above that only five clas-
ses of DACs are known of which most have been identified in Gram-positive and only some 
in Gram-negative bacteria and archaea. Furthermore, it is known that most bacteria possess 
only one DAC class which is different to c-di-GMP synthesizing enzymes (Galperin et al. 2001; 
Corrigan et al. 2013; Commichau et al. 2019). DGCs are ubiquitously distributed in bacteria, 
in addition many bacteria are known to synthesize more than one DGC (e.g. Escherichia coli 
(E. coli) (Pfiffer et al. 2019) or Bdellovibrio Bacteriovorus (Meek et al. 2019)). Even though 
both Gram-positive and Gram-negative bacteria are known to carry c-di-GMP synthesizing 
enzymes. It has been also shown that Gram-positive bacteria possess fewer DGCs in compari-
son to Gram-negative bacteria (Galperin et al., 2001; Pei & Grishin, 2001). DGCs often exhibit 
a modular domain architecture (Jenal 2004; Pfiffer et al. 2019). They are either present as stand-
alone proteins or in multidomain proteins accompanied by specific c-di-GMP degrading phos-
phodiesterases namely EAL and HD-GYP domains (Pesavento and Hengge 2009; Romling et 
al. 2013; Opoku-Temeng et al. 2016). In many cases an N-terminal domain is linked to the 
membrane where it can function as a signaling receptor for external stimuli. This is similar to 
the DAC domains that were described to be accompanied by different regulatory domains 
(Witte et al. 2008; Corrigan Rebecca M and Gründling 2013; Commichau et al. 2015b; 
Figure 10: Crystal structure of a GGDEF do-
main of a diguanylate cyclase from Xanthomo-
nas campestris. The protein is composed of a b-
sheet formed by five b-strands which are sur-
rounded by five a-helices. The overall fold is dif-
ferent to the DAC domain fold. The protein struc-
ture is depicted in cartoon mode in yellow (PDB 
code: 3QYY) (Yang et al. 2011). 
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Rosenberg et al. 2015). Even though it seems to be likely that the DGCs and DACs share 
structural and sequence similarities, both protein groups are rather different. 
The active DGC domain consists, as described for DACs, of a central b-sheet yet it is composed 
of usually five b-strands instead of seven (DACs) which are surrounded by five a-helices. 
Compared to the overall fold of the DAC domain, the DGC domains are elongated and not 
globular (Fig. 4/Introduction and Fig. 10) (Yang et al. 2011). Amino acids in the active site that 
contribute to the cyclase activity are also different. DACs most commonly use the conserved 
DGA and RHR motif for cyclase activity while DGC activity is dependent on the GGDEF 
motif (Witte et al. 2008; Pesavento and Hengge 2009; Romling et al. 2013; Müller et al. 2015; 
Rosenberg et al. 2015; Römling et al. 2017). Due to the sequence and structural differences it 
is assumed that the c-di-AMP and c-di-GMP signaling pathways evolved differently during 
evolution (Fahmi et al. 2017). Furthermore, some DGC were described to get allosterically 
inhibited by its product c-di-GMP. This inhibition requires formation of c-di-GMP dimeric 
assembly which subsequently binds to the so called I-site (inhibitory-site) (Christen et al. 2006; 
Gentner et al. 2012; Dahlstrom et al. 2016). Such a behavior of forming dimeric assemblies has 
also been reported for c-di-AMP, although in contrast to c-di-GMP its biological relevance has 
not been discovered so far (Blommers et al. 1988; Manikandan et al. 2014).  
These two secondary metabolites differ not only in their synthesizing enzymes, but they also 
show differences in their biological role in bacteria. The major difference between these two 
molecules is their essentiality. c-di-AMP was reported to be essential for the survival of the 
bacteria since osmolyte control is indispensable. An osmolyte imbalance e.g. for K+ ions can 
be toxic to the cell and needs to be tightly controlled (Epstein 2003). Based on these findings 
it was suggested that DACs seem to be an interesting target for novel antibiotic substances.  
Even though c-di-GMP was shown to be ubiquitously distributed in bacteria it has not been 
reported to be essential for the bacterial survival. c-di-GMP is mainly involved in the molecular 
decision between the motile-to-sessile transition and therefore biofilm formation. Interestingly, 
biofilm formation in pathogenic bacteria leads to an increase in their resistance to antibiotics. 
An increase in the intracellular c-di-GMP level triggers the formation of biofilms, while its 
reduction was observed in biofilm dispersal (Roy and Sauer 2015). Therefore, it was suggested 
to develop DGCs inhibitor in order to support the efficacy of applied antibiotics by increase 
the bacterial susceptibility. Lowering of the intracellular c-di-GMP pool might be much more 
difficult as it is possible for c-di-AMP since there is a much higher number of different DGCs 
compared to the known number DAC classes (see the c-di-GMP census 
[http://ncbi.nlm.nih.gov/Complete_Genomes/c-di-GMP.html]) (Chou and Galperin 2016). 
Furthermore, not all DGCs contribute to the global c-di-GMP level, some are known to increase 
concentration of c-di-GMP in a specific region (Kader et al. 2006; Opoku-Temeng et al. 2016).  
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6.6 DACs as a new drug target  
The discovery of antibacterial substances in 1928 by Alexander Fleming revolutionized mod-
ern medicine (Fleming 1945). However, due to the rapid adaptability to environmental changes 
bacteria developed resistances to the pool of available antibiotics. Hence, it is of great im-
portance to develop new ones. Many bacteria gained resistances to several antibiotics, resulting 
in multi-drug resistant bacteria not only due to an extensive misuse in e.g. agriculture and also 
healthcare systems (Phillips et al. 2004; Hume 2011; Michael et al. 2014; Woolhouse et al. 
2016). One major challenge of antibiotic development is the identification of new suitable tar-
gets. Such a target needs to be absent in humans and at its best essential in a wide range of 
bacteria (Silver 2011). The discovery of c-di-AMP and its functional diversity opened new 
perspectives in antibiotic research.  
This work is mainly focused on the understanding of how the most distributed c-di-AMP syn-
thesizing enzyme CdaA is functioning and regulated in order to lay a foundation for drug de-
velopment. However, the question whether DACs are a good drug target based on the scientific 
knowledge has not been discussed so far. Indeed, many facts seem to render DACs as a good 
drug target. DACs are widely distributed in a great diversity of different bacteria including 
bacteria that are on the “priority pathogen” list of the WHO (S. aureus, S. pneumonia, M tu-
berculosis) and most importantly they are not present in humans (Song et al. 2005; Woodward 
et al. 2010; Corrigan et al. 2011; Luo Yun and Helmann 2012; Andrade et al. 2016; Devaux et 
al. 2018). Its product c-di-AMP is involved in a plethora of different cellular functions and in 
some bacteria its absence has been lethal (Corrigan et al. 2011; Bai et al. 2012; Luo Y and 
Helmann 2012; Bai et al. 2013; Gundlach et al. 2017b). Therefore, diadenylate cyclases seem 
to be a very promising new drug target in the fight against bacterial infections.  
In L. monocytogenes c-di-AMP controls the accumulation of the second messenger ppGpp to 
toxic levels (Whiteley et al. 2015). Therefore, its absence triggers the accumulation of ppGpp 
in L. monocytogenes leading to cell death. As c-di-AMP controls the K+ ion influx under hy-
perosmotic stress conditions in B. subtilis here a deletion of all DACs leads to an uncontrolled 
K+ influx and therefore cell lysis (Gundlach et al. 2017b). Yet it has been reported that B. 
subtilis is able to form suppressor mutants under high external potassium concentrations in a 
Na+ K+ ion efflux transporter NahK, suggesting an increased K+ ion efflux activity restoring 
the ion balance (Gundlach et al. 2017b). This leads to the conclusion that bacteria may have 
the ability to compensate an inhibition of DACs in order to survive.  
Bacteria are equipped with the selective advantage of fast adaption to environmental changes. 
This includes not only the adaptation to environmental stress like changes in the temperature, 
pH or osmolyte availability but also to antibiotics that are given to cure infections (Hawkey 
1998; Casadesús 2012). Bacteria evolved different mechanisms to make antibiotics ineffective 
like enzymatic degradation, alteration of the antimicrobial target or permeability reduction of 
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the cell membrane (Dever and Dermody 1991; Zaman et al. 2017). The development of anti-
biotics and as a result the adaptation of the bacterium is a very dynamic process which should 
be considered in antibiotic drug discovery.  
In addition to its essential role in bacterial survival, c-di-AMP has also been reported to be 
involved in cell wall homeostasis for example by modulating the cell turgor e.g. in S. aureus 
(Corrigan et al. 2011; Commichau et al. 2017; Commichau and Stülke 2018). The cell wall is 
an essential organ and forms a bacterial weak point. Therefore, inhibition of cell wall enzymes 
is in many cases lethal or leads to virulence defects (for review (Schneider and Sahl 2010)). 
Research on cell wall maintenance upon different intracellular c-di-AMP concentrations 
showed that an up-regulated c-di-AMP level significantly increases the number of cross-linked 
peptidoglycans. This in turn increases resistance to cell wall targeting enzymes (Corrigan et al. 
2011). Hence, a reduced intracellular c-di-AMP level leads to weakened cell wall and therefore 
a higher susceptibility (Dengler et al. 2013; Witte et al. 2013; Cheng et al. 2016; Rismondo et 
al. 2016).  
Bacteria with an inhered sessile lifestyle are highly tolerant to antibiotics. Infections of biofilm 
forming bacteria usually need higher antibiotic doses over a longer time (reviewed in 
(Gebreyohannes et al. 2019)). As it has been reported for c-di-GMP, in a plethora of different 
bacterial species also c-di-AMP influences the biofilm formation in e.g. S. aureus and Strepto-
coccus mutans (Corrigan et al. 2011; Peng et al. 2016; Valentini and Filloux 2016). 
It has been proposed previously that single enzymes might not be a good antibiotic drug target 
as they are prone to develop resistances very rapid (Silver 2011).  
A leverage point in the future could be a combined antibiotic therapy of a DAC inhibitor and 
antibiotics that are already on the marked as it is already described for M. tuberculosis infec-
tions (Silver 2011). A reduction of the c-di-AMP level has been shown to increase bacterial 
susceptibility to already existing antibiotics and for some bacteria the absence of c-di-AMP is 
lethal. However, it should always be considered that identification of new antibiotics and the 
development of resistances is a very dynamic process and resistances will probably occur soon 
after the first treatment (Ventola 2015). In order to combat antibiotic resistance, research should 
additionally focus on understanding how adaptation and therefore resistances develop.  
In addition to what has been reported on c-di-AMP in literature, our structural and biochemical 
characterization of CdaA unveiled important information that can be used for inhibitor devel-
opment. As discussed previously it is assumed that in contrast to DisA, the active CdaA dimer 
is only transiently existing and is formed upon ATP binding. Therefore, it seems to be expected 
that CdaA comprises an amino acid which is able to lock ATP in the active site until dimeriza-
tion will take place. Indeed, a tyrosine (187 in L. monocytogenes) has been shown to im-
portantly contribute to the cyclase activity. Structural analysis unveiled that this tyrosine is 
positioned in the active site and is able to lock an ATP molecule by p-p stacking interactions. 
Upon dimerization this tyrosine is displaced by a threonine of the second CdaA monomer form-
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ing the active dimeric assembly. These biochemical and structural data help to interpret frag-
ment hits that were identified by using the fragment screen approach. Three binding pockets 
were identified on the surface of a CdaA monomer. The first fragment binding site (binding 
site I) is positioned in the upper part of the ATP/c-di-AMP binding pocket (Chapter 5) and 
involves p-p stacking with the tyrosine 187. This leads to the assumption that a potential in-
hibitor should be large enough to span between binding sites I and II (Chapter 5) and gain 
binding specificity by forming additional interactions outside the ATP binding site. Some of 
the fragments positioned in the first and second binding pocket are either protruding out or into 
the ATP binding site. Further fragment development might result in a specific inhibitor which 
hampers dimer formation as it is assumed that a catalytic CdaA dimer is only transient. In order 
to make potential CdaA inhibitors into a real future drug, physicochemical properties need to 
be considered like molecule permeability and accumulation in the bacterial cell (Jones 2017). 
Sintim and colleagues have been successful in identifying four DisA inhibitors. However, fur-
ther optimization has been difficult and failed due to permeability issues, easy metabolization 
or low bioavailability in vivo (Spencer 2003; Opoku-Temeng et al. 2017).
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Chapter 7: Summary and Outlook 
7.1 Summary  
One major concern of today’s life is the increase of antimicrobial resistance and the rising 
number of multi drug resistant bacterial species. There is an urgent need of identifying new 
antibiotic drug targets since resistances threaten the repertoire of available antibiotics.  
Cyclic di-AMP (c-di-AMP) is the only known essential second messenger mainly found in 
Gram-positive bacteria of which several are known as human pathogens (Woodward et al. 
2010; Luo Y and Helmann 2012; Mehne et al. 2013; Gundlach et al. 2015a; Commichau et al. 
2017; Gundlach et al. 2017a; Gundlach et al. 2017b; Commichau et al. 2019). It is involved in 
many cellular processes like cell wall metabolism and DNA integrity scanning (Corrigan 
Rebecca M and Gründling 2013; Commichau et al. 2019). c-di-AMP is synthesised by proteins 
containing diadenylate cyclase domains (DAC) (Romling 2008; Corrigan Rebecca M and 
Gründling 2013; Blötz et al. 2017; Commichau et al. 2019). CdaA is the sole DAC in the human 
pathogen Listeria monocytogenes, which is also conserved in many other human pathogenic 
bacteria (Rosenberg et al. 2015; Heidemann et al. 2019; Tosi et al. 2019). Since c-di-AMP is 
also essential for the growth of these pathogenic bacteria, CdaA seems to be an attractive target 
for the development of novel antibiotic compounds (Corrigan R. M. and Gründling 2013; 
Zheng et al. 2014; Rosenberg et al. 2015; Opoku-Temeng and Sintim 2016a; Commichau et 
al. 2019).  
This work is focused on functionality and regulation of the most prevailing DAC class CdaA 
from L. monocytogenes and the c-di-AMP receptor DarB/YkuL from B. subtilis.  
Here we report new crystal forms of CdaA from Listeria monocytogenes in its apo-state, post-
catalytic state with bound c-di-AMP and two catalytic Co2+ ions as well as in complex with 
AMP. The comparison of the determined crystal structures revealed a tyrosine side chain 
(Tyr187) positioned in different orientations but locking the adenine ring after ATP binding. A 
mutation of Tyr187 to Ala unveiled its essential role during catalysis. This data enables the 
suggestion of a slightly different mechanism compared to its homolog DisA which is also 
known to synthesize c-di-AMP. Each monomer of CdaA needs to bind an ATP molecule, sub-
sequently a dimer is formed in order to perform catalysis. We suggest that this dimer formation 
is only transiently existing which is different to the stable associated DisA dimer comprising 
DAC domains positioned in a head to head assembly. This is an interesting and important as-
sumption and helps to develop CdaA specific inhibitors that prevent dimerization. In order to 
identify potential compounds that reduce the CdaA activity we used crystallographic fragment 
screening. This approach requires well diffracting (~ 2.0 Å) crystals of CdaA in its apo-state. 
Obtained apo CdaA crystals belong to the space group P212121 and diffracted up to 1.7 Å res-
olution. Furthermore, the active site of apo CdaA in the crystal is exposed to solvent channels 
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making it suitable for fragment screening. The results of our first crystallographic fragment 
screen unveiled three fragment binding sites in CdaA. Some fragments could be used to design 
inhibitors capable of preventing CdaA dimerisation and ATP binding due to π-π stacking in-
teractions with the side chain of the Tyr187. Additional in vitro and in silico experiments are 
needed to come up with a potential CdaA inhibitor.  
Furthermore, we showed that the phosphoglucosamine mutase GlmM inhibits CdaA under hy-
perosmotic conditions. A phenylalanine 155 which is exposed on the surface of GlmM im-
portantly contributes to the CdaA regulation. Further biochemical and structural experiments 
on how GlmM inhibits CdaA might also help to develop CdaA inhibitor which is based on the 
inhibitory mechanism of GlmM.  
Beside studying the regulation and inhibition of CdaA it is not less interesting to understand 
more abound the function of c-di-AMP. Up to the present time a plethora of c-di-AMP binding 
proteins have been discovered. Many of these proteins are involved in potassium or osmolyte 
uptake (Gundlach et al. 2019). c-di-AMP was identified to bind to conserved domains like the 
RCK_C domain or the CBS domain.  
It has been reported that B. subtilis carries 16 CBS domain containing proteins. c-di-AMP 
binding assays resulted in the identification of the CBS domain protein DarB/YkuL as a c-di-
AMP receptor (Gundlach et al. 2019). Homologs have been identified in different Gram-posi-
tive bacteria like L. monocytogenes (CbpB) (Sureka et al. 2014). In order to get further insights 
into its function we crystallized DarB from B. subtilis in presence of c-di-AMP. Here we report 
new crystal forms of DarB in its apo-state and in complex with either c-di-AMP, 3’3’cGAMP 
or AMP. All determined crystals diffracted to a resolution of 1.5 - 1.8.4 Å and exhibit the same 
crystal packing (P212121). The crystal structures revealed two DarB monomers in the asym-
metric unit forming a disk-like dimer. Surprisingly, the difference electron density map of each 
complex crystal suggested one of the described ligands in each of the supposed nucleotide 
binding site. This is different to the CBS domain containing protein OpuCA which is known 
to bind only one c-di-AMP in an extended conformation (Schuster et al. 2016).  
 
7.2 Outlook 
In this work we succeeded in crystallizing CdaA from the human pathogen L. monocytogenes 
in its catalytic active dimeric form and also in its inactive apo form. The reproducibility of well 
diffracting crystals of apo CdaA provided the opportunity to perform a crystallographic frag-
ment screen. This resulted in the identification of eight unique fragment hits. A next step will 
be a follow-up campaign in order to identify lead compounds. The resulting compounds will 
be used for in silico docking experiments which will be computationally scored. We aim to 
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come up with a compound which has an increased binding affinity to CdaA and inhibits its c-
di-AMP synthesis.  
Since c-di-AMP covers important regulatory functions in e.g. osmolyte homeostasis yet an 
excess of c-di-AMP is toxic to the cell its synthesis needs to be regulated. Here we succeeded 
in identifying the regulation of CdaA by GlmM in L. monocytogenes. We were able to show 
that CdaA and GlmM form a complex under hyperosmotic stress. So far, no crystallographic 
data on the GlmM-CdaA complex are available, therefore we aim to crystallize the GlmM-
CdaA complex in order to get further insights into the inhibition mechanism.  
c-di-AMP has been shown in several studies to bind to diverse binding partners. During this 
work we were able to crystallize DarB/YkuL from B. subtilis with bound c-di-AMP. Our col-
laboration partners were able to identify its interaction partner and putative function (Krüger 
et al. 2020, manuscript submitted). These results form the basis for further experimental work 
like crystallization and biochemical characterization. 
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8.1 In vitro diadenylate cyclase assay  
 
Figure 6: In vitro diadenylate cyclase activity of ∆100CdaA from S. aureus and L. monocytogenes. L. mon-
ocytogenes ∆100CdaA was cloned as described in Chapter 2. The S. aureus ∆100CdaA plasmid purification sys-
tem was generated synthetically using the BioCat gene synthesis supply service (BioCat GmbH, used vector: 
pGEX-6P-1). Purification was performed as previously described for ∆100CdaA in Chapter 2 (Buffer: 300 mM 
NaCl, 20 mM Tris/HCl pH 7.5). The tag-less proteins were used for measuring the conversion of two ATPs to c-
di-AMP. The cyclase activity was measured with the quantitative coralyne fluorescence assay (Zhou et al. 2014) 
as described in Chapter 2 (Heidemann et al. 2019). Three independent measurements were performed for each 
sample. 10 μM Δ100CdaA was incubated for around 1 h at 30 °C with 100 μM ATP and either 10 mM MnCl2, 
CoCl2 or MgCl2. The control measurements were performed using ∆100CdaA constructs without addition of any 
metal ion. The results suggested a similar metal dependence of CdaA from S. aureus and L. monocytogenes. 
According to our results Mn2+ is the main cofactor for CdaA from both organisms. However, activity in presence 
of Mg2+ was neither observed for L. monocytogenes CdaA nor S. aureus CdaA.  
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Figure 7: In vitro diadenylate cyclase activity of ∆80CdaA and ∆100CdaA. Construct ∆100CdaA was cloned 
and purified as described in Chapter 2 (Heidemann et al. 2019). For the purification procedure the longer construct 
∆80CdaA was, as previously reported for the ∆100CdaA construct, equipped with a GST-tag. The ∆240cdaA 
allele was amplified using the primer pair (JH003 forward 5’-CCGGATCCTTCCAACCGGAATTACGCCG-
3’)/JH005 reverse (5’-GGCTCGAGTCATTCGCTTTTGCCTCCTTTCC-3’). As a template the plasmid pBP119 
was used (Rosenberg et al. 2015). Subsequently the PCR product was cloned into the pGEX-6P-1 expression 
vector with the restriction sites XhoI and BamHI. The resulting plasmid encodes the purification construct 
∆80CdaA with an N-terminal GST-tag. Purification was performed as previously described for ∆100CdaA in 
Chapter 2 (Buffer: 300 mM NaCl, 20 mM Tris/HCl pH 7.5). The tag-less proteins were used for measuring the 
conversion of two ATPs to c-di-AMP. The cyclase activity was measured with the quantitative coralyne fluores-
cence assay (Zhou et al. 2014) as described in Chapter 2 (Heidemann et al. 2019). Three independent measure-
ments were performed for each sample. 10 μM Δ100CdaA and Δ80CdaA were incubated for around 1 h at 30 °C 
with 100 μM ATP + 10 mM MnCl2. The control measurements were performed using either the wt ∆80CdaA or 
the wt ∆100CdaA construct without addition of any metal ion.  
No significant difference in activity was observed comparing the longer ∆80CdaA with the shorter ∆100CdaA 
construct.  
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8.2 Superposition of in the PDB available CdaA structures 
 
Figure 8: Superposition of in the PDB available CdaA structures from three different organisms. All struc-
tures show the same non-catalytic dimeric assembly in the asymmetric unit. L. monocytogenes ∆100CdaA (blue 
and light blue) was crystallised in two different space groups (dark blue, space group H32 (PDB code: 6HVL); 
light blue: space group P212121 (PDB code: 6HVM)) (Heidemann et al. 2019); S. aureus (light brown, space group 
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∆80CdaA cyclic di-AMP synthase A lacking the first 80 amino acids 
∆100CdaA  cyclic di-AMP synthase A lacking the first 100 amino acids 
°C Degree Celsius  
2YT 2X YT medium (yeast tryptone) 
3’ OH 3’ hydroxyl 
3’3’ cGAMP Adenosine-Guanosine-3',3'-cyclic monophosphate 
3’dATP 3’ deoxy Adenosine triphosphate 
5’pApA 5'- Phosphoadenylyl- adenosine 
Å Angstrom (1Å = 10-10 𝑚) 
Ala (A) Alanine 
AMP Adenosine monophosphate 
Asp (D) Aspartic acid 
ATP adenosine triphosphate 
Arg (R) Arginine 
B04 Acetamide, 2-[(cyanomethyl) methylamino] -N- (6- methyl- 2- 
pyridinyl) 
B06 Benzeneacetic acid, 4- fluoro-, hydrazid 
B2H bacterial two-hybrid 
BDC Background Density Correction factor 
BHI medium Brain-heart-infusion medium 
B. subtilis Bacillus subtilis  
Ca2+ Calcium ion  
CaCl2 Calcium chloride 
cAMP Cyclic adenosine monophosphate  
C08 Benzoic acid, 4-(amino methyl)-, methyl ester, hydrochloride 
(1:1) 
C11 1H-Indole-3-ethanamine, N-[(1-methyl-1H-pyrrol-2-yl) methyl] 
CBS cystathionine-beta-synthase domain 
CC Coiled-coil 
CdaA/DacA cyclic di-AMP synthase A 
CdaM c-di-AMP synthase of Mycoplasma 
CdaR cyclic di-AMP synthase A regulator 
CdaS cyclic di-AMP synthase S, sporulation-specific 
Abbreviation 
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c-di-AMP Bis-(3'-5')-cyclic dimeric adenosine monophosphate 
c-di-GMP bis-(3’,5’)-cyclic dimeric guanosine monophosphate 
cGAS cyclic GMP-AMP synthase 
Co2+ Cobalt ion 
CoCl2 Cobalt chlorid  
C-terminal Carboxy-terminal 
D07 1H-Pyrazole-4-acetamide, 1,3,5-trimethyl-N-2-pyridinyl 
DAC Diadenylate cyclase  
DarB/YkuL c-di- AMP receptor protein B 
DFG Deutsche Forschungsgemeinschaft 
DESY Deutsches Elektronen-Synchrotron 
DGC diguanylate cyclase 
DisA DNA integrity scanning protein A 
DMSO Dimethylsulfoxid 
DNA deoxyribonucleic acid 
E01 Carbamimidothioic acid, (2-chlorophenyl) methyl ester 
E. coli Escherichia coli  
EDTA ethylenediaminetetraacetic acid 
EMBL European Molecular Biology Laboratory 
ESRF European Synchrotron Radiation Facility 
GDP guanosine diphosphate 
GGDEF domain Gly-Gly-Asp-Glu- Phe domain  
GlmM phosphoglucoseamine mutase 
Glu (E) Glutamic acid  
Gly (G) Glycine 
GMP Guanosine monophosphate 
GTP guanosine triphosphate 
GST glutathione S transferase 
H04 Butanedioic acid, 1-(2,2-dimethylhydrazide) 
H1 inhibitory helix 1 
H2 inhibitory helix 2 
HhH helix-hinge-helix domain 
HZB Helmholtz-Zentrum Berlin 
HZB083 GMP, Guanosine monophosphate 
His (H) Histidine 
Abbreviation 
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IC50 50 % inhibitor concentration 
IPTG isopropyl-β-D-thiogalactopyranosid 
Ile (I) Isoleucine  
ITC Isothermal titration calorimetry 
I-site Inhibitory site 
K+ Potassium ion 
KD Dissociation constant  
kDa Kilodalton 1 kDa = 1.000 Dalton 
LB medium lysogeny broth medium 
Leu (L) Leucine 
L. lactis Lactococcus lactis 
LSM Listeria Synthetic Medium 
lmo/L. monocytogenes Listeria monocytogenes 
MDR multidrug efflux pumps 
Mg2+ Magnesium ion 
MgCl2 Magnesium chloride  
min minute 
Mn2+ Manganese ion 
MnCl2 Manganese chloride  
mRNA messenger RNA 
M. smegmatis Mycobacterium smegmatis 
M. tuberculosis Mycobacterium tuberculosis 
NADH Nicotinamide adenine dinucleotide 
N-terminus  Amino terminal 
OD Optical density  
ONPG o-nitrophenyl-β-D-galactopyranoside 
PanDDA Pan-Density Dataset Analysis 
PAS Per-Arnt-Sim 
PCR polymerase chain reaction 
PDB Protein Data Bank  
PDE Phosphodiesterase 
PEG Polyethylene glycol 
PETRA III Positron-Elektron-Tandem-Ring-Anlage III 




PPi Pyrophosphate  
PYK Pyruvate kinase-like domain  
RCK_C regulator of conductance of K+ 
RNA Ribonucleic acid 
rpm Revolutions per minute 
SAM S-Adenosylmethionine 
SAXS small-angle x-ray scattering 
SDS sodium dodecyl sulfate 
SDS-PAGE SDS polyacrylamide gel electrophoresis 
sec/s Second  
SEC-MALS size exclusion chromatography with multiangle light scattering 
Ser (S) Serine 
S. aureus Staphylococcus aureus 
S. pneumonia Staphylococcus pneumonia 
SUMO small ubiquitin-like modifier 
T. maritima Thermotoga maritima  
tRNA transfer RNA 
Thr (T) Threonine  
TM Transmembrane domain  
wt Wild type  




First and foremost, I am grateful to Prof. Dr. Ralf Ficner for the opportunity to work on this 
amazing project. His continuous support and encouragement over the past few years as well as 
his fruitful discussions and many ideas. Thank you! 
 
Additionally, I would like to thank the members of my thesis committee, Prof. Dr. Kai 
Tittmann for his ideas and helpful advice and especially Prof. Dr. Fabian Commichau for his 
continuous support, many discussions and ideas as well as a rewarding collaboration. I would 
like to thank Prof. Dr. Rolf Daniel, Dr. Till Ischebeck and Prof. Dr. Carsten Lüder for willingly 
accept to be part of my extended examination board.  
 
Furthermore, I would like to thank our collaboration partners from the microbiology depart-
ment, Prof. Dr. Jörg Stülke, Dr. Johannes Gibhardt, Christina Herzberg, Larissa Krüger and 
Rica Bremenkamp for the excellent collaboration. 
In addition, I would like to acknowledge the work of our collaboration partners from the Helm-
holz Zentrum Berlin Dr. Manfred Weiss and especially Dr. Jan Wollenhaupt for all the help 
and tips concerning fragment screening.  
 
I am very grateful to all present and former members of the Department of Molecular and 
Structural Biology for the nice working atmosphere. In particular I would like to thank Dr. 
Achim Dickmanns for all his advice, answering all my questions and his constant efforts to 
keep the lab running. A special thanks goes to Dr. Piotr Neumann for never getting tired of 
answering all my questions concerning crystallography but also all the non-scientific discus-
sions and amazing synchrotron trips.  
Furthermore, I would like to thank Beate Heinze, for all the work she does for us so we can 
fully concentrate on our research and Anette Berndt, for being the best lab partner I can think 
of. Thank you two for all the nice and funny discussions but also your words of encouragement.  
 
Thank you, Kathi, for the everyday coffee and the chitchat about life and work. Thank you, 
Alaa, for expressing your passion about food or your thesis project which makes us all smile. 
Thank you, guys, for all the exhausting but lovely synchrotron trips, for your help and patience 
during long nights were we all together measured hundreds of CdaA crystals. You guys are the 
best office partners. Thank you, Flo, for always offering your help, for your patience and for 
your comments on my thesis. Additionally, I am grateful for the valuable contribution of my 
master students Liza Vinhoven and Patrick Kloskowski.  
 
Last but not least I am grateful to my parents, my little sister and Janek for their constant un-
conditional support and their encouragement. I would like to thank and all my friends who 
always had a sympathetic ear.  
 
Thank you all!
 
 194
 
